var title_f0_26_416="Visible vessel GU Endosc";
var content_f0_26_416=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric ulcer with a visible vessel",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcer in the gastric antrum seen on endoscopy. The visible vessel appears as a small protuberance in the one o'clock position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eric D Libby, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_416=[""].join("\n");
var outline_f0_26_416=null;
var title_f0_26_417="Diagnosis of adrenal insufficiency in children";
var content_f0_26_417=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 656px\">",
"   <div class=\"ttl\">",
"    Diagnosis of adrenal insufficiency in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 636px; height: 406px; background-image: url(data:image/gif;base64,R0lGODlhfAKWAdUAAP///wAAAIiIiLu7u0RERCIiIpmZmd3d3WZmZhERETMzM8zMzO7u7lVVVQAz/3d3d6qqqhFB/4ig/1V3/zNc/6q7/3eS/+7x/8zW/5+fn9/f3z8/P8/Pz19fX+/v7w8PD39/fyJO/x8fH0Rp/7+/v93k/5mt/2aF/7vJ/6+vr09PT29vby8vLwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAB8ApYBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbJWAbW2t7i5uru8vb6/wMHCw8TFtbPIybMBynXMzdDRps/Sb9TV2NmY19pp3N3g4Yrf4mPk5ejpfOfqXezt8PFu70sCBJMBA3f2RvTy/wDNGSFgS4ASfvmMDCCXkMpCIQ+ZRGTCj4BBAA3RZETCr4i/gCBDZvlGAAGAhQuSdDwycUvLJi+ZWBSy0UxNIyuHfBTJs+cT/5ImASQwIKBWgZRFa93Ld8CWAgYFjC5caCBhg1oJiAgokCDA06a1nkYNUODhAQW1TG6NKtboEAYBUg5JAMFe1VpV0QYwQIQBwQAJmuozUACAga4BBCxEexRA0sZXASOwdeAxUlv3PPrczHkKUMNxE6R80GBBQoT6hDSFEHHhxXxbD+AswADqRQCrWzNrYPKA6NgMhsZUIOBAAQMLslZ8bXArkYUMVCckDIDAgyEoATQoLRoA6dg69SUfXfp0ZiI7O6vfTNKWgbtGqTteOmDB3726wyMIWqRjSfvu5TcWXh0dFxNpCEBQgAANzFfda4MVRsQDgBU3XWEDoEXAAhFtBf8fWfuhN9gtx0mYE03rpagiegPxN94QpqXUAH0IKAAAXAZAdxI1sBUgW3/3+GZAjTfiF0B0D/GmVWYGHllEcoU1kEBz91hHU4RHmNYUXwRIKARvESmAwItCgEcTBACQmWZc2p2n04pwrvfZEEkFYNJkXtE3QFdRGcAAYxMl9FdWdNrS4J5k7fUnWWbpFUBlTPrJWBFTAgDBow7eVRWW2NmiVliF/XXUQmHJVqdJgwKAZ2WeqhqWmyjGKatP6ZVxYiIxfVHrrLyCs+sYtyKSqxe/9mqsNMXKeeyy8CSrnrPMRvsKtFbMZEWwUxBEAKmpBUKttOCm8i0V1laR07BLQJD/QHTEOQikHuOGK+8o8UpRLhXYRtFRAt0KUu+8AHfyrxFgeRVdZIlhRBgCA4zFpV4mwaeWmw+tZbBfWAlmmI+5LHhPw7UIwA/Ie2GkF19n1cJbZlaGMXDAMF/y8hGrgTdTAA0KxZe61X2MqRBVMXAuM8AJ5yRuF7prnlC38TOUpVkl7NyMQzR1gNVizBzz1pFoLQSAeIX4IEb6FFzLATNZbYCjkD5HdKTeVagxdR2Zh3WZBJj9aNLHEWHRA/yB4TXXhC8yOJE4blXbgmQL8fQQaT9awHWXtt2pu31/vTeXhdWtj9NN3/P4lRu3+RxXcrlc+OqoDI5on4smwHhDJIdq/5DVjz06NOY5tpqUAp1ntjSiiY08VmFJp4yzEArAqivr0JMyuCjB9St49NiDMn0oD9hIxvbZh48H+OqQL/75cpiPjvrot88G++LA7/78Ns0rP/34qy7v/fn3z4UxAAygAAdIwAIaw38IVBH/EshA9y2wgRAM3wMjSEHWTbCCGNzaBTPIQft18INXMKAIR0jCEprwhChMoQpXyMIWulAXMNugJmS4Bxo6YxoxBIgN87DDOfTQGjn8xw/tMEQ4FPF9QZTHEX0oLhwGbImQgGIcpLgGKp7Biq7AouGy2MRSaBEVGuBArDigAXRwQAQZ8EAAPJABEYixFGdM4xrb+MZPxP9RjWx0oyfuOEc9MkuNG8hAADKwgTWmo5AfCEAiN4AKRCoyAIwUhSMXCYpJQhJcHcBFB9QhyFtkABWdtMUnRRHKWozSE6UcJLg4gIs6okMEthCBKmBZC1mSgpYBsCUocKlLaRWyFpFUBwhsAQJVDLMWxSTFMQOQTFAss5nSCuUp06EBW5QxFdWsxTVHkc0AbPMT3fymtBL5AXlkcpOrOOcp1DkKdsprmNBUBwkCQAJWzLOeprgnKfQ5r2qKUx3oZEVATTFQURQ0XPgEoUIXytCGOrQSL4woDJMg0YqW0CMWlShGM8rRYTSioy+8IUSV8MV5aIYS3CjpFT86UjqoNAr/73hpFU+KD5q2jqUoFWlOKRqLlLb0TaqQaT9+mj5LxLSnNu1aUp24xZ0ykahDhYVPnRqrLja1pi7dgnESFoZ7/YSkSGURFnL1kpvgxHm0WKoXvIo3t00BXVgQqlqjwFYkmPV7Om3CX/hihAeg9Qh3LcJDrFVXJhxVqnNdwgL0sqCyDsCxFPkrFabKBcKEZQD3qhjFPpKP/FyPEe8w23WOUNh+WE+wz4ArTPOq19sUoQGuJelplUDY2DrhsFmo673ydRDJrlSsUPBNUBhE1pTO9l1boKwWLsVXBNjDtu6CSHo8+zzQKgFrGcpZEUrrkeNKt7pPfcJMFgOYBcCnYE8h/69o8PQzALRrCA14AFXcQwCIQQG3UqhTA9Dm2uUsqQmdfUa+LOuVARQlZ4w7jFJSd9/EqsR7nUJLdwKMG0d1Cy4MpovFnlIdpURntcDVQny3a1/NnmRAROAZjI6Uj+Opl8EjwSkS7mYaBigPVfZlXHAgoLwAzzcsUJEKM5R3nQ1/2LCslYlBplIdVLk2N4IySU1I02ShcIgZhPXZjwAM1ik8oDFowyx0d+tb1Lb1CMwVgnMFkICnLQguaGJAA/gKYqBCQQCB25E+SkK2JAmvX8QxDnKU46PgEIU2f4LuEpSbWzoLgQBaNnGlWoJhwlSmQRTWc5X/J2OatTcfSvKNff+0TB3qUK3PXJUOa1K7mwYlx8CFHt2ik7yE8T4jRDMBm5HULGXrqYsoCuDZYC8SuS0jmadToAuJ0+KgmdTJTVSmk41abBQjE2HEWlnQut6c6sk6mCNe+q6qev2QzG0EQQpiEO/EhmcpMBoLSvLb7R6lWexygzgKGBJsUS1usSW30wT7WY0HtJdiVy/fADD3Y5+h6959N3MEIArcuJxVKNia12ND3K7HjRE0USowbD4Ulkdb7K8i293G7tmO2mYR03zOTTxDwD32nemiOTri/aFNAhCQ4L8g4MgNDrETfJMz4t6a3K1eU7+gpJ1KFejQi1N0l+28XK46t9iSbg432Gz/kjanJMBIOro7AF4E7IpJO4EruQAUQKjtKD0iGu9d2LXjatjA7dQnL6p48QJ3J5+ETxsP0aqufQ8c7Qg0BZ93yqcOWCrIemy4q5IA5JMTOFvnMF9f+Jkz96U8Oycprv3TaOtcVShkKCyKETuFF8CWmlSqcrzrcAAIAPTbfnsKbFaKmJF2ABPfBS1PSsiXr7Sosoid09ZNgtku0mP+8r5IF2G9VzL9OkUBash6KTLc+DXrilM1qlL4ctm2VezlxMh01x5KcggF9tgP4VIXWbOEoqKYDd3ovaTHCFTlmjWyZ2FPtQcGEFBm+ud9WGVXVcBeCOB8kZdxr9If6+JeQZEP/8X3dBCoe84BGsWBMNqVf/zXfVR3Ch9YelugAKM3RbT2CPjVCu+mgrf3CSNYgAeod9/3gtJjg4fQgjeYfDOIgkigWvYidQKRdyyIg8ilLwRILEkVWJsQg9/AW4NgQ+wAhHQlhFFAhSRohKGgg5GFe0k4dkLHhFaAhU8wLNTlbmQHhVjAXUoWdOGlEAPDhvqDgNWyZLXgXVWEh56hhXTyhUf4WyEohnRghuPihGc1BnKIfG+IWhJmXhG4duTVGL9zGUrxIIcRHWvnGLbAIQ6DEWOBJzbyEBJDhHy4XQaBf2PFalUgiI9mhSSYLEaGXgywWCqTbV3BYZGBi0D2Yt4Whv8nozHQUV/MdmMP0iVbcYsM0Ci2sHBRkQCRcR3EaGTHI4suhn21UGQFwBYBmIU5OBvaKHOPJl/TJ4lh8XUn4yp4AR8GYBFdEo1joQB6gSYzcTwwVor994NRlnB80SQyUh4pIXOmgSb+1TfH4XJzsTNRYxA8dzWZBjRHA36NV4dCoYemV4gU6YH4Emt0VjMQlm1Rt3bsIjIcRhxMxmd7GIbNURiChyp1twChJhr1ZSqI1li74T0+lnD3UBVohxu/oZEvAWXf5XavZnN0eFV0opFWYzXZsR3nB45SE25EQlgKIBsvuQCx0RQKKXlEMDmM54MsIXb2oCCH5xglAhFl2Wz/VCKW8oE0t6AxniOKbFOUEYlazfiM6FgyFoEnoeJhU7EXiWInYcGWBlONFXaNZKmNdnWO7FgA7MUlBjF9JQORMoiEQlCQ92EAB3AVCNeHj7Yft+CZntJ3vRiIWLInWGMte0Fw63gR/sEwzKBwEXFxqvl0EdFwAsJXEWeBczkOh6iPDwI4Y+khEtIwjUM3iGE7rViZtyBxpLMcDKCAXWlESSCawdEuYTImbDIj50c1M1GdBmGQjuNoS8NvXAl7uymZ0qUPBZCT1xCVj/k5iEaSXJUwC6kxqpYfQskvRAlYzZEVMUkE7okRKXmesBgpcXeU/yUkICltRyaaJ0mapVMd/wqQMzNROfGWnA4iJElSd5o3NkkSOLTpJHGnIxuqdBaId9xoCE8INw3THde5nfSxMavhHaFCchdxoUrzcpboJGfHZgEohdN5fA8QgaTiFaZSjui4nmPjHRGoibXAiW4xnhSWO4uXotwYm3boGMc5NgnBbq4ZHjlqm6oIcczpm4ClDwvhfFrqFjfDKUuIL5FSfUThHlphKF9CpwjjcBz3oK/IKZeSGvdxO2xjLfp1eNIXFR16cc33dMUnp41qjQGgfZXJF9wndIiwopPKPJlRpFPppAqQeaUjKoWhKdayqH+GlsrDmNoBXUBqcReBhTi6pPVDimNpazM6fG1KllEXKP86SjYj6iQl6nInCivCh5y3ipxJI5kxKJeTyRHnkYjRlSXtBQcDiJ7dyATVI251EBzb2KpOcCkfplp/0anv95BlsILidnGiyqWAypc80qudBXiSwiiQKqm+Wak6IRVLuq65upZhuH9L4BseJ6v1gFZF6orSyYNK0D2XAwje2oP2aAfVileW6oIVu4NGqVQGKAnougpcqLDNylS8WYNA9H/UQJwbG7Gc8LFkAK1/eGwhaFpcQIZeObKkhbAw8Q40i4Yp6xDU4FxfwDh8aq1BdXs7Szq05YomFq0wa6VIqwVHm7T3mLHyBrU6uysu+7Bj+AzBUaUmRatFe7Fu5W566LL/HaGG/ypbM2tFhogELrsEcBW1JreIRkCPJoMXJ2YLQJMZk6gwqipddWmYo0h/nvp1CwO2Tsu0biC3ZjaWtie2Q1CNVGEZCWcUC8BemQlk2lEQRICK8ZWmnmJtIJi4kImZCRGM9kVkhXmH5WYQO0YyxWFfWxEW8Tg2dnsEfbuY0XmtpJVjrqthXGEwm2swz+WXabIgsqiMdkKWtFsL8mgQt3ueCcsEXPmUTDOWwbYm/7gUHahpSqqTQxA0D9KU3Du6RMuZcsC4Y8uzMQuH0vWd3RFtlXkdpzGSIuMjBEtlfCYaS7ufXUkP1ruS1dGS+TkADWCTmldqhVEpnceTVukj/1ipKloZuSe4YtsroV7bviqaBJC2cgqsq7axoMSxFWgaF2VBBEBZlVdJnxM8v4iLREnwnK1yIfaWJoQiH8RZE1h6eGtDGZY4nMijhx1bNZ7COEqZKM5omIjyNMWbcgqWMLkoNMHbFmQhe7RXdtlHlshImMrTvW8Kt6qIeEYhw8zWpZ8pNvfya2snbG+zeY7GrABcmoGBKahJGLhpx1fyEAdnuls2m6fqnNBpBDiMnOZ7qRyseHvsLiXBXnbSEQuRAKMlppXrHp6DlmS8vMw6vUcgvmeXNE7HDA8QydkZo2Mrm5RDxwIAo42zuxqMvkZMbwnxvcxQKZdIwqQ1eiJ8v/+7KmDxOXluUcCKYxv4mYQsuyNzZ8Opw8lSJpAcViYzGVttVhnOeHiZ6H7/u2icUl8UahAWyqFCWXNs5zi3gaOVvBzKrKVHpspy2LY3+3xrRyj8oKDN7C5TUSm/upPouzQWcc6ZXLIzxli9Vjq/N8up07c6/AwXR6VjY9BCzMqurHg7DLo/ojt/dXobwshX15kO2m5beceteZsU18pvcX2Fkhapeidnk6exI7TwVXgl8xDJ0cgTd81qKx9/+micq7qHmmlw8aqIEbuUUc6Sd9Kr2h9Ius7+l5xY09NlYqfDuxeOzAzJwTDyqrwU3ZxDDdAvPFNbAAEd6QUMzL7S2x//3sNnRdF7CJ2lTrcu/ACer+Vc8xzPRoOJz/xaHCrXcnd4KEqEy0qg+fWsCKslz9GkXcCtMQaycNukaFuzjJ0Hk0GuYn2+X9MVrjl9aJ2cD7HEfMEPJyIqMkLJdlp8Vlx7qluoj7q6Xpy2PbgrAgs5QniwRWCC65DUSCDbZzbbPWux/RwGCnCR6HsFi920Iavbias9tI3Y/gyxkAsHwd1bWlDMiQDdnsDOHJuCb9sGiTjEVlXcq3wG6vvFTqAt+HhFvh1Cx021yV21TdDcXZDdDn1Ty/20ZkCFQCjdUNOtHeqFhpUad8Xe7x2FUKXJ6r0H7r3V3UW275PfcfWCrLi2//8W37/9leZCgA3R4OYNWiDVQtYtuxbhl8xWEfYFoHQqjMtb2u9Yu41piY/41U5bKxYOpth8BY61tGllqZFojng7isVbFYEbqWLcG3qxX1msvNBoYcrrxdJdMATWGBQGjvrYl3NKFqlTMAuYxUOAuaVbjB7TFCkBHSTzxv9dhDDoti1py+F7JBWhZUcQlVoGzBDMwgBqI/O4j2A+3CItszBV3u6g4Bces0uJaQN65lJcwurJnkQQNHhXwMHKLwecx7shWfZ9ItWreU7eJPBLHv9FdzbcLxU+oP9ZESahJE+jYiGdDH2df65NE2Xaw2fjX3dTJltabGQq1Gtaxc5GAP9iOdZ3vrr54OTWQYvLk+VM4RSzGORkI4t29YmBadWaB+LDGOI0PbbOkTSsftW1mqXVLmiRe8fldsew+Zp1/opPwA+XjHQSPKkR8SHhpps4B+NJQ6gfM8cM2ZaPqwyn7oamaCnWXp5XXXKqRqOQ9yjfbGB/nDcBgCa4+ruoCLn+cGrDzpCV0ZFSEzXdwpEiQsQD6xEK+eaa5/DNXiVt3hvdEe0N28lYwu+WE9GvecqZeR4DH6ygxqF+xtfjzp7sYu7OsSd6qiZa4T0Djx4e9+6sySRKqjORvQzGTVqce7ZG0e+K5zdGYayPUtoFL3vZuKRDuo12XtwK95u9oZl8cbr/e1Mfl5m5CJcPDWdX8Kp5346WvKea5vsNnCobSUOlUY3ZRNP0VxPkqkvkx5somtfFylrzq6uqFLZVbKenTorJk20nqiviYx+qQ++QqVE7c2vqSZ8IpaXd8MWhJzbyztw4w9frNmJ4oU/6RcIXey2lHS/zbVxssUry2poHgl3qWy8K9w6IAqMI4PrC/iB9aJEazdPUeGsLJxyviRLlJYP8fTKRB/6WUt16Hx/we+/Dsu+4dgDb9c7d032pGc5RjR1FYX4E2Xqmy+WHs7rr0a2yAe4vb5BQXJ3eGrvbS8Cwaj//3M+7+b+yhgwEAOGQWDQekUnlktkUBpxRKRE6tV6x/8sqcpv1fsHYLmCMHZTDQ0KAkB2j03H5FT63F+t3vTe/N/b9Av+UAAUN5d7CzvYgEhj48A4l7Qon6SwxtTIHNy3zKufW2ugGjhaNDgoCBMISwU7vBEbd8AJsb3FzdXd5e31/gYOFbzvjQIv3jpOHmZudn20J92SPGh+XCFj/So1giR5mCbmlqbwGVKMPFGwfABbWAxoAGmwVGN5t5YfU2Q9uDWgh0ySQIKKCm5QdbKWQDCZqbsYR8TakgTYtEblEypKA1aIG8hYkGCBAwRCSjxQIIHnkozuRDwMyLCeTJhMNHJ4I4aChpp2bOQHs7KknYSBAAm4tyEagAIJ/AAjAQ/8AgNqABAESGPBnywC6AguoJs0GwCvYABHPEeMXAIGBWweQBvg6z1YCp7YOkBtSVIi/vIsKAISqlZ4CA3dtIThQWLCQwEIIGIApZmjDypeFeAiwIUOADBsCeMAcRjNnz6BFj07DN9mSBWfVKMg7BEFJAm3OwG3DEYABR5PJPng9buyQAu1gD+HtceqBBEpZhQT7oGKB2WQwHnGFhTfSeSCTUy1w0oiAAkRaDgduhfWh9qoPdcjVAT4Y+bjo1wfzntKSrkSKE+AquaBixS9Z/HpCNwAYQKyt89QQoMFbpgovQcBwMWAst25paqq9suNkLy84XAeAtdqJKwCA6OFKxcb/ToQnxXAuGYo//fbgIBeccMRCR1x47JEyhfoYLsITA4AAgAfOG+vA3VgRkAFq3EIJASMhE6BKABSoMKLuoGjgwyxdAksI865LkonthGziRj/ebFMO0GzZQM4r6Nzszih+skwogY4SS5s15GrSwAAWtAorgKhZq6mwbIHOUS+JKBGKtRANkEKo6gLgruu002hPvRTiQIQMNPMgAxGCHDWTzmzJwNUoYPVs1iVK6+yz0AiK89Yk2Px1RJpA+yAAY+0UFhNjP1CWCWadReK+W/IDNNo7glXWVzlqjfVaSUAIAIRvkQh3XHKH+PGWVovZ9tts9Qsvo5pEuEUEdA3RIACe//AlQl9++80z2V77XWgmLIorLor1mJhI3lBrCteWcwveg4SKibi44lplLcjda+GNQmErGGYvxINl0tcWgDFu2eU9oD3o42jhbTEBSBUwq6sMx1JxgbhyXjIpCtNasUCmUARgEUwH8M0Wi4atSb5qX67a6jDMJfJqKbJFU4jXwEKgjXjILBBLsD0dW8kzR8kKgEagku07lwbwaJSzCGhn3ppICEBjOaEJXPDBn6mF8MMJp+lfrbd2IlsExvxP6fOSS1hLCHuD8Bzx2Jqyja3eKu6xwQAT7KwB1iHATJRporrNmQEX9XW+GYJdW9nPtO7rAMBqYGxu8s7ybN7nCSerlf8AcPvIuYfzCLxxxBSxcaKmjxqo2KvfO3vtLSuC0JuBNosbDjWMMqnwGRjQnpDYKtrQvmRUGooFVFlnAELnwn371bYPuT7bZ4U4AQ6QgLnQn7D4UkAFQqM12fMffMqwQAlOEID8w0wFCVajW8EOg/E6oAc/WLEOfmGEJCRXAhHYwExMZBo0Goj1hjIy/ZXQRhccDQ0RMqQNqjAJazjUyazAQiecomREKCLEYCi5QFiOCTJkXfeqhkMNVqYOokCGE9mjwwDyEAlMQZQ/gDgFITZhjEg4ovSgmDlDYLGHUJvh1qSYRRtWwxGbeAgbuaZFV3GwiWIjABg5xQYGnOEMbkH/x11KAjp7TMRninLbUgrgFWo8IClJOyPuxqBEnC0AbkN4zTWEYLNNkmFn/8gGA76ntKs80o1PjKNMXpnHOZbHhZK4YyvlmMstUg8bCDgDUkZSAAYwICW/fAIrEGAdQPYlSd7AUvJY4RtUyo2IaqMISF5SS2DhToloExsDeNcVuOgjd7Px5tj0YbkzgJI30sRjBG8YRrbpUSF9qsKfaoIG0EmmHjp7lBDOoIoEtKgdSSPkiuKSPyQlJiqJWWgAFglRrKwuhC9swuiuUDS9EQGcmCMQgxKAOTdx8QgEmEqLBgC5M/lyC7B5yFmU8g9vKDFBZDhAcarJOQQwYHSRuSTr/zKJOcltLiWGQUBFiKBSIQyVcsAbFCsoyZGaZgqX14OhUo3CjYdpR55U0eaaepKr0/CqJ3CgxjnJQE6AwqYAbXAL80RiTOksSa13xA2i9tFM2JiUe1E4BkatoIB2QACvRlSASJ6gJkPKElt9XGgwhzkeWLj0biktCTgN4MzwdMcROA3AIyaTlfSc5axbRWNQPUk831HFLsl7jhF15w7V/g4yelPYa5wTpc7qFpRW9S1W4dRVKnT1p0hs3XyoaEa3aq6pRTjFWEoHmcxWgUO2EOktkXSAmHLlFMB9ouOkgNGkUcewSc3ZOXpLFgEolQ1tUABTGNufXgrBKaUgFAEG2f/SUry0bldRxXSL0MhVAqQ4xJSLLNJXDwZYsg0/DVZ1VxE+2ZaCSUZIpYSTQ75snMGhjiQwK5D6xqSOKZD4Ja9JSrIPeMjjvvnl8FtguuJRhgecFE0ABMxTv0e0KKLreC0MGaIuW7ALlsqVbe9oK5EqQDdMzzvFXMuTYichqjYMWlF3SfzdkUYBo+kRCdzENg+ooc4pblynVR6xihuPR6Rg5SW6FCDcB8okfelNYxqxap5hpgTMbQhxKGehZ2IKwJjYecJIUnzktBl6CClJhQFCIp4DpE8y9uASofdK4lg2QWCXMesoMIyR53bkUvGDhYpIzD6xHeoAivovlvsKXi7/N6anBgAnBPLmGxsrKX1ro2+GSFlm88R3DpvOZ0VVA88R0+ZD6711rn/smMYodb2T1eoAFgNRAzCV0UKgDgIgMB55PCQwiGlfFYBr7CVwzNMnpKcSuvy8eWQlJDcjQgLaERJf9/pMJVlRSKbUZosWu3/IviEa8yxMnoKY3gmwN0UCrXDJtnRt4TEP2lYrr5CcpwHdGUVgyLNW+mr6MjFL7rvenQR04CV+rLWScwe00d483B+vacyw/UrSq8354Lgz9/1sgV+XcynLa2Fx0PNLG7yQ9imhLgJvCJsXcrNIpugmeWWy1m6UT3GPOqeEcMlYwQeWEQ9gb6zB0aXuJSxO/+sgSzn2zp5VM3SBhYQdEwNaFAAm5QIpgnkrUJXgsBCZ1ttG+xo8xqOL3ND3q769c8vUvoS/nVxmZkeCw94+uzcHNw0svE0duWRp1In8CX4PVh7IPlwkpO82fWktVfTxkMUvmlSOh/z+Mi+J5BA+Cpjn+qj4OIQz+BgsGO6K2NDhxQTkpSzdPlpgNmWeq0R0csQgQs0f88lutNT0mAy8RF8Lm7yzQqKGH4JvEoS8AI9i9mGu/eMxFvk9qXv3ljcFz2PtBzbi0YiNh7/B1sq+roR4woxsoMKt2ApqjsP5ogJUqkTQJg6a5CfASqIqBG4CEwsXvC8JCAkqvERA8mIsVv9BPLynHXomy+ZJfnDB/5TNcexvCVJP9/yKgmhQcHLOiPopbhxqLbJMLhKjHiAD6YZvohDDH+ABRhQpv4iv+qJBy9wsC5gIG6pqZBjmjIKP9CCH2yqH1LJkQhxKXorDAOABUe6IpS5kDFYOUXBr+/ai+wCPA60OO5RKBEtBk0CHQHBu/dZqNtxvm9AOROQgBqWA/97PD0XoBncnbNqg9XIjepyDokYwmQ4AjAStmDKN0UYwD69PrwRQAn1Pl66AEL1nCqtKDwvRgrBwAJGM0ZgsS7akSxhQGxYw6holKxYBTJTsGoJHAagpxSbLDWEI9eKQtCSO/OrwulKs15wj9mL/j/0Kqw/76hh4L6PUDhTkbxKssVKYq0CyKw1hhLIOjdpYauQw8RiJYLuuzOrO8A/RiCI6xfi88ZRSycO4saSkwquYEApyDKLs7P/2Q8nI0em4cdQmJRbPxLrI8BbkYREsJanIyTdO5Hv05heX6vS+jxzPwsAOzNA0aTxoYyHhISVSsP1YsB0J4QgBaZ0aii1ihB1a0hbqBgo8steKRgB4kHMgCh6UpGeSQta27BB9UtFWa8oWAwUPDR+xAwIxDSMrzhxp47LSkRxx0QkHrpwScdEMUJ0+Szmiabe66K4WBN8mEE0ozbgITiGKC07Y8Qh4CkZyaC0z8TxUSqUIADwW/8DLBqABUux0oOA//oM3Qqk5ngNN/AGZFlEAnikoqzLtEPEgIQosiBJTQAUcDa3FYO1TYEOTXC0qPWUqGpIqCxGrtNCpyCSqbLKwqKqLWA1B8GoRps4sDQIt/c8Q8E87gi6DQLPs1MgqEqQ4VqTWRocvQQp1tKKwyCJD+Asfs0GTFPMUt+4naebdvEYokyx46lG2csvlegb0yORJJNA7XtMkUXF6apPygEwc1Chu0okVom608tLJqoAk7A0w54HEkpMasiExoXMx3a05U+j3ghArZmx8uGLDNoUex+LPupMMEdAHkRKwznM8G6c8awgunZKwgOcWDCR+6McHY1IIwP9JGxRlFSTzPg8TUohnP53T7fzzV1AIE+psCjRxRU0IPgTRCRiGQstKPBdmFkQROyWCOzEhG+OvMZ3lRYciLhBLRY2Bq5rgRwMxTnJ0LXeUSovAOXyN/17MjQSrXYx0CiBUCjRqSL/0giwPSXcp7lSviUpRD260CaY0N2cpQoGSSWctC7o06jzBSKH0TS2sTZ3U+Y4ITbtu834NLxJqAVCpLqrLLSHjHg3qLFbEB9kCCJPQYY6vaAjsHqtrKuJ0L2qwBnm0YIgUC8Qrfk6s38xrAdArqZ7Ci9hAoEAFFGn0InXv2oitTOsDOK5Q9eaKOtZpeUoKLPGy0CJRmSxEr/D/QB/cBm4Y0TgfsJZwSIqusRNK9QrijW76TMwkoktG8AiqrPXcohQ8MiaesAtT6fwGxDysq8SUUC7M4gi5sfwAgmmUbunkdZJ6kk6rsqNwMB8I5RZu40OW6RB4VecyExfOwzSv80+7UTAiw9qQEqYCFsBU7w5T0y/E8C0+VQbJdOd01Qkwqtae7QF07d547caMaEDeZ9QgQTEN1M6sEwMrEdN6Rx4y8WZEMEo4bi8jYvd4Fh/VZFTfTz65gUnA4qZw1QOZ6QW94GAN9QmUBMrOMVP0RkoAhNXcU2L5q8owS/CEQHkWNBUGi0FhUxCoFY5C9qIawz3nDdIc7unyTWWZ/0lJKqwVG5ZWDbE0sWLMUodV45AqxpEEYSM36FCNgvNncfU/qIFdd0pOYXM8lIpudZNpkeRk6FWVFsWr+s4HB8olOxUp+bVGi+BTUO3FPJMrFJQb/SJSAZG/NtNiAZEJ3+dAEHJBiFZNdS9UedcGW1RkcSFphg4Wg9QlAcS6WnbJAJU/zfK2jJMiWAq0ivEUYBE27tYY1cht96Ip1Si0vlGPzqyOnnd2AxYmuSBo2+k3CqAUOrCteqMLotVK1zYKYhT4PrZIk+32YBbTHEoNrEtR16FJhPAW5KZD7At7/6NDVSEiMNMcEUx9eotQzQ0gxHZN+epyueAYpwp3XZYhx/8Qd0f3ZatnWl2mWmv1dn7XHN7A8tYQAKegC/iNKkqCSUpBaY/ScgFptVTvL3lL9pR3AmfRbCEXQK2GhPW35+r0XOMAbBtGQ5t0iiCSmcKGQmajcggWNpYUEP+DHn2YTFzzdqFWd9V2T494TvvlWo8097IA16zV617BfEEIG0sYgjoBFjbHY+10h4gY7uTLDkTSCqLwfvE4iduuFdgXEGABAbTBX0E07/YOF/quIvM4d+dPjXGkV+UgiwdxedFWkMnFnnSCZY7NGMzuFNJnNoxWCHjxEUYPA0lJkpX4hEeRZGaTTfeYeTVPjMPgLpri46ZrCVXkRXjyMclAXnXZKAr/Rqx2JTUqNPDQwSbjRxaQomL7cl3d9RQ0xDjWayq0z7m4D5Zx2UqhtP/AYJyHmErNWQnS8oXdmIRKwf0CowNN6pksB63iMmo7uWCmxRZcZ5SVgD7x0jxwdRFmtmapd23Cd5AucLIMKJb3tgkaFZJuslNBB/mCTlYhZS7otVHZ+ZZLanlFMUed9pw7+utoL56tTpMsZzTTs48HGV2ELACIjCb6oKbIAmIlYxYKFwpQhw0WQBwXIdIOlStaGCBLD5xl2R9V81HzwhGjLX4P8H3JFTFfi7zuOZ1tb5I/2paXQKRJ16URYb/OwyosFnLo2bYQc7Y48gJd2D0wptPM+AgA//p5YEJNvEFMlHIRHkBvYnglePEvfPGb31erSboeRSdDNhZRRwFvl1Nh1zpvU5hGNZUbExVFX+Q3fWnAvColKxVR/3dRBTSp9daQT6R+bDEOfUbDzIeYM5Ot/5GMC4bd4rob1pXB7vWt8AcyBzh5zCSKkWQBbqouJlKw/y6cC9s6iyN6jKNs4ULKuNBsou2xZzZXI7tZdZaqp6MB6FkbDDB9PaczwRs2frUBgtWhJXSM5RhjTK6QMwECEi29CdsIVBt+OPZ2VY2xV5slW/t9zS+yH/pKc+GmtERhVZq7axg1E2X58CphO0Ro6DP/2hq9Xxpfsm62+zO+74RQjaCC8/8z2s76hjnru9VTasvECIr6bM8bZGG7YNjOwp/TvPV4tIXPKyg7+pKCfJKDi0cBQw8VLohmU0S7pMnTk/tl8tgbX9AYhWV8EtYZxl97hIkc95DhRqZxSOUpyf9zyQ8BS2PzmKMoyqW8jfdjpF3whtEzqU0YrOe3RzBZwt16yns3znvBo8s8Gc70yte8kun8kpdBzv3cGcAcvhlTyxFUFkRqr5AuVWX4+mTMMiU1eGMsHwbUuENYz7W8nDn5LFm0jN8SyT3auxuw7Gp2WxVUh8VjzzDNwA9N/ewZzx3nz+Xckr2AChUSReXGylzbyQuV0zMhzdv5vzexigV8G8SxZE//1jimrdkGtxyzzTBYOshX3DzvgArPIxVUAkK6VIY1mbpd9GWMzdfxWddD3ImIMbIYDm4fDtBMYnopzswvTq2rHNzBXX4RY1P7d/xgKzCHbeEcY5tlnY8JuddJ1aMLfRvcdXiLrtF3u8eZjismHdoFXdqnIFzB0muo3SX4qX8Tes8z3NutRU7GuSjm/denPH9JhmVZl8o+hNYdatiqzFOA7dItHX+91Am8Sw8CuY3ynJKznKZNXgr8wW5rlwyLMd/XXZV3im7Vj9v3hAT4pQqcHl1AOShEecKT4OanPdPLBsPld+aNwAOqPuKbeRCRN+UnzcfKNXeM3tppLkWZ/k70/0UFUsAzWOBe0EWZUaPTmQC4wqeTdqe3RKnFSCkeJeTCcjDkOb7bj4AD5GOmrd6f01RY8mRi+mWfA6CfHx9cx+ScakycBKCuYqtm06psYvYqwwzxZb7nhWBX9KTmXTyXhWXucSHsnSWmHZ82o0A0t7GoDkNBsUocWfGpHPxyAOp9/BvFe8JPDVEDQMBYbqFjxPz1hWTkv6Be+Lli4FrvlwCrMK7BWsvhKGo6lZIV0Tq1uh+ygV3XZUL556VvYN0Xfj7yhUVi/GZjnt/19x4XRiIHjQQIHgUAsUgIBBKAY4DAAAQGRAPSQBAMkAEEQIBULJaCIrlcDJjTZrRaHTAUEP8HBZL70C4EhURA8WQ6ZdElhN0hLczVkRUgDQE+taWxAWiAfGgFZERucnZ6foKGnomSlppCnaaqenogsazCxnpefsiSTtrmxuJ+8nIGNBA1cB0QBkAU6TEwFAgoMyhgRS1xHRcNAxSHEWURPUeH+mZsIG3onqP3pq9H+rK/l3VkwtN/ggSA1Evq86/dhksBwEiLAT1bGAggQIQAgobeEHQD4NAgAmaYDBSJ6LALF1DuAHCQx6EfyVQfS8I6idIWh1orS2oIoGGlype6aroBKKxjmQQFFRYrWGBZM408AfjEZibLk2fNwkXyMNMm1XaYrmLNqnUr165etVZNRyIsv7H/NMmyw7nPY8BEh/j0Qagl2BIkgdg0ZADXj9sAB4pAC+DILiR1aA+HVYt4MePGKR3bUlxGcqiEjClDzmxSM+fOnjdhXmn5VGhUukYjLv15dU7Wk7/Cji17Nu2sZGrjzo27jWqSqEuV7u3a9PDiUI0TR076tvJRrTtlyVKw0QIGTJQQoLMlm/YHXQow8rNAezAvgrdl0yKnu8d/zQ2/jz9ZufD3uOofPik5y5gFhAA80ABTRgSzQAALNFBgAgPocYBeBSlQhH+F0OWNQgAkCIB/AXUSnC2/LYaffI2JSFWJxt0Xn36fRESFFkPckcAYVxDxRgEYLfETETce0EAfBrjY/wgZo924EI4dumfKbyAC+IaE2jWDVRZ/SXThGRy2gyVzI77HgQgZtOJBBiKM5NqJxaVoH28ssjGhGQYeQCMEfmVoIIMXFulNAW6aIUCEGBY4jSceygKiXgRcWExHAtA12pREIGBljVq6QWmNXMZHDi0BmDPcmZ5u2dyKnkTUhXpZKMJEAGO45R2R01VhqiIS8rEeEt7B194acDRE0BLacWGZeU2UYUACB/jVxZ9lOJpslWQgoEWPXzAwHhLDSOsPps1lcJUmoKIj6EJjpMKkJ+Ze6pyoa+ZCY35J3lYhpBESEGgeBNjZhaRLeEejAEclcyGqWuw7jZ9PROPnbZYmt/+tcSJoIQKKvDXCcBs0iitGJOgOue+4m3Cc5icYOFCyAyNgUMYFDkSA0qi2uIsWoZMFJABcjpD7RkJwWEgGsi9+l0azVEZKs0SYyOGjAhhlHKrDxt2DRD5o8oaRzcBhGbOSHmu8Mdfpgu0JyRQAgIIDZJP18tMNDyqJFMgiI4TGcx6QkIFhNCCpwgDoBUExjTYqsLNF34bMwX0OYc1aaxcXExJTgSsJRnA+Yi0w1iGB3Rh9xOovdR03ecgAfPik79FVBAnrnrIS+xzbm4wNwMotU+DABA5UEEHLFpwcgQMn3B5Byr6XPAEAFZxNAQUjOCABAMynnOt8jL/+i9sLNTL/GBJjWBZtH5I+BWkwA2gHjukAPPostEhMW8WwGHlPpdPUsyZPB8jpB38zQ0HjzLIDfmxVXdCcmwIEOsUhZQzGQoikEECv/vwnQPkK2fw4ETsT2A4AtStZ7nbXPAD4rgQYPAEZQuAAFCCvZBRAHgVKcLLjLG4VWnuXKDAzw9V8in79IEEAzEI1N1BnI/+a1tKaJCONTWNKVwiSYEBHETjVqG4KsZmQaMTEGw3hfDHEDMlMNoELaNAB0dMdAHjnPN9dAHnG453JKqDGIpjwdhWAobawRoYb0kF+w8rbVa6QRYGQq2ecMNfMPHHDz+RQh/y4H/6qlgz+hS9oRKDc5qQg/7cr8IlZkvLJEW3GQLgByBHeyeTdMPS15HDxbGWo3Rg9eEYHpNF2EnihHN9IhFk6IAQ1ZBcsZjg68wkhDHEKiKD0UIRIatFrMZQe4xKpyGeqIn93JMz7BsYFjFVMY8M6SkL0Qq3RJcFqCmECeADgIlhtx3sKOKXIxKZKMrCSCGQ0IwhhqcYL1C4CtXNjBolwAd85j47Ty0gU3qAFPwjiPFCQgo+2VwYENIBnSEHGGmr2x0j+bAtu4YKxtqeegepKh86EJknhVdJ2huWfLdul69AnwCLALQt4C0YUGtQ1IvRNL1JwltFY59CA7SQbhCAArpKprpDSb6TP1A1Tm2qbtP+U1GlKPcUsLWDS+UVkAaoyQESMGYWNaI2JXChdRfV0zECebyBVIF8T7rXMtilyqiJtJFSjGja58kNtLp0X394QEQVUg0GQRCtRuREABgjhbQQgpkXPOqQ/KaUMw9gbSJm5NrxSD7N1XYdmHYPSibU0IuBkBFcP+pcoBCYBGD2QY72n0UmZdUdo9Y9GteMXci6AtgArZGbtKovOpgOvwF0oSghZwVSgcRUkM55Aj6uGUrGGt8307S7oyllQQNeOpnDXIcugNeMedRXJVcVyWfrWNmQXkbdwKnvbGxvqPga019VH00LR3XNx7bPIhaVy+4nUyjpsuJuBb+QKHC5JDET/nXvVQ3ie0FCEFhQOn5vGIzCUOVmBAQoSJojnREc6jHS4dSANTRdL5rwLME93sOTdBCJggQvcLpcVmF2KUxbjk5WgvM0Nb4A7I2AC/1YVbERBESqwQbJt0ItVJcI+l7PZ24wBAQU4ALIG0I0GPehw0eBPGQrgnZryL2FTniRriwaMj4khX0Q44gIxabD8OrcTJGvZ7V55ATY6wAJydGEIZgeAWTKXCHXW8X/jPKIfmwLRQF4Ffkz4OyKYrYV/tmoZP/jnPDMZd06er9FGE4Ur48kArt1CRBjg2sAKsSE8kegAEhcQ7gpAoumh0m1jnUXwhs0TJbgxLOOJRnrW02Sw/2TZ8TIoAUfnmdCWzXWPOaPoRQ/YFCzUHRhP4AATmAHYSw7jHBP9Dne8eVKg3hGECtOiwwIAsAt1ijPGrCHW5o24/BqXmhM4QOsIoJTxrmP1IlHneqJY07+29O2w7U9iq3HOl7aAsuEqCfdCPOJa8DG0cZiKOv87nmXQtrA5uOngXs/TVkbDqyy8Vja4JQ7ErfB1MBwGQZ0zxAsAZ+lopE4489iCvqMAGktgQp6v2NIwNlkE/PzGGNeO4f5dtssqDmCne/YULhQ22QqebUtvu8nefvJJDW3xtDldA2ViAwcgB/XLULWfJkRBpEswaSJwnNJaB863qatfA9vk2Y1pxf8GujWOAHjg7FE3hQm7zTsSGlmFRYh7prtNd66T9O5mkhnU5YEJRgoe7fIFuW8lH13KO50DVylT5kNkXc6TIr3YO2VqvB6KgLfM2mKkL+idTo5ylJ5Epz9wKVQPgQQ8ob71zbvTgE2KWTrPbGu0NBn8HBmqiD1dZYd2t5Dwrdy3fvO8T707OKZ5Zp+Cd3NEHqVpbxO++50cgYc2LbD//cys8Ly5CE2rJ77RjFKBoReexoMZkND/DEu+ABB33IpLSQcd4QLy0RjLpAyefRGxARounYzJUADyAYAJOBrZkBEGMA+OLaDwXGAGAtqlBVS/LdJVYN6i3cPUuB8NlYItlYH/HMmCBVhABaLM082fKBxRN2CDNoicTU2KlkmDFDBEvTnERgiDgowcWuVKAjaPnwEaCxUBFGaQDC4Z8o0NGMlTy4RA0Y0QFU5AFvoTtXWh69GD6GEC6S1aTJhdCybGOcjgDJZM9JhhNIUCsvxFN6iVzlzIVx3FVyGNUcga+hwLTwkEjhBAaT1e2CggwtlOwJkYGAKAFWIa8m3bFpaYChmdLGFaEdzO7ZSfCfLD7XHK2fmQG4IdPNkO7nBgyYyA2zlgeZkA8USABFJAJjoP74yA7xjP0HGQL4bAHNGgDdIh+OVgKHQSGkTW+YCZ/NSUHxAUpCBAvf2KvADKu43cIiZH/yO2DAwiT5+xzAWMICVaFRaejRaCEBdGgNsdXDfajhgSQYmxozGSRPXNAyriY0nwQpJVQBdewAhJYTw+IsvMYxwKpCvVEwb8m6DhDp8VQfzx2/Z9govQAQGyj8jVRRIQV0P5FV4ECx4AwJxoSavsFbw4oQRs4gTYojC6YhVq2hV+EAYq3gZ24EC6o/HI5DvVTqDRI0m0Xz4CZV6t0uxl4jnWpASUl+y55BztmrDd2Qex0ngFm8mgY0udg959gvfZYc5pRu0QWR3SwwpmhsSRZVkGZXhpXBfOY5HlEqH9kwM0Jbb928A5Dyst5CReG9MFGWQUA0VdJViiRaRF5Euw4f9YRt5Z5prGtWLxrORylVgtAgAG7Jxkng1dhhEG+CLuZOZKtUPddR5gGiZZnKLuQRNW0sfu/eVncuXkoaJpkoRrat/nQV5pgiZkwKZn3Kb5nWVuaqNEssMNDZ9QrqZshkNZGicSPB9tIiZvXtVNvERw6iYUHOd0goV5UdxeogSqWIxv5iNzWid3ikJ06Ax1YI5GXkF5JoBr1c2EaQdG1N+qbBSjveb7OVtyRsIevpQa3JcamA8ZzAlPWE6UXMUBmpNaeKd6xaZzpgKXFZCAoNu4DOA0NCgUcM8QHFFQacNWCmf24aZ9boLqmcF+psGChCgBAJ9QLUrgnAGOUAGSLCf/airoKZwb0MTIjIxBjRLXFeXolPHUHh7J1m2oC15ndUEHG5jHnqBn6hgCayXDFyyA9/xReixAkVAW6NQIixooYkondVKnZ8pom/xHGVCShPiFNWTSjtpbUBFpkNbekMYXJ3RDgw6guyAQmYaBmWmJwggLwAjSlk6c9Whp7uFHqWyTNYmBocbPNqEpOMGnbckPkEZnm9Yndn4oGugojroLRRQGq7lal2FC3UQpUF3pFGRpoJbegUYqPRxob6RQCZZAB64jnpWM8LwT74SiXjZnGsRpmJIB5RTVmh2JvilExgAQUf2NN6joqBaoi5qq4KFqPXRW9JnG9KUiKcSYLslO/xeOH3PZUuxU2q063JtWqjecyke5CBXFxZA4qbyJTxEYC/qUD7mghpMsK6A269k9q6rWA/plgvpJ6ieoVJONkBl0a6124o593FzdK77anT5YnhakYFWoRgRmkPGxJXMV5cEWWrTF1cIyrGqe4egJKSggWzjOEgmVQcGija3mKqQqrMdWXL7Cw3CRYqf8ayeYDbbW2QVo6/Fwaz95K8t+ZxlIBcJeFsw6ncx6KT3Y4/VVKyiAIhF8IwC86qyyo8rCncYuW0gEgBoyq2OoHojaK9ICGZeabVP1w0+OrGaIw+3ZLK6axHaGQnZ9GsmNExPyEtnqbemJJYcOaSVcghY4bf+4zp/cYpc7QJeIDufeMi58FabfTioPsVcadJQA9Z9bOKh0HOmTSot5ZJiNHIEUDGBGQRgdrE7d6kvqJNGD1mbjui79jObTTiolWAImDO7XGkFRCeG+uRQEUQhxlZKZ0cUR8ml6QIBMXSPqWoa7EK/8ve7zQi/uxqCmpYHsFaO+lsHfleKOsRW+jJqUHcmMCsk0cKq8jQ4e9upWdZWrjZu7nK8hLm70yu/8mqBBkoHyVVoJTiGxxWgZcK3Xjq0ZTBY0CoOVZBWvQgEyCCu7Zoc1OlBfKWK6BVb7FlUDWyX9YvBVnu0GOxUOMqTjkQH56WNUtGEAY49CcaQBYC6hflT/oq6ruIhkGYxWR37BaWWjZZxTSAan0mZwd8bs08me78yRBCIlBVpgTmpgyyzmK35gyiDxCFpg63bmS2jl1uRtD2MxpRIYL/jCOOLOkplQCcBkEVMAOpKRP34hBL7jOY5h0ZWhB/dmP/SlLszxBWfxHbssfHHx1TmPHPHaF1di81xiOhZlGTuiSmrsJ2qtKA5tb+HxI3PsFgPYkjFPBZwsGYwxPKYjAKjl/t6kJsvjYEZyUkFyKcdxwx5XijWZBIrRGIfgTCpxTT7gTb6yTi5d/BrtAxAwKSjuoBguen0ED5uys9LXLxuSiHkoI6OEVzrvKQvVX1RxGmDMdmoldMJp/zAPczYT7h1iQqhWSofI7e8VxjHiMkkIZjPnKgL8Ki/jrXZxnx1rczz3JCegby/8sjUbVTILczkvWwFQ1PICiznBRax5JBKN3CCgh+lkhyL0xQC0qER8pOgMhHuqFTzLszYLRz1LqUtZhEJFwUM7xEDsiXpuLkwRhOe+HK8k7D7PcyNDAZUsr0IoUVGB9DVVUnRQA+ggikv1SB86tEfWW+n8nr2BKEtftB6fQkY1EUNgyFF42ULV9CJ8mRRMKFAF77Bao0kZ9acEM0zf7ax17wJE9TQbhU6zil/kyUd7pKwpdZnmITYfdVwrcxtoNCHioal9lFpLI14rAvl2M+iUL/8+4+5WJ/Mx/fNXa/QwTMkc2PRClTVQ0Qge1kndUhlgBfWPJqNFyzUkZzT8godCUAHCTLBfMHZoS3ACawgCWzW8DasxTzE/y66GPhSuLO9Zx8nnHEECqBtZFzRk2/aUcg4RJoG6BeB7DgFFwvVmy3NnA02Bvg2UBFZd6LatCAYXuPCsCBJKs6vLcrB7FTYRFMOjyodRK/dhQht5c5oZ6PI4q0h5L/cPLxp6y7Z7m7J8o54kKyd9D7N9g6dd1UQ0g0IvL61+c3aiya1gn4OAXzEqtwGAf4KCX3MeE/gd9wY+15fY4lef3lE7b6x/gwzrsbOJTHh9GzhouDYoaCWEo3P/fqsBg8UF4RBVQq1OhQ3L3S6QspicEpS0YNTBF+yVa/0oaIx4KeNClZmTIwR0Q5schEnHV11IjJMceKQrR6LV/amHZdAciHHPuta4kQ/gXL9si0/Zg+AhHiJvgnxDvllDbR/iIQLhhAqQlFEZ6hbBA2/zkPdwkZOvI8g0nfi0EHLZQpW5X1zZmPuEzfyF1vQgIYyGZbAZ8LnZneLLmitE80pxszV4qInBA3DB+qaaRLF5QkDAECChjoabY5PczcAtnkOvnksBz0Q2WuMIIJbrlWx6p9stuYEVWvlooxNAPdcap4K6TBeiePN3/wqNprfaf/wVArDbAtOIXoDDmyPw/6lTtjXITZouOKtjMBeDGM7M2mQzyC6XShLtQRiMm5sPFhks4944OvdAuprjzaTP+0IoQFYfOzm3uKanm+DUcEY6wekUwFcDyIlmpI7ntRSIXDeQ0xD4B3uLMrfPLy94LrjjIXDTgf6dnK33u2GllQEEhmBUuaPqFpZ/mDatK5ReSAzDsXmDgk55fCcs403ZwgNw+KVL/MLiFcx3AjMEeS4oBa7hNyjocjRGAhMowKPOCcRDa85jMV4V/S/YBTog/V/UccuzeJg7/cTDd9m6/NZz/XmLfS44eNOBPf3mu74jNdmDuIiffdjH99h/SNsT39vLb9p/t4erwnvm+lOUOf95kK6DacGW98HLtad82n30dvfi70bcq0ICeMe4+b2fmwHcIHqaldmwVijiJ37nYz3aqwL6Sr5t54mGbNWuB/are3PLev7Z4/2hrUJmL+9H9nSdRwgD6MxgLfCec37re/7rj/cquAgjmA6q5NEK8wFphfxTaDfvz7fv2z3wt3csGFMq+PyAQ//bS7+aqIJ5kGiiTT32Zz/Yb/+6ZP34dyfjqz+XLtXXo78PN2v5v3Y/IHh/v7/7yf8Id+wpwBoQAIRDYlEYGBgHAeHS+IRGiUxp1XrFZrVbbtf7BYfFY3KVWkan1dbz2k1udwmCL1IZf+Pfe37f/wcM9NITLPwjNBT/RIRiIAgISDB4DDCYAwgoeER4VACQFEJAuBw4mFRgyMR0OlB4fAAQKMg8rUu0vcXN1QVc3PXd6v1NCy5aYhiyBLAMoEMoOCgd+AQIHR0qhXACcGpoAFhIGIg9YIisFUZPV18vJGZfd3/vih96gKRLXk4SIDiSpqqGZIGjRwa0OSlgQAgBA/yEJDwnT+JEihWFcFBB4hIAEio4WEyHUSOTjh9BRtyyIMABAq+U0bHjcNQSaApEIUHQiQElY9uYdPuGRCbEBv2AnUSaVKkgEQGaPl3q66lTp1GPalmiyVNBfbCM2nGUwObMBJgoMWhVYFWrAK+GKgzHhZ5VunXtAsgw/+lRhru28url21fKXHUQjF4VnFixVQ8fJn3wsDhQ48eRJRchbDfzZc6dC62YtMKzH9CPRI/eiHqKatatDWmYpMH1GtiPZKPeTDf3bN69q2wIsMF3GuDCVe+WNyDBgSjIhz/3nSJACuhkpFM/fihJIZlPnFcHz9p4+DDjcWs3tJO5d/Lt3b+HPxgKK1deBaxElopApuWwHhVYYJOCEjhGAAWWWMKAVAC8hC2FlINEIQLYEoW+AEQRQgE62IuvQw8/9I0QoMARR60iCOhHkiQKEACcBQB4wBs7AIAooSU2HKKAV5iBJQEAEqDDAAJR9OmABipM4EVqcMQMRCefhHIxQv8gUqahw5ChQ5s5JJmkAGu8gsBLbRgQ8EJraMLvEpboKOWAVAoChcnVoqRzDL3uxDNPPffks08//wQUUCMCJbRQQw9FNNE97YRiRKGuXChLKuZwcQoIhChHQ5+EkOSYsex4wEsge2yEzZWONEJTDutkdRAP8fgOvu8IsdAtSF/aFNf7tBKQuQcIzNXCAm76LwkIzbGkTQvxUw+KWFt18tnLYIXWDEYLScaM7b7obtBqv8VCWsmoBXdVMMS9AoIAjmFj2y6UW8/ccuedMz5y6R1i1tnQxRc8fhO7t199Xfu33+f+XSATb3Tz1uDUwvhXGzVmFKNgh3vLrIFJFjbCESX/r9D40ix2DaAB5nby8giFtoK44ZRKJuI+l7rYyccn7mNS5okGVkPiYdw992J6N7NHTiJaYRfkAES+ItQXWdpHgbguWXkalI6wQoCyAiCAOZU49m9mLmouopUFcI65LTRQzrdqKhTkBOjmru35X4pbFrpconmsOawFNH4EAsC5JgcSv0k+hSAeE7B5iASYzlGAaqjmFLmAb4YZnAIY+DptsbcgG/Oc1S7DwKkpqRwAdVdGwGhn6Y4ilrJOQZCSXRV4cYA3qTGKqEd83JXBIbg0c4okCCKAgRhj7sTavMHdmw6y7/OmrKQB0FiA6WEOGcbihWAcs3ibWFe5Y/DEu14o/zJZbxMDOueyrFfghlldBe4ngv5TDIfkRY3P5lH82tK3ddHPG/YgQFkWFr4isGhyqGNZAz4XLthBIRYMQIUAbhSUFyGgH6Nyggcf0pBnCKFSyzNCp4x3QbQIAAI+EmEDXNek530regAgm7qqty5YvOkBOeTe0r6RiiRBwRxEKBPqIGg1V9GQEZAYgsy+phIvSTEAnXCfujgxBJXQAodQpB72AgDAFmEibDuZRBepQYmi/WiMP2oc+RhgvkvcqUrzqODNjEIABGhDQU14Bn5C2DsDTG4rXcofW9Lkj8lJbieGeYCQPja3GlbrhkDcIefAOEAo6lCMKxOCPUTBwHqYiP8lLxSZgSjHsh/N0HnqewL7QEGJr3lSZiRzhSc9NwRMipGMtuSkzXDZljaaDQpJVMgSf4IhxAStCg45QCS0oRL/fZAO9+nhNiIxDhMW0Qg6Ut0iR8FCFmEvEuCIIyUr2aqMbayX1hPjFYMZTm+A44qD6xocjVAmBAjpGmNU5jeAJReXWTBzCdjc15bQCSs2Twi65OIV2dXL/+FsoWeEYlAc6j06GJOUOHycEFQZUHVtqHWtfKUzpUAyb0jsdi/iUisA4KYrIut3/tFKFP8jTrA8InmkAsBY2LBOaFksHQ9wZUqx9syt5bNz9pDn/N7kQpgVQX8UHSPaoNqKH2bUE1P/LeYbP+pPIZRCJW4TaVMHAI7ryauJK70Vw4jKKqNqpqBPQupQK5a1uFqlrnOd1qvuOrQ8juavgJWSYJ0osMJ65rCIBdguskWEyUJMblm4HGH36gef7eKxkO0LcuyxMpqAwigsHR+WYtaPyvpDLpel4GLFUI7UhqixVjhIMDqri8+C1q5fKAeRimRaGDEIak9oLa4GBdvBMFevsBxCK9rHTBptLF6VwJQZj5CyclSxquXsQrdWmwuebWG3UjgvLnrrW7l6QUhtGi7vfgQ5KExIKw6xxIICNIkDBO9FlBiWfr+ER9k2QSwmpS5EWLK5hazMdNsJ3FaqyDiFgJcL4hVG/3m3kQoB1Mo+elELE4T0CHz4dI5xAHAfU6EQqGa1ALM7BvJO3IokNeKmuoMTdNkrKzC0BFdZmUQ/xFnfemaVtUwCpx1OKCOw0WhHzlXqw5DYgD9SI8GgDGk02eVADHGtHwrYTw+1lsH1/WcB0fhqKTRxLIXgVz/8YY5ZLrRFEdIomQ7acI5ft1nH4WhE4YiFsajgBB+LdHMt7GxVzfHCSzCNnAJgoYYQpIw+8hB8CmG0jnfsntyo+T/xFeERpZAM2x2ZTJO4SRKIZ0Y7nFord2vmUolQDgiUIwmGtLNqH+ASY9CRGY9jURU3lwBnJNXJaP6jTEYlJAbgN0V2KCePnP8BDZwQ8hLXFBWm01lgApd1kVRiiExyu41WECBAGJJcopPg6Uf0NxMIaPYeQ4HuSoNCFPYAErt5uukP5UaVIM1GmkQYqnUTYK13s4S6+ntkFX7qUpXKl6p5+Ckoy6fAqxYFrqk03x8pCZlU2wSkhY1T17n6QsiuYj/gqyb8SipS1pBJtUdoDQXpu7b5quCohOAocRilJz470qPVfeknbFPl2zw0i7RhSJVEE5Tc5jd5cmNhBDSgtPJdoyYWfqJJXPPIwsp4u0mW6pmyZVgDJmiBC20MjStkwaprHq1F2glaEigW2azuNQe6FU/dREJVbN6oxtzyXHUl5iXSZjJVnW3/IqhEbhqGEDM8LBO0qIIJBGGQjIeeZ0yUgxPN3thCTLz0SmsFx9rFedTtZYgDgeRyZo1cEk9fsmPIkFONMysEs3n3rdDB9tcwuyhu5yV79rEs5iC8lmCyj6+QYhbmsMMfT59yt3Z7HRiGg+pX36HM0szSYShHWynS+sFaXx3Yv632D6ZYTUMv/YFVP6fZn3qDafg88W+PO9KrBYQbu2IVj632s6H3Gxf8yz8s2D/McpfkQgNYuxopqwMAvAIHrJv/C0CVYo31MsCdQUDn6D8+oEDzg8Ao2L8QfK12AYMEDBcJtD/D2sDwiIMyeZDd4Yf7MJLPW6j+qS5M+K8FpJCd//u8WOAEtrgUNvswFaEEeUIdGeQ8JrAQ6hpB/UMEEwQGCUxBD2RBO1GULeTCLtTAF3wHQsgJlHKCQIMFWpA0sEiwJ6OsfqAJA/EUkaO2ZrAmT7A7E9mga8M7UOiEBHgFbkCSSeq+WPqPaQgIPDs9CeGHZ2ALKgMIspOxBWjEUZDER2iyHDGzJnyJMAOcU4iFWTgGAaNCAQTDUvSFONCa/4CvMjSKJKo3KzM5slOtNnHFw/OKlVsJcTuD6JswVRQkJngT3YvCDkwdK9NDrfkRbVMGBWCOohieRxynQ9OQf/MHaqwCcAKhy2PGM4zDcSiHp0uyLDTFcVSHNsCG4kIpbP+SCTgcAtJrOFl8uTZhR5FqPq9IR7vzuV1cvHMMlXRcpj0jxXZ8G2i0AzTRizWZuWIMiAFoJAS4QQVQvId8Ol7ip1W8PJPSi9YhpFhEO4sjx488Ra7DBC+JKSbojsExiEcEO7RLFvxASVt0CCPUxYj7KmX4D5LcqbLjL+iSwmOgCVYgu34UNeVyRvKpiVR7tCjyEoq5uzF7xr7zR+WaR3u0s3fsSHUCyay8hS9EB97DSlmrgsrzkrD4lGLhvLHcEAvxBrKERBMjGcV7S+xhkpUsSeWKp1IboZUcRfrTyr5sB97Ylan5yhFEivArR79ETEWYP7DEF65MzI90TIsYRPf/e8zK3IPIrIjJHEDL5MyJWUzCTAMVFAMG9KzONM0ywEyK0EwyEM0wIE3eOs3YhBgvpM3atM1HKL/QNKrXJC/Z9M1KqqscLCL/uoRUEJDm0TwkSEIF8aAfJJ4KUaQk6ETx88zftM6LCU41XDI9nLZoiDQN4pFLWBgiuTq+a4DmEQo09D8+u872nJfstLdVW0rmYyR6k5gZackDMABFcpOVwYmM7IPUdM8BvQv4tDKIc63DEzp9jMeVACeF47mpDFACpdCi6gPSwykziYl6TE6axBV53KkDSBizkM5JmMg1ENAKVVGkSFE/aLq/XNEYBZEWfQMgW8/qlNEc5TGHoVEdU/XRDMPOHxVSfwnSITVS2+LRI1XSfSnSJXVSw7rNKJXSKdWTJ7XSK8XSLNXSLeXSLvXSLwXTMBXTMSXTMjXTM0XTNFXTNWXTNnXTN4XTOJVTiQgCADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system; ACTH: adrenocorticotropic hormone; CAH: congenital adrenal hyperplasia; AHC: adrenal hypoplasia congenita; ALD: adrenoleukodystrophy; AMN: adrenomyeloneuropathy; PRA: plasma renin activity.",
"     <br/>",
"     * ACTH resistance is a characteristic of familial glucocorticoid deficiency (usually caused by a mutation in the melanocortin 2 receptor [MCR2]), and of \"triple A syndrome\" (Allgrove syndrome).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_417=[""].join("\n");
var outline_f0_26_417=null;
var title_f0_26_418="Heliotrope eruption in DM";
var content_f0_26_418=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heliotrope euption in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 232px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADoAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0CG586VJrd+AdjR9D16/pjFa0MscSl4fMKNliGOAG9OKwznzZY1Cie3kL7McuP881cif5TGQ3lSEMhPr3ryW7H3NSmmSid7iO3IXypoSTjuy5/pWgDFFMz2shVJAAWcZKk9ax76T7PcLhfMJXeGUYUjuM1at5I5oY1JfyyMhXHHrj65oSuROF4prYsTKlrMlsFQk/MHfnI9j261JCXdpY/wDVMRt3t0PGTzWSJHnjliY45+Uk524/Hj6Ul9cO0KwW2HlCjgnoM/54qloHsm9L6/1qWv8AR5JWWQAsB2Gcj/PeqdzE7TkSnEa8owJG4+ntSuRuSQK7KSA4GSy+9K/nCKTf8ka/MuPvcetPyRpZxZWOCVmkCrnP7sA8f/XqjDbLPLsBWzhcFpAeHY9z6DtTr+7NvE0mY2wchGbBHrzXL3xnJW5mkldSS2xEwFB77ev4mtIo0Ub6Jlye8VJ5fsNoWhTrdMOo9vWi6vbZlWJndoWAZijEkfU9Pwrn5tftVfPkXF66Hbs6J+IzVeTWt0To1hKJQuVV2Cqnpn2rVIxqSjfU211SJSTEtsApKu0jBPl/Hk1h694n0tJtsUkIl6EIpfcfoOtcze3dzrM3lwiOf+GTyMJFGP8AafGSfYVk3UsVnMsNiRdXecE28eAv/AjkkfStIo46lW+xvS6xeyStHJ5wDnKlUEbY+naqU8LwL5/2u2ilY4RmTzZPpyf5CsC51W5gk/eS20coyDx5jj29/wAarPdXU/7x52L8HzZpNmP91ep/Cr5ephKrbQ35L+Q27pKkJJ6loFVm98mqcurTIqvtt9+Nmwoq4A49Oa52cTK5aV9oB++wK557E81HPdNI+WuGf1ZlJ5/GnymE6tjZTUiLnzrlX6fIIG27fcipYtUwQSFnQDb8wCsM+46/lXNPLESSXO4nkBKWbBdVhjDFgPuKSSfx/pVWRzyqpm7fyMYyfLmQhtwPmFsD3GP5Va0rVEMDpdRpJCx+ZkYhvxXv9a5lUuEViYpkZedpyuPeiO5mM4k8yRT0LkbiP5frRYn2p2kU8D7fs/kzkjABkKlR/vDH61ZvNO2r9uklnsGdcql2QQ3HXeuePqK5Q6Xeyobq0mV7V2wJQQvPv2B/Gprme+W9Z9R1C4kmwEdXbqAMBeOKOVFqo3samdSRRI1q1zARlpLUhww9WAyKuQXk0SC2eRbiNydpkYrgdxuJIA/OsuxntkC+TchZGPzR73jJGOqn8xgg/Wtq31jTLm6ht9TtG2/xTWxIdRjnjJB6dV59qVi1LsNPNu8ENxPJA5Li3uVDMD03I3f061GNVmEgElwszrHkCRtrYPY55+mc10L6HDLslsLy2u7djuCTExl1x0B7+mCM1FNaPOsUkIS1IzhJRuPIIySf4ePTvS5bFxqPoc19ulmuJZleaC6A+V1BYEDqGwclfcc+1TWurSXEyNFAstwm7zI0YESLj0xhh+Z9elPJEkyrrVp5IZjsmhzHGffcv3fyI9qbqHh93jt7hL2Jd5PkvNgE46YkXgjPQ/yp2KcmyGxupCLuTSICOjPZBcnOf7v+HIrU0PXVuZCWYjCkIHO7Htk9RjPB5FY1xDfRXg/tmK4WT/llc2pBaT2PQN/Os6ZJIGnuPN89CyqZUXy2z1G5T0P6imawqNHqpIESSW7duR1I/Okgu5HgPkNukRsryOnTn246e1cNZ69mATG53uvAdv4Rxy6gDB5xmr8Os20UjMj/ACudrqX5B/vY6/nU27FxndHdTTRytIRJ5kJJyzrgMcdPwOeD6H61nTD5XEeNqnk46g+hrNhvfMdoyxZN43on44YZPHGKu3DH7KvktlFGGYjBHP5n9KnlHy6GfcsFjMiNwAQV78dKzb1d2Vi3M+QyEgqDzznPbHFbDtFJalg2117cHtziqORvADASKpMffnr/ACND0MJqzMrVCGt1SAF2HLnjn2xWW1yWgQTKSEHy44/Wp7xmjmbeGQOMNkg54qlMNkJJznOME/SqSJSsQSDBTcMFh+v0qEgqFIyeehpS+8ZBJx831FI53xA7t2DjGOKoTZSm+aY9SDUDfMD+tWnAMoxkcc+xqtMD5n60zCZf8JA/8JXoipjd9utwufXzVoqXwhj/AIS7Q88f8TC35/7arRXvZPLlhL1PLxfxI+o40jLl0k2XURB3ryXAHcVZgYzzMY1fk7025wp7gf4e9UUnSUi5uFkgaUBDIhwQ3+0K1oitvZpbtMi7WPlyIMLIcZ5/InNfEybZ95VdgN1K6vCArbOufvJ/9eoI2wZIiWwfunOFLf3sUOuGaQRgXJILN03D19xUN9JNIm2PAUYw7dj9OtLzRnFW0J5RJBZB5GTMYwRjBzk88damurhRCjsysY124Uc/Ws23mui0rzMqnj5c/r+NRtOVuGkQgh+UA5+vNVHa5oqd3qXvM2/vUmZI0yxDDLAentWXf/a3LNp5Lhjw85Kp+A61eDqSzKq4I+Yk8k/4VTc+fHMCsihm5zwD7g+lWrkPRnL3MQhnUzyvJO7EBy2EHchBz+ZpddVZY1QzyyyuQFtQ3ykerY6/yqzcQvHJ9pnQqEBVA3Hlx9j9T3/Csi5uJXinneIQK/AYn5sep/LOOa6IjvzGX9ntLOQvPPuuCflSLjafRAOtY8sYvzu1BZo7SRj5dlC2Zp/eQ9l9gauwQIrPc3MhLTfN58jZdE9AO3/16hnu7e3kEkcpMzfIhhiJwoPvWqOSrruZGsRXX2Y2JgjsoIxu8mI/Mw/2j0Rf1NZMOk3HleddTC1svT/Vl1+nXH1610ayQTymRlZLFH3SPLy1y4PB/wBoCmardvKpub5Jfsa8pC6hd57ZHYex5NNPoccotmBNZ/6GZrS2tbOwGMSyrh3GeoB7e5rEup4o2VbWWO4lPJMYJK/8Cx/IVsXts2pTm91YywW5HyQxIWdvoOgFS/bzY2LRWFqlvEwwGmUmTPZsKDz+NX0MZKXQ5dreZsNIsmT/ABMhI/M9ajeJY2w6GU+jNtP5dauTyXMzb7iS7nIPBztAquYJGYGCMgf3gd369Ko53T7L+vyIN0S5XyVB/vHcDSh0GWEvzAjCgsMj60/7JeMC4tpWTON2zj8Kvabply8kjy2Mc0ew485yqoSOG4649KLmFpdF+BnyywtGoS0KOvJk8wsTQbiSUgvMMrwN5wcfWtiLQ9ScqyeYi4zuigKg/icZpW8LamcH7LK2T9/OQT/L9adyvZVH/X+RnrcSRDypVSRcglGOVP5dKfcvYOy+VayQMR80bM2PwJqzJ4bv44/M+zycnBWPB/PmmvaSuywz2080/O1cuzDP0/rRcfs5roSJZo/l/LNZLksJpMyKMdMFRkc9xV2SGRZE869t7x5f9WZsqzHPaTj/AMeNVI/DurW6PNJp03krwSdqsB34zmmPFPtZIYbaVQCAIgshK/7QxnP1oK5erRq2Gq6hZzypFJ9oMh+e0kQq4wMZU9/pyDWzpfiHT5wy3UctpNuxslAZFAHbIyD27Yrig6QApq0N5KOCgEhRozjuGByOlX7iKG4ffDqMvAAxdTKp6cDnsD3zQNR10OzvDcROGsjD5G0O8Mb70II7qx/UHrWdcnTbl2juIzo87Lkk8wTEH7rL909umDXP2N/qsaiCzlhlfIfyo5dyyD/cPGR6gj8amn1MxWRi1HQ0JYY3OCNvuGHb2OaT3NE7GgFvLRDHcxb9Mkb5ZogZ4QO+Vzlf6d/WkuVjiKmV1jJO2O5jffE47KT3X/ZJJrFt7yKyOFeRLd+dscu1h6bWxhgM9Gz061csdfaC4MSyQywMMK06bcd8OQMfiR+NFiua2hUu9MXznMUqQXGQyrINqEH0I4/kfUVlzPPp8hWRWibG0g8o49D7eh/Sunu3SJG821ubaDBIdF862IPfjlefT8qw55LaUbbmR4oWOFmgO9PxU4wOnTFCJlpqnY2tC1e2lgEcruJSQvzfeGPu4P5846/WukN5HJbF4kR0lGwsSGAI4OR6Hr7fTmvM7jTbmEGaEC5t16tHyNvb6fhV+x1SdIVlQyFBkCQfN+Dj8ev607XNaVZ3tLc9Al3x5WMb43wu1s5DcZBPp15qq3zRy/fyB0x19SfTFZ2kanHcxyKWEbrhWicfdbtgdcZ6H8KsxXuxStyRHtOD/dyR69j9fTrUtGspc2xS1CMR4kBZmHCseay5t0rNyBt4I29O9bl9LEFWPHy9MZ4HH6ViXYcFfm4TOeMZzTRle5RmGyTKkBcZ2g5p9u5G7bsClCpLLkHj+dJcrsyuV3cjhgee+cVHF8odSRyMjBoXYhsiKlt2Bz357VWmXY/HTtmrT5UqQTz2P+FV7jk/MMe9NGUkX/DbE+KNIYcAXkBz/wBtFopvhxXXxBpRhBeT7XDhcdT5gwKK+myGKdOd+54+O0kj6phUyyq9tNHOoO2XcvcYwRn/APXV2NtnAVhG+VdF5wP8KzyIY/OUAW0gbzCY+Rz6/r+NTQsi3CzKzLGxIkVDkfUDPWvgJdz7ySuWL4XIhtlk8tNpzDIBw691PpVbzFSX7reXIcSHO4Kf/r1euBNFHK9s0b2pHKt8zYPTgisUB5JT5KO9oRktGeE/D+VC00CmlJF4wZk8w87eAVbPH0qrdBIVTfGVHcDpimWMkW9S88juBtUhuD/vClnkYO8MkhZskgEYBGfWrKSalYpzb1Mqx58tQSef1zTo5SsJVpWZgvLHg1N+5lPmRMM8jGePyrP1CTcm5IxvY7WAwciqj5BKSl7pRvw15I++USWqjJVRje3Xk+lZV1HHLGN87OmduH5wO+AKv/aAqNbyKflPy/J0BFZt1ve5VixWNOAMgbie59q3WhmRPFiEyLGWVj8qP8oCjvnrWLe6e1z8s0wHmozmJWIyBwAT1x7cVqXk+xMzKSEIPzNnPv3qm120riSJSmSMuVxkD0z/AIVabMZK+494oLcBowBKi7FAXJAxjCjtVL+zkmuBPMwkkxxzwpPoO1WDKykASEBsjbkH9acFU4YDD9yTiqVzJpEbRqbgyzyBptgXnAAHAAA7Y9qrvp6PvbZES2ckguT+Z/StFCXHMXBGTgfnz+VTx26yRgiN9n3mBPb1x6e4pNsnkSMiLToWaPzEWQr9wuB8g9h0H5VfXToi+fLTPQNkE5/Wr8dshJMgaOPkkKRx2HX+tWYo3EbebvKFgPnyAMnnPGOc0c1twVNdDOXTFHzSeY2MHgZGP/106S1RE3tGrsOQetacUbRx+dj902VLBwdueMHnNSB4BIyzyiEjG0tEGU8jg+nHNTzMtUUYay8K7MZI8DAVOh9O1attbyXEeZWjjC/8si2GcYzn0x9KbJZ26sZozhT8gniU7d307cH8akt0vIl8uS8W4iiB2BuMA8nBJyPw70+dnQ6FOS00J7vSormBHktw6RnJ+UKcH2PXHrimp5FrDJAcrCpBC7AoPHBI6VJzJFmWZIi4A8zGY8AnjcOQfYik8xp5P33kzsn7tbhAN20YxgkZxzg560+Zoy+qq2pm31pb6nkRWgdccN/qxnrk45P4VXHhvQbJH88wJcD5iQcbs5zkknd2610zqoaPDuqsTjJCg+nLDleOpxmqEkSTTyJBJbHGScEYCfXHP60KbJ+rRaMXULHS50aIRSzW/B221sYy314x+tc/d+FbaUK9jpdzaAnISVd6keoBOB+f0rvfLkN5FA8sNtGwwJLo7VfjqTnAHbHSqUmr2cpaHfukQkMYo2YnHTP+elac/c55YVrU4ltChmiYQ31wr9WSQISCOmCMceh/xrHvdN1Jdkb6piFgDudmKBR03A88fjXpkZgmQtHo8DuG5dwMj/vrP5Ad+elMurU/ZsxQWTRyMC8UcSr06ZYjnr04HrmrUjH2LTtY8yXS5VjWUQW13atgM1pe7CT7kgkde49KoS+HpTMBapNFuHQypIB7A/KD74r0W60Rbs+bHptnbykcOyo+7H4Hj9ahHhi5ELedqchklU/u4I0jwPXkE/n19KE2RKknueZ3en32k4O1kHIO+IDJHptY5+tQSRyuD5tg24874w3/ANcGu8m8GMzblnlVkO13llZ2I5O0BCOfasi58GxQ3Eafa4N8h+SNoiCT6YL5/nTuZOm9l/X3nIrJdWQAiaZVzxEwOD68UxLwqwdY/KkPGUyNw9Dxgj/PNdu/hma22sslugB4IYIOe/C8D6ntXPXtpaKWDahG75z5UStICe5JzwelMzdOUfhZRF5HsUM0eR93dlHT6MP6/rW1pWswt+6unjdm4Ej4IP1GeuOKzbe2aQqbdnlQDLDYpcfgeD9M5q6thDMVi810nJIVZIEUt7dOaDWPNu/6/E15bS1O52ihxgsUCLgd8d8fpVS/sYwIhHEoXbnKrjjr/n6VZs9JW3KqPKTCkuAnQjvlcc0y4MUJjDSB+oGTjP4GgoxrhPLYYb5QMj3HpUAdmkPPBUnj61YulYSMGyFXHQcVAqABFBGTnnNBDG+YDJg8Y/Woi5bcxz1qWeGSFombGGBIOQf/ANVMckCQkZz+VMhmp4SEY8T6QHcoftsGG9P3i80U3wwzL4n0eZCodbyDqeMiRaK+gyaMpQly9/L/ACZ5mMa5ldH1hcRRRyW90xjjuc7N8anaeejf4VbtlSe6DMI1eRg0jwkfIfVV4GOlR6ZcGyQvcwzkJMC0ZQyBlPTn0qbUvssV285DWwuMgBBkAeoGMgnHTtXwjaPsXdy5fx/T+rlaaFC4E00YkDbQ0ak9+jZqjPaukryWzB8jMiA4KnHUetXblpMNJDbqZGHALA7xg84PQ/59KptPIFX/AEYFnbaRt2upHvmhWvc2pqVtCNoF+Xb5eCuRldpznPbtVW4eSFT9oRRGWwsijI9s+makkkXJkuAfLJ+UE/d9eR3qKS5hmd42Zl6AqwJz6Hmrsacr33K7bJpFUOyvnPycBvwqldbFcJulMoXAyMYB/Q1dmifCyxuJZV5+c4IP4Vl3TtJId+5SOSoOQM+/SrijFq73Mm8kduI5lcc84yf/AKxqhcPhWVo97DgqecVeuw4cbHAQHJBGay7iclyBySeFzk4roSInOyKgJLnc7YwdoPY44GfSovLLyL5oPQkjuPU+1SyMRwzKWzkKnzOf6frVSe6aMNxt7DIycjsB/j+tbKJz8zm7IvhRFH5jo/AzjBG3PQ5o86RiotbZXeT+FVyzYHIz1/LFYs96JmLSKzBsDAfOTxnkiqJ8ws4SPc4GfkbJx7nPWrUUdVOgup0ct6FxlIsKmfk2n88Hnr35q1Z3keXEsRYtjkKAVPbqMg9+2a561kWTzhPbBZSAYzkqRgdSDyykDt+datiXuojEJZTcIPMREYOJB/F1Oc8E456Gk4mzpRSNWYOsayGNzvfy1Zk4Zh2z68jilFxIsTBHwCMDy2yo7dOx96ztI1CQ5tm+0SI7GVRAFO0DILHPt2xV03UEqhp4uSnztGNmG5wVxnIwQTkZHTvUSiS48ujRoSXLyRR/aIYwcAeZCow2Oxxxnt6ikM8LeaYZhGQQMEZ4xnj8j71izXSWyc+VIjRMA7fePPXA5znIA/pVqExOkXnDzYCB88TgSOMgkHsXG707fWp5Bci3JLe+uY5jCQjq7DKqduR3+X6dDW1GhktpxbzqAAGaBziQgf7XQgZ79a5rzPMto7WRtoD4TCDOf59voK0ra0nICxSxS7BlQjgMo7/KcEn0puNypqL12JpLuKJZBsRJHGXbGRnPXPJI6cVQa3mmk2weQSXOXXALNjI5yO3c9KvRXI89JtQklZ1wQhiC+YOwLdPY/wBazjPp8UzKJHhl4BRCCAd3UH+LueKcUbU20tDpbWMGEJ5lyhjZTLvBdGP8PAPIzngZOCao6iUmdJPKtQiHIjhXLsM856evT3qgmrfZ5mMM9rcbG2K0hLZ7Ejv7cVVXUmlhIF1CoWTaWXknjghj0UcD8/Wny31M405J3Ll0jb2e3Nxb3JlI2KMKiH7q7iTjr0JIAqOzXMwiBEoMvzYYqm7GOWOMfX0qkt00rrHGpRUQtHmTauR36ZJOcZx+NNF0gjeVpGIkyygScDAG7dnBP5H+VKxTi+WzNe7uG+z22woh5XEKAADOPx6U1rwSyIyhwin5WKhs+uQevSqen3UJE0Ra2SIgFmyWwOuVA+8eOlS2RFwBJF+8PLcKRgjn04FK1mcs4xW6NAiMbQVdVK5DOpG4diT2z+XpWVqF1DboFW5JOS3RW5PqMZ//AFVoTXJAPkM2Sc4UZ49c8Vi31vDNIZnTzBnqMcnr0rS9jljBN3ZFeX7AB3voTuXgIjBz25XBA/zzXP3lxHIClw1ztztOLIkY9sn+ldQHeJFETzY+8QhJ9qqtbwmXzHhDEn5i0YY/rTvcxlFnFzw2U26OzsJrhF5kZhKfp8uFQf8A1qaFazgkWexlIyMRCVYkT/gAPP1Oa6m9mSMN5drlf4QOMfTt+NURNezLG0dugC9H3fzHBzRfojL2VjCnllCJ5+klFXksyEFR2Bwuf8fpUDIkkLkS+ZCxysZhm2scdM4NdJILhWUyQySsTwiuign35yfrVLVLe3ZmMlvNA2AftHl4z7Eg+nvVEtGTaXTWkQKsjBePIl3Hg9dhOOcdjn8KvT3sc0fybsJ1Ujn2BFQHzyQYRLJGrYIl5Bb/AH+uTjvmmXV3ATC84kgkAwxZMcfXoaYmkihdR/xCIrx0HApsbBcyBR8pztPNWLy5t3t9vm7nzx1Ax/Kq0BVRIG6HoQeKZm/IbcY3YIGOvTNRnhBjnNK+7auGAHcYx/nvSQ58w8dqRn1NPwwpbxToigKCb2ADI65kWin+GmX/AISPSnZWbbeQnCnBP7wcZor6PJIydOdu55+N+JH19bS3InaOb5LMKMSqQDznA+Ye2atxRyPP9me6tppiD5bSpjOOxI79u+awbe9ujeyR3EEc0CLwjtlcYwO+Px7Vr2l4r2UKxW62d5G2A2ce2Tk/yNfBbn1NalKOy/L7+/qUL+O6eeaSe2gDQsAsUA2jGM8e361jzG3CyySKybivAY4BPJ59a3pUjljNzbyRu67mlTlRjIxwcg5yfy96w7mb7STFF85TH7vbnAx3pWR10HdW7fIqyoDIkkTOoY/KhG8EYqrFcNJugZgFQ7lG3jPrxx0/StCxjeUSy3e1BCMtjAdR0BA4B/CnXVlCFAaIgtnDKMHPvjrVJ6nRzxXuyMq6OcHy8gcAhsfiayZ5xErLyckDAOP1rVv2FrwzfMOcdce1c3duHXILMDz6e/51vTVzKW3kUL1y0pPyrk9u3NZc0uM+VnGMEnFO1CcO3DEgH8qoO4RhluccY5AHc12QjZXPMrzcnYsGUBlL7m5+70AHvj+lQ3BSRXIClQOgB69uoNQTT8qOCdwXGc5/GtCG2ZwHXzGyDzgcDvj6VXqZ0/dd2czeJtZmVDgNkFV5J+gqC2ujDJbu23fG24jqPxH+c1uX8TZcRqWk25PHIOBk/lzXPztl1adnfBO5MY2gdOee/tWkXc9elO61L9vOl47i7m8kkEKHJ2J+ABwPf3py3DweY6iM71Kh2XchXPXJ5z71kRzkKq7lG0H5sc5PY+tTG5H2cRBt5BO0En93nrjsQf6U2tS3M35UljZXgcNGhYhR8zQ84+YjAPt6/Wrul3sJgMPlSecZN6vyQgxhgw9MfMD7Vy1lNFHG7O7AEDocH6j1x2q7HdjMU/mZw2HRSM7u5/EVDRm5M2NSELyyiGARKuMEElnA6kd+cE+3TpVCzglkuIlsb3/WN83mrsEeTxuPfjBOOB706O5E0cbyy7ckuylMsFB4C+p5J7CtD7O5ljV8x3OFYKcbcY6Z6Z6cUtivaWVmWo1miiLzwRSlV8oSKx+ds9VIPPueOtXIZbtBCWjmjUxgo0QyXUE4HPQE+n/1qhhjLTgyXMcRQRp8gPyjbjBU91/rjPFdNZWsC2UnmzxQqsgd/kHnSMoBJ4OfmyOAR3PUcw7syqVVFGYJomECuGjG9vMjaNdmwjlQ5+cN19h2qi7WZwSreTHn5rcpgKM8upwSf9rj1rrLewvry1abbdpIo3JCyrLG6rhpGfPB4I9+B71h+LIYrJorbVxb7pHDQzPZMn7r+9gEMqEY6BiT1IqomdOsm7XMBvOYxiGQ3LlFXaGDYJOFXA44GD65PWok+zQwAPbv5+C293C8HoB69z/+qq7yNEhMKJCVfKJkktu5XCHIUc56/rWXNeMdkbg4XO35c5z7n+tW1c6HUZ0dwklvHF9odt0sIYDzDuHGNrHtj09qzGuEQws7NF5gK53AkgdcDr178dKwri/lLMFMYUY3KgGCe2OvPqR6VUNwrTeZPEZd3Lb25b3pqAlJ21Z2QmsrVbcQwvJM48xw2F/3AMHIBXBI4Pb0pg1WTynUhl3ksBt46849hXN/2jG0uRvION7TMWYgcc49uw/Oo7i/XkRswXdyANqgZ4xznpjrmjkM209zqFvX8kBJCVXHPTH4mn/2mojRIGXccBj3JPb9elcXJfu5x5mRkcZwPanrcBynmBMerZwD+tJ0yHZ7nZLdqcqS3mEnAB5HbOD60klyoi8vaeG+Zicj+dc3aXsSGQkBSQM+3Xv/AJ71aku4pYNmA0WcnA6+3+fSo5Wc7WproUfdhnLYxgA4FJK5Z9ke10zuXacge/pWfZXBKHHyY42j+L06VYmmDnaFQOTzzgn6jv2o2MnuUxHbsztLG0ig/NkEkD69B9PpVW7t7Nnw0Ea98upfjHGFGefyrQMUu0D5jzwcAfjzimhJdrAzbivDEBsdPX6U3KxnNJsyEsrV1cR2Eh3fKrMgTd+HX9M1UguWjXyYo1aT7pSPOM+pzx/+ut2WATK3ynaxIOCRux645rLNqvmvEIyicMqDA+uTx6CqTuZ2RnzxsD+9CgsMbccCqQh2t3Cjk8/0rQuLJCTuiVew3NwKqiPaVY42kkADnFUKUSsz4LAgH04pUz2yT2waa6Eyd8dMGnQMqSYf8MUmc/U3PCRK+KNCKjpfQHg8n94tFHhmTZ4l0eSLIK3sJHpnzF9KK9/J6bnCWnU4MbJxkj66srS8jupoo418lVA3Bgwzk8AcfjUlzpyfNOIVfcBvw2MrwDjJ6/40AwNsSKQKAMMUf27r6/rUIuEsrYFFklCjAZZCxAzzke9fDPTRn0t5uV47/wBeYTwpA0zW0DXEUZBYJ/AMjkAgepFY03lrf5UCBpJAqN0zzxn0rSld0YzQh4wwDMp5Hy9yPr/Oq00qXAWabYwJLBQcY9x+tC7HTSvHfX+vuJo7hlIhjVSN25GOAzDHQ9se3fFZbyMgMRdlxkDOSAenApNSf91HLCwwp3EIMevAz2xWYbl3UOXGMHcr8BQT2/Sqs2aqnZXKt6ihSDgPnoRmuY1MBFKfNx0A/rW/eTFllZMIQOAOpFcnq1w3zBy5IXjjJrqoxMpyZgXMwkkKs5Azgkc4/wDrVnvKPOMe4nvtHI/GqlzdIZmbeyMD820cVasV+4yn8VPTNdbTOapGxYjgknmVIVJy3BHBxW3pkIknEE25JFJ3MnTbg8gdz60/RrAXU5UsqEgYAOMdO/IAzWhrdukYiMjhbu3Ysk4zuwMbQwPUADHQccdhVW927MYvmlyGLe3CNd2e9nVgRHuQZY9e2RnOQMcdK53UY5kMzRmJ8jY4jbLgZGcZ/AZHUH61pa9dxTTI8FqURgQVMh+VlwdqsRlTw2M5yGAxxVDxPJZreRSaZKjW4iXACMpGUHDqxJ3hiyswOCVyOMUQVjsj7tihZyo1zEGSHZHE2D5eSRg/eAIJbPHXI96oySHZ5fVAc7en9KaZDEwK7QSu3+8Gz1PP1H5UyA4kTzAGQNlypG4j0yf0471qU5t6lma58wKGkfeTuf5hjjpjv07GnxT75PujfwMjjHTn+tVISoLAqpZsYLE5Xnt/9elUbnCLnfx05zQOMmXob8xDY7DGeflznv8Akeh9qtWl7czDy422qV2zSyPgD3+nNUJoZFIkG9mBy+7BA/WprSaVVmYIqIAytgdc9OPrx+NKyZotdTr9E1G2gnhkjtftkVvE8kqO7RiVBwcnPQZ7c8110Vvrd2h1jE9tPBGZ7eKaMRSzRgZMqlyPMAX+Ibmwoz2J870fVbw3Fvax20UiQsTHD5eTubHAyc9cHAz9K7PT9d1jT5I5dTdpLZ40Zru6sGn/ALPb5RtRGOMopwAeCH4qHFEVKct4/wBf1/VzpNNvdGk8KLPqkM1xcWM8bXbrMyrEzFgu9ShQL93LMGYscDPGOK8b6pYwGK2tLnT74XcPmz3FujSTQux+ZN+FGBnhQAFHBBr0rxXMNKluxod9ZbNXtdpOlrItxesWKqFLboVweSFw2GYALjNeL+J7S5SOW8m1dZ7stukhkuTJLhhksScZPXP0pxSMsPFTvPZf1+pQuLkRbiod4AcpOy4+Yj5dxzyeM89BWcbwfaMFkIYgDj5Tz157fWmyNNdXXlQh5icgJIQ2eMZx0zx+lUAFUnzFLMRnrxir5UbyjroWZbwPAsGyIBSTvXh2OeNx746fSqhlGRliR/FzwfSiTLYYpgv930x04pJhheV43YBJ54p2M3cmeYySGdgA5VfuKFGBx0Ax2qAyZdnTAUj+L5j/ACpgXJJkYYHUDqfpSSSRkHEcg4AHz5OemTxSMpNoRXIcHqRnANT/AGklCshDDPT0qqzMACMDI7Z6VGMgZAOP60GbmzTimZQzIQEHysWBIH4/hU0NyGgl3CRmz8pUAAe59B/jWOJJANoJ2k5I7Z9atwy7QyDPJwDnHP8APJ/xqWiFO5r28rqu2KVdpG7AfG31JBH9asrNHEgaM7um4jge/XvWTNdIzmGJEVN7P12j8ecduP61XNyqhVU5CZw3bGfap5bgnc623uoiQUmVNnJIbdz9etPN1HNHtBX5eAT3z35PrXKCeQOqjDFhyMA4FacEsUewE7i5B3Asuz61DgRKBoMAYl2EnuoDfzz/APWqBlCSZXcvygbV4GeefWpRKjc2ucKDmVupOeeO350942aRZJS3UYb3A559fXNJC5TPuYC27cQ8mM7CMYHqT3+lZtyihmAC7ecEHmtW9aMsfLHGe/8AhVDywxbfuAHXjg1ohyjpczHQxqxyGYj60qQrIGYn94F3exqaZCvGeDUZhVY1JJ3HsKDmcNTU8IqZ/E2kRjHzXkKjt1kFFHhJQPFGkfw5vIRuPQfOKK+gyaUlCXK7anmY2ykrn1c0cBnWeNGG4hlbeFOeM4GP0p0vkeQ26TaypzsXGGz/ABD/AA9aruI5VhMih2Q7sv8AL29RUU8MhHnFQIsDCjB2t2LCvht9T61K9rsmtixaaVvm81M5b+HBHNQzxxIS6dBneqjIB6fSmvJGTtQlXI2nBOCeM5otpyBiUrG8YI3f3wemR+lTYtXWqKciFDtHMe3C5PAOQeP1rKutsYZYQMAHKlQCQa1JN2wLjdn7vtxWTfoDmPbnB+bnitIbl3u9TNmGAd5wVXH3sDFcvrMMUsRyZFxjp3NdXdjyoGDKd/Q9DiuP1KZv3hf5dqlQuDn1yK7qehyTu3ocfJZtLK5ZmBxySOMVLYbGZRFLhM4zn/PFTOcsvmAmNs5Unnr0rPlmME6bo+M5wBj6CujVqw1ByO70UCzgubiWY4kjCdSoYAgleOvIB544rN1W68yUNCWaTJyefmGOm09Oa5+XUnmQpIiooweGbnjgYHrzS3ckc0LIMrs+64Zhkn1BJ/TH40NO1mbU8MoLme5BKLmX7RHH8+CZJFLYIK8c5/CpILG9vbW+ezGY7WIO6F/uLnuDjALfdyPvEDqwzWuNau1mhfz33wR/Z0lwA2whgVJA+bhiOc8cdAKZPr9wdXbUPM/fuuyUn7swPUMB2PX2OD2GKSZz1Z32H6fpsN9fQWkl5Bbpd4ZJC25ImK7lVyB3zjA6HryMVXu7OKxmvbS5nje5tZWjVofmjmwdpKsOo6EE9R060+/uQiTnT1dLG4kEsSN/AVOduc9cEdPUVV1G4eSGDMdqgYDBSPawIGPmOPTHQkHg9aZipO9xkiqlrEyzESOzhkUg42hdpI6gHLflx3pVX/R1dZt0u4hkKEbVAGG3d8knjtj3qrIpEzYyoDYBk79uTjHr6VNPHLp93cWtwFFxbuY2CMrruBwSGBwR3BGQeoqi1UVzTW5KKFlAZDwAvGfXP0q7D/pBaYHYXHzFsfNgenesIzFyqbQoHQngY/CrdncSRngKBIMkZ69s/XiocdDfmutDbOlzSR7yVderOrAr/nitGxurjRo1itJdSi8yMpPGJ2VJeSVyg4Kj0Oc5PQ1nWc7TIwCFifmI59Dxg9auxvO0JkijDheDmUfOCeMruzjg5I/Q1F2Q69tJFzUPGWqSTWBSZ9Pt7DHlpa72Usv3WKsxGQOBjAHYVyetaze6r5TXs4kkGSDtRcZ+gFdNbahrbaidJ07QIZL+CaRJYbe3lmZT93Yy7ioAPQ4BBzkmsIahd21vcI8MyXBJQyvGF8kBcFFUrgcYBIwccVomawnFbIyJ7tp3zIqyHAXCoF2gYxjHFQTyiQqcZXGACxOB7d615tM1GGe1hFvLC+5VhXzFVm3gMMnPcMOvQGsNoycbSrEAkjPTrxk8dqtDdRPYGfjAbCgfzqGQqf4Rj0FJwevejHXI/CgxlMFII+bA6kbTjB/wpARnOAMeh6Uh25HJA7kDOKI0UyKGyOR6D9T0pXMnIlnwZZAww+47g3Bz/SoCA3Tj6GlZAu7J6HHBHrUGMnjJoIlIlZFjXkfN39vak3MsZZR0YD2Bx/OhYZDAXUMIi2Cc4BIGf6/r71HJH5Z2vkdiew6cfh3pGMpWH+YDnJYk888c1IMFQxOTnODjrVfI3DCjAHUHr+dOxkjI6/pQTGZctnwwZlG1fmIJwDz0/wD1Vpwz+ewVsZCg84wR7VihyUKZyoPTHQ1NavhzkHPt/Wk0brU6jS4RcSgqCrk/w8ce/wCFW71WWYbCAFxwOn/1zWVb3TW0QVJefQ5IGf51f3l1XzDvJwRnOPx9qyaZShLchmiV8uVBLdywGKouqJGwVhkZBJNaE7BSuYvmA/g9KpSmSZiSVVQfwFUvMbi2UpAmcEfvPU9qrElsoADk9RVqQMJRwhyOmKpunLZIHsKoxlE1vCzg+JNMTkhbuElR3+cdKKg8K5XxHpjpkAXcXX/fFFfR5HG9Odu54WY6SifUkVysiTB2LFTkfIcfQ85BpDjygBgA4+XP86yLucR52OCR1A7/AIVL9u3o8jFIyFAIzzn1Ar4VQ6n2bptaosXUwjnjjZAqHneM5H0Hp0qvfTuj4YhT1VlPBz6VRnummiDgNhOG688UsjqLdSrK5frzk/8A6sUcvQ1jG1rkE964mKIMsMZH4+lW7lxKpfAC4xuzwaw13tMdj/MSOvb2HtV23uN0Z3vjqRmtOWxFaNtUR6gFj+aUseOM+vtXGayuS21mKkEBvT1Ge1drelJowjvudByCOn0rl75QBwC2DkEAce1dFPY4JSOXnjEMRnZCQqlT3wSP/rZzXOvGzlQzbygBIIOTXaagnyhIeVYFSFXLevA9B1rnr+LZOJ3JEckZyFB6dDj2FdEJHVQehRgttzhWcRlW2/McHkEg59eKlsIfOgYt5jDBJ8sjK84+b0/+vVYOJFtiFDeVtWXBPzDJwT6fL8v4V1GlQWgEohy0bP8AKhGD7DI6DB5x+tVN2RpUmmrHOS6NBNHJkTpJuI3KwZemcYyOcj/PSufe3KKPJaQjnIx+teh6jBHJGzRs0OdqOqArlefXr+PvXNy2LzNhg6xgbf3fG7Geeevfp1xSg+5wToxetjlzPNANpbKDOFY9M9cCrVleQBY/Mj3zAkeXJnbID06dMeh60SQRLu+Qh+wUc/8A1hUVxYS28QeaGRFf7pKEL+B71eqOCUKtN6PQ0Lqea9SWSSQZO0kYCgEcBcDoPTj1qvM0hCC4L4TCICckAdgKzWedP3nmP0GNxzn04NOTUJ90bMVJjA2EDaVA6Yx/nNHMZfW4xdpKxs3EYivFjtJAyNErAy/KFJXJXLehyM8cikimjW3hYplc7XDZ5bOeMdBjA796o2t+HnVppHTndhvmBJOe/XnPrU1wktowZVxCSHR+GXPTgj3qtOh0068ZapnQaRDcahII7B7ZpOdttK7ARLgktvPCgEd2HJHWoJbmWK423CukiZ5ZBuPYkjo3+c1n2+m3s9xI9uh3w4ZpImBAJ6EkHIz245/Ougsr+1ls4jqEpe/LkrC6earMMgFlbjGepGDjp0wTlKdSzF0bxlr+jW7W+i6tNYxTSrLKlttTeV4HGMdOoAwe+axrnUNQ1G9b7Tc3M91PLuPmPlnYnOTz1J71LJaG7WGGytGEiJhpRuBkzn5jkkEHHBGBj3rNS9ltmIZUlaP5RHMu7aR6A/8A6utFik4rVLUtzZFnCpgRgS20gqT975vu89cY3Z9uKzp0MUzI6ncp5A6im3F0bjylmCARrtARAOMk8nqeuMnntninLA8ke2JJTkjAwcsewC96ZXtNCW2sbm6sL69hVPs9mEactIoI3MFGFzlueuAcDk1ULEsNpViTgDqc1feLyvDtvcpNKgkLwyxFGwxyCGVtoGOxGScoegIpLuNItDtd91A8xlkAtoRh0xjEkjYxg5woBPAPTujPnbIFRY55FvVnTaxV0C4IYZ4OenPbGanuJLZ2lFvFcJbhQqGUBmHXqRgfjioLvUp7tp5rorPcztvluJCXkJJ5OSevA5/+vVN3CceZz14PU0CdVLVks7733Y25xyAFB+gHFQEA45wM96EYuELOrMSRtLcr05Oeg561dMPlBSbRyxYoZCwdGbHRcDGR16k0rmXtefYijuCsPlg5EZLKAOcnhsHpzgevQYxULhywUtkA8Ac/j79anKEAArtA6cdPWjYxfcW5PGcUGipN7kEcLbC5GUBAOfU56fkaeqY6rz6+lW4oS2wF2I9ByB+H51dWw22wkcO0bEqDjPIPH04/+tSudFOikZIUnOKVW2vg8itaTT2WMOV+8Mjgjjsah+wlT83J7ep/Ci6NvZW2IYtzYJ4VefQ1pWkjBl8wkZ6kenb+tW7K0hjiIZQ0mcMOuKkuIVCrsdVU8kqNwH1xU8y2NY66DHkkfaqp9MDk/T9aVU/d+YzHdjtyRTGeVAhV2IxgEjOPcVbjk3ho/L3Nt65HPqce9JuxlUVjFuY2VssdrZ4ycHFVmiyiuxJOTnPatC5tvM4XIwO+M1RwRlctgHk9qsxkibwydvijSgehvIef+BiipNCCr4g035QcXUZyOv3hRX0OSpckvU+dzRuM42Z9CmVSWITEgOcnvzWfcSSC9M25AHGTx3p9rcSKz+aVdgTg+gpWEbZLZLdxnNfGJWZ9w3yNjI3LoG3eU2cAqeD+FVEuP3eVXB/ugZxj/wDXT3BUg72bpxjvVdiTGCDjPGehBoSLTTJo5QQS6FiDjcOBiprpAEVypLY4OSMH+tZiS4nIKjJGGX1/+vVxxiJXibcuPuseQfSmZ1FZkvlOUYGQo/foc/lWHqscuWKgKRgkjAC//rrXSVtjsQyjPBC4yepFQ3cY8tzhvmGQpGc+1axemp59SNpHGzyNGUe2n2SRvvjIXlSD1zUGot9puLsrAIWmYyKsfKJkklQp5xk+v1zW5eWTrLCURRGBtAGNymqs1iyTIyAZ/iQ9R9PrzVqVi4yS1OLFlHG6szgfMQR3c9uOw6frXQW1w1rbH7KxjkI2Kq8Fu5U+2cfUcUX8ASZpADGeTg/dJPXHpVXcXd081UkkGEZlGd3QKD0HXitFLmG58xJdXpldVx5mECu7Acnj5QB2HT1FUZm3XTLNFMvQtGqhCq9eM9B9elTMl1byw2sojlaMBxE7cp8p2ZPRsA7h+vpUEUqSwybrifbl5GyCTKQOMtgZ5/Xt3rVJFWTRlX4LX7vAxLltxDgMTjoOODj8uKuaKlzc3UEEhS8tthBgkcv8uDxgdBnnHHIFQvDIZzIZF8xk3ufu7Qfb/wDUOlL9u8m4YQoVkGPKdGwV78nHPGOO1U0Y1qd42sYWtxRi8uFt0HkxuUUJ3Ycce2c1klTyAfb2AFa9xA0pDuyjc2AQQADnvVCZMbgoG4nbx2AqZI8bEUHe7K8QBYOy7o1/hbOD7cY6+2O9KJWUFI8oGOSqk4HoOTyAB3q6Y1CqqE+WoBORjL4x0yfz/SqIG6RtvTk59B/nFS1Y5J0nC3dl/SdU1Gxu1uNNnlguYgSskJKOBjnp29qsXWoypFbysqi4k/eeavXqcc5PXGSOOvpiqcEAiUtPGWUxHad2AGxkc+ozyKqLFvcquNwjLfkM/nxTu0VKVWFnfVmtf61d6s/+m3LzNlm+cAcnnoOPp+lUEkw6ndtI5GeKhQMoOD8odT17np/WpThNUZZQDGsp3LGRgjP8J5HfjrRzNlLEVEkWY55HKojquGG0dApPTk/Tuab9qkld7h3kcr8vmb2yCc4OfzqtMgVGjVWDJIcbjn5D2Pv/AI01PLZkHKKGIz6Keh/CjmZUsTUbsyzLODGI03BepUf59ulQmYqPlQ9D16VG26KQEDc8bZwRxV69S3jnZbYFrcnzUZj8+GA+Ujpwc84H+Bdh7apO/Qqr5khBiLYPcf56Ui26srK8hSYMApYjaw7jdng/zqWzcQTLwH2vkZOB7qfTNa85gmBaEEI3yypgAhcjAHOXIOT9APwBwpe0V3uVNM2z3CWk7WtvKpwXlc7WPQEbQ2e3TIPX3q2IipeOSNY2XCsFOc89c+lVZYY2icOk88QGElIz07McZGBx6fSiBLiPZGz5TIILHI9Ovbj/AOtQd9BTjpLX+v61LqWvzJtDyHG4+4H9P0pXt2jbb8ob3B4z/ntU6zzRxyQOzIufujAzn+8R1+hzjNWlic7RJAQw4Ax3/wAfrSbsehBGdbR4Yg5JzgEe/wDOtqxgGApfAkwxI6Z/qPaqy2rNKrOMEjOAMZrc0628vYXR9hGeOwxUTl2HKy2JZIDHM0JVeRuDRnIwenP9KpTWKL8rY3N0ZRyPYfyrSMDrgAnPUEH/ADmppIFeJHZ9wBYDGAc+h7nrWSfUpaGG6tAVBJOegXJPPrTL2Pzot4IWTO0fNgEe9aTR/KjKfmA4zxjj0Peo2iR5ysZyD1DEVadhp2M2JtgIXqvB9s+ntVmPzcEBVyBxnj9atNADPECpVUG3nnj+VVbhXkR0QhoyRzgHHtihvUyqO6M6QskhAGUz37VWuipLAgnPUjpVra7Tzb0URgHb14/Cqk4/d7SRg9M1omYS3I9JLJrVgynJFxHg4z/EPzop1hiLVrNnB/16EHP+0KK+hyZLklfufMZ1NxqR9D3IOftDeWAR0OfSoZWZDmIgP1Cg9aS9dXLqoZSGPPQg1QaYK+FbOcAnNfIpdz7+SbLEkrPgl8HnHaoY7jYArqWP8RHHHrVee5i8tYwDjoMHrRLiReB24xxTaHGLtqiZ9rqZOAh9OTTraUliEAaPGGx3H+NUgwjXklY2BGOvPrj8KWCY2825Tt3feK9/84pNFyTaNhZ1dGzCxjJxng4PsP60TjMJIJAAyWJ5J7fhTLeWNrYLsLsAANvbPrTWZUDeYrZPy4JGAPpSTscjhfYr5V1ARY2YnJY9Rx79eapXEwXYGXGB1UZ5z3HWp7h7hI3zslBwcY27QPT1p9q0g2s2MkfPxjb/AImtEZShbUx7uCG64UqZFG7ofT/Gsq6gZCFPzIeo2gjkV095ARISyKo4bJyP5dvasu6X5AzkkMThQMn2/OtIyMeTqjCuLN7yRlRkQklvu/MxxnGR/KqS3BtPMiGwSygFZUJ+6cEj0zkV099CJFcxDdxmRtnJHqBWPe6eZnBBVU34Uxg7lzyP/wBVbKRVOfSRVmCOTMFeEblWJACwBAznJ5JwB+dVJYZbuO0gghKxMcouSzM/Tv6nsKnuoFgs4t8rAlmZt/cgjGMeuSM1KtzNGgW1DLvDxwySjaoww+6eh4A+maq5u46aHOeUzOgiJyBkv02HP9PU1G1kysyq0bMgI3I2RwMn8f5nHpWtFZIt20U3yhCrMR1xxuOPxHtT75BaXY+yoqKzFY3J4j5wGz6455+vSquYTpRkzm7ltls8K+WCisx3LgjkcZx1qtHB+6wMA5AxjOf8/wA639U08eXA4MkguJvmlfq/JJJ9+KWSzMTqUVWh52g8dMZBAPHX9fXNLQ5PqvNO77FCVUMVwyvMgABUHByf4snPHHoDn9ax5k2XDsq7UbONw5wa6xrNN4WSILtO2VDkAkYwM9s8d+9Vtd02MWUUsVxI7qrqYnQ4iGQQFPcHc3pyvPWkzLFYZyV10OckjaJVJBGVWTBHUev6VqWyLqHiCWMsVNwhjRm/vEBVye1Jb2y3EqiQkH7K+dvPzLnAPpTtItZrjUoEiHzyoVGTjdk9Md+gGKRzRw+qXmv6/En1mydYvtDbPtCHZOoPzcAAgjpwy4z6561nJalWcKFljJygzyRgt09MA59MV2NhbvA85jRWhVlMsckYZQxJBXHf+vOKzRpO9fII8uWEBVKsWL5bKkcHBG5eM8j8anmR0Tw2tzHmtEnsEmhLCaIFZEKj1657/jTtORXslaSMkQS+WT5ZKlWHIJHccMPYV0mk27bGjkV8yp5cn2dih3qCVJB/hKjPTnaO9RW+mPa3iyqXeFso5jBAjYY2Nz/X+lHMhqglLmRjXmlG1v7dN6SRXBUK6NnGTx1x+uPetgaXGIwYsrOE/eIArIuc/Lg9OOepxk+hFbcmkiW1ubO8dYyDlF24xk46HBypHQZPTpU2n287xedcqryxAK7O3mEMB3BOccfhxjip9obwpqL0MK3tcK0zKkZHGxQVxgY7cfj3pi2kUN35vk+ZDnLQj7pGOvfHr3/Guh+yrPMVQIzqfLwAVJBP8X58du1OltprefdcLhw20g/fHb3/AJUlUdzpskYcelwOgW2NwZNoI+UMCSQCADjpn72fyoWO4WRxLIwYEqwLE89Djrn61uCNoRLJAxRgpAfaZFyRgjIHBwevGOOM1nRWBe4854AxY5K5wCPpnimnfcal3LVoQ6EnahBzuYBhwf8A63etGGGUlmKRtGP+WqZwc9Pp/Kq8FiVGF3Ek5C7sDH547mr1lAgRD5nlOP7w5z7+9ZXMkr6lmzLNsMm3BJ5IyP06U27gjKOssexsfex0x6j1461ajbahUjKkZUrjn8P88Gk858EuCQBtdwOgz6e1NqxrG99DIkt28gOjHqCP4t3r9DVUW21lEykvk/Jj+RrXlRdpDKcDkAfqKoXLSebGMlgvzAkcn0wTz60K/UbuVIwWdwhJBPC8HIqO4UJhgrsucggY/Op2CF5CoGWO7B5IqCc7GRkyVA5x/wDXp3MpGTcv8+wYGBuz3IrPnG7aWz/n0q7fbXb5GIIHBHQcVRYknkHA9Bz9a2S0M5KxFZEf2hbEZciVSQR159aKZZSqNYgRT8nmLz+NFe/lHwS9T5bO1epH0PcdQRfNlLtkhiBjkD3qgbMuZx91sAn39xWvdRIt0ykgEOfYtz/Oq9woDOmcJ1GD+dfKWP0BzadkY9va+ehCtnY3U8c1dWAxBUdAMAZNFu+QELAFW6Y4qxLlmDK3O3nNOTuW7vRlSeMN0GeOQTwKzVyjmMhgvTOMkVrbSrAFiSOD/tUy5tAF3JwxJOT1x2pJlQtsxlnAXnWKGVF5IDE4BI5H54/OpnLEkSmQSDsw5zVDzHWXymGGI/MVqCZ3jiiuMyqCWDMoySfU9/pUvRkyi7lIyo07w3SyovUZGQD7n0yRWlHAIcIGkCDhcDOD/P8ACmEq6ER5ZScqMnDdf61Yt4JWBEUbsx42qe31/wAKpM560brTQGXdGNxCk8Hf+lZV/ajIcbywPLADmt1wJY+UCN94c9T3OfwNQpLCdyqUQ4xgj9RTjLocyjZXOcRPIPUFT1B459Kp39uWhAyoJJH3sD8fc11d5p0MgRkIlBwdw5IPQ/jWZLasiOpVfKU9duSPp6j2q4yIst0crPYmK4iedDjAJDndkHoRxkcVD9ilVZo1txLah+QGzjB++nof6V0t1A5Ztq4QkEbWJCj2PXpVb7MtvG4Dsy4ITbjPPUE+/wDjWl7msXociRNBckwzncqsM7cgqeo5/LmmKrXMaxylkQoSc8jd24J7+tbM9szNG6FBGgIOeeBzg4696atvH5ZYOo2jeG2k4z6/yq+bQ25TLvILiaGCMqjRJENgI5zjHHpgc/zqeSAx2cAUrO7ZViF+cZByobuF546Z6cVLcGMShlHyf3PfHUCpEucK7qCFKgBc42nPYdxjvx/iOTY1TII7GOOFG+0QymMbnixtEibgMgnqeenUYPpWj/ZMUkQlkJj0+fALKu5kBHykJncc9D9QaowgpMjyRM9soBx0JBJ4zzg1oQTq2IomMkAb5YpfvJz+HzfTrj2oZEqbOfi8PrBdyRXErqFGI5oiHRlPqR6jvU2gab5eyR0XeHeRkfqnQA7TyQAO3rXSWCKyef8AZzNbkmOY5YbiCCMtj5SPX8+KvW6TQGX7SvEK7V84BjCrHKn6HruXoenXnNyZi6KRBHZeffxKzx27sQEkmXcmcZwxAOB+Bx39RHJo0v8AabJIqwSTRssiM3ysR05GRzzjnA45Ga1LOeKIECWKMIyk/Izq5z2I5B+hHtVxf3KqUtImtpQd/lnCSZGAy9djD1GP9oeubJlB7GW+i5RLi3TcS4SbgHHf5lzuBDZ54PoecVcksoZIlnuo/wByZQBdWuGUjPKkHG7g5CttPPTrjeig3RLckyyQQsEe6QHzLfPQMc8rx0I68g9qdbF4Y5LwNGJAuFngk8kTkc7e6Fu+1tpOOM5zSuYSTe39f1/SMCPSbSf5YkVpoiQn7suCowcbANyHtjHupqGeyt7CSWW4D2sDxgJLD+9iB4xuweRjPcnnnJGK3JZLeITNqNlO0kS4ZI1KNC27JyBho+/zAMue3PEE0xijhaKZ8zEeW0yqfPHcFhlWI6EHPrwae4LmT1MqeeSSECdLa6hBIUxAZX6HGQPYgD8c1VWRbg5i3ebjDK3O/wB8H/63StVYvs0xMIa3aQ+WcHG7PZgTwD75X27CGf5HxLAgGMFCuCD1/wADVbaMp26FAWzO4EyCEjIWSLJ+nv8A0qrHE4uSUbcynK5GSMd8jn/JrSVMKGWQhSf9U54P0Pak/s87uAd5zw2TjPP5UX7EpW3K7xmSRW2IDjJYdf5896siFkjzJ90fdduuKIohHGJCEdujq4O4fT37ZqaO3aUPJB+8C5JjZhnpztz3/wA4pXW5tFdClJGY1JgmUYwdu7p7kf4VA88qSgMwG9QSzrxj3+lTpMkkW6Z+QuChxx26kcf/AF6ikSdo9iYVV+fGAdy98enfv3zSNlFrcimuGgEhmEqgDB44YeoP+etVWlillBTOz1OTtz0GalkSVIDgnyyBgbs9vX8MY/yaiJEYm2NuVumTyvoR704g7DXjZWzI5CjJGR3P9aqyMQW3D5Dzj3/lThIwmWOZnKsCeBnP+HSiUvLGUVVDdyrEg/SrRlIyriRXmDLCOfbrWc6u8rMAVzzk559quS7izRhlzkMAOv4VVlfcwUjDDo3rWyVjCWhBAVXULRzkASKScY6EUUkUcpuopCmFEq/Nnoc0V62XzcYysfL51b2kfQ931OYM02wbSGIHPTms977ES/aCE3fIp9TgnH6Gp9RkEk0iplV3Zbcc9apnK5RRwehPSvnbaI/QnDWzHWhDIXZQSWwcjpT1JCb/AJcgHAFK6FUwHAQdaguJWDqY1YgEAFTj/PWjyHFc2xbdVaZQAOQMip4428p8KMHtmoIOYzvBJGBz1qwrKrktu3fdx2NQxbaGJdq0N1HhdwIwSB+lbNouE2NsCYJKnOB6YxRcQfvNyoWIxweBUM0nlMdgJUjLAe3X6UPU1aU0kTxkNL+6cKcjcp4FSvOISAXMbnAUZzk/4VQn81Y4bvYypIOGzww6cEVbiCeSGcBldQ3zDke/1p8pjKCLnlvIiMHCCU7g6+o4I9jVA6PAt6ZDI5lwU+Vzkd/pzzWlbSRJCkbYx3yB9etRK8xuASG25OSV5KnmpvbYxtJXtoLHALZXMeWhxyX7E0qxIsZLsiqTg+59v/r5qy0LxAFWA3DaFzncfxrMlMlwJAFIwcqp704y7mCpc+ojwGFZWhjOzjcJVyAPXHb2NYt3Zu0zBAjQPkgoeF7j6/SrkK6j5ii0mHzAlkk7Ff4cdc+nFMme4WXJQqSNrpJ8qgjjntWinY29g47O5Uayhkttwc/aFBAPlnDH0J9+cGqyWYNv51srmRMrMikEYxyR/M10FtEYZxIjC3bjY8ZJAJ5H09xSx2McLRShnV35ckcr+PcGr5rmXM4M4XU9ImZfKjHzueAGGD3x6Z74rMNldLbmaPgE4fLDcoHqPbg59816FdWYSUG5TbBJzFKuCoOeCMdPpWfcW00dzJPbxiZhgsJVDBsDowzzx264q1OyOynV5lqcjZxXk0koh/hXdJAzcyDByQO/rj8e1PijkktxlcrGx3xhcNCc+vTHSty+tvPigmtkw6uNrxDJjPpyc4+ueKW0hWZt+TbXEQG4uT87E4IyOnXjPHY1d1YvTcdp9/NLFLBO8a3GAzLKfL8wAkHnocg9x9OvOvABdTxwQN5LbWWGB2xt4wYyzduhGeCOuDzWW9qJ7SWIW/lS2zErv7LgYBUgHOeCQSOnfmrUTs5j0+7hKaguNssmB5qYyAcng+h6HAzgjJzMpU1uiM2c9qysFhEqckqw2yDO3GM/eHOVPOOmRWxpBm/tGFrGUWt7z+6lGIps8HGfl6H17kGm/ZLqH7O7FblJSNok+5Ke6N3Djpz9QelXra0F+vm6W87IHJe3mXc8LY5U8fMOOoAJ7juYZhUaa1BbuMXaxHdpd+jMTsXaFTsPXGc8HseMjAp19aQW0P2qa2EMkmfLltFPkS44O4djyMjkDPK81dsMXt5a29/dyQ3wUR29243RlT0Ug5yvUYyB6g1nX1nLp2oSRCSG3lErIokdvs7legyB8hOCCDwOnFSc6S5rL+v6+Y2zaVoo1SI3ClSkSOpWRQeuxxncB6A/gKVEiSMy2yJPAwzJAqbf+/id+/zL06+oNqOJWmmjmieylEiu1ow25Yj76MpxuHUHPI9atXMUDwsJpyl9vxHcrlUk4xkn+FunUc+tOxjUfvWRivcS5xNtlgiUSIsrAyqAOMSYyyjHB56dBURCXfzqwjJwR2yOvI6Zq0IJ7SZo7hDDOG+9tDZz3I6emCpqWI5hkE9uXTjE8f3TjuR9MfnQm1uVKHYy5Y1ZSqRkMD0U7ce/Tmh3aWBEWdjHGcKGQZX8P8P8K1Z4Bb2q3UbLcx9C0bHch9R6Efl9KpSOggRnH2m3Y7QV+8vt6H6fl7puw4q62KNyxhG2dAGIDJs5Bz+v4VC8UUxVlb5l4AdSvb27/X9auSMnkll2zwvgIQMFT6DHQ+oNZ58oxlot0u05eMcHH9D78/zFVqzaC0H3Qj2xxzhVZjtLbPm/EdDVC5E6Jw6AMPMEn3lyPft6Yq+s8T3EUUk0ckTPlZJH2gZ4BYjpj1wMH2qK/fy5zF5e0k8h1yODjr0zSNEmnYzHbbGD5TgkZwrcHg8gis7cxLMBhgcdQpPpx/hWrcxALsB8xSPlQNwq9fy5zn1rDmnaFzKMMT8hVm4wRkY/zmqSuJoHkLTF8F8fw55PqMVWnuVQ/uwQo49CD2NJKzOscuOhycrggn6/l+NMvpgWWT/lo3DBScj8a0S1MZLUoTNulYZ5B55zVbzGVj5i9DxzVuVoxCTIpDHnk9R6Y/KqWwSS7cH2Pr+VamM3caqiOVGZiAzggD0zzRUT/LOhOAMjj8aK9DBO0WfL5zb2kfQ9yfY11KvORzgd6pySRKi4O1uuWPX8au3ksIvZWyqlm54x+NU7xJEkG35lOPcV4SufosruWoyxumZijplQeG7kVJdsFRgvrkj1qKAhmdUIXaeRjioHZ4nZyQ2V+tJGNmpFyxnd7c7x+8HSrdtckTqGTtyR1JqlBJvhV4+o5Ge/tVln8zcyqEccYx/WkNPUvXExYqxZEB/LBomjWOBpAec4PqO+c+lQQQBI3LuMY64ByPr/AEq/ZgFSJtnlNyhfgD2JqbWNNkZ9rbR5UlD67fU9jV+2iSMGN13CU5UEZK/nxj2p99ZlY3kj3MwHSNegpsEgEUccobKp8z4wcE8fgc0nK+qCWquWlWGEOzbQSB17/SozcoHj8tdznLYGSAPaiP5pvLkQ7cE8nnHbj3prNIqymNcKozGeuT7j0qWupglfcekzPEVuokBb++4AAPOQcdarZhW3+0LMTFu2senln34/HOKmUNK8ZZSQACU9/pVbUUS0aQwMyu4AyhOcHrx0Pbj/AAqoe9oUoq9iOWe3Z9ixqW+8WQbgOnI/HmnfZo9RLiEqwGFCyuMnrwoP+RUEd3EkyotrBPvKqyk7SwxwOOh96PITc+4uFZiUZDyMH0NU/Ivkt5E1lAYNitmS1flUkyAD3Bxj25q1tV0CgSIgf5kZuByMc9j9abbkxxCO+X92WJM4XJIPZse/etGK0dFR423SMDsXIbeD7Hrxn6GmpX2OOqrO7KrQLBE8M6A2ko+VVGcN1H0/zxTEd7TEF5EJbSTHlhyNpJAxk+vowOR+lW4tggChVyPvRMOB7jHJ4pIsyo8MKGRdvzKPv4PPI7+xqr2MfU5+4h8248zTU8uWMkzJKCC57ZGcMeeowTj8akGlwX1v9tiV4Zht82QtujBPUsOuDketbvkoI4y6YLP+7u8dD/cbHSriWM5Q3OnB3EQJZlBPlN74Hpnr+oqnI09u0kcjd2Uc8MMUTSR36Ix2l8q+BwUY9eP4ckHtUsBhu41s9ViiWdRsKOTGAeMMoxwx5yM4P6npJ7SG9JlitotrD99aINqg/wDTM87W9Oo5/GrK2FrcQkSh7oG2HkvEw8yIjJKSKcbsYHTJ6EZ5w+a60KddJambaWrafCI72RZLC64MpUswwPuuv5DI5HYjFWpNPMc8d1DqHk37MDDdByQBjklh/rFHQsPmQ5yKy0uLzToTY35ItJ2AMituDDqDjs4yecZ/lVzTWOn5OpI1zp5YhyJCCrHBVuCPmAwcjG76g1DMpwesk/8AgiPBBrE2L0Ja6gyllJx5dwQSSxPHUg8jkY6UxpN1ktlqUSW2o5O2dhmO7weVkXn94OQGHXvjvevII5Jj5B+2WEm50L/f4wNpGchlB4bvg9eaZbPBNbGC8C4JDW8xIAyBgLKOqH3Hf1HSrmD79Py/rt/SrWNu0dqLa6hMlip8xbbdmSAHOSG7LznB+U/nTzDHLa5ElspH7oXMiExsxP3JVH3PTONuTWrHdtbzeVem42Ro6278NNGMAk7gP3qYPvwcgetK6WGOOa/sI1kVSEurdD2HXdH2U5+8OAc8DOKhgoybu/6/r8zOU3HNpd20riIsVhJ3PbjqVQdWTA+6Ce5GOaRdkMLyxPm1cHhQdoH8JzkspGeRz+Pa1fuiPEcJJbOd1tdxEkqeoBxg8HjP3lPHPSqax3Fqq3aGPAOWO4YcgYO9eoyeNwH1prQ1UE0QefcQXSyRhVY4xKFBSUZwM+ncbhjrj1qEwJcSuyKkd6P9bCVwGA9u46/Tp1xUjD+1I54rSIW7I/meXGx+VjzwOhyR056dDVVR9rt9qllvxn92q8EAZ3Ajn1yOh4IpqzNVT07GPqBmhupJoYVt+QXRclW9xz90/jilnREuRBJNF5in5JY8FTuAIDHuD79Oh9p7uVry3Xz1QXEWGLjIZxnv6kZ6+g5qlFFH5LqwWQY7D7nPUeh//XVWNVHTUr3ESmYjyhC7dVBAVfdT1weBgihm3xpGXGApxuJODxjP0x+WKL6MwyiJkdivCMBz7A+oNUpJQYVbLx7T8zN19RgVXL2H0uLHK7IQ4hWNj8rOuO3T3/zz1rD1uEOVcmNU7sSdpI5xgZP/AOuunz9shJkRUlAHOzcp9/asm9to7gSYBJOV56j2FUnYzcrM5v7SXYxgsy9OWycf/WpUdNjlwWZV+6RkYPcZ5yKbLA8CtuBXdgAjkelRmJsKsZV8ryc4J9h61rp0MKnkQyMZGBLqAeNvTPvzUKTSIEUADHcdfrVtoGEOWO4YPJOT34xVNRGVLEESdB3yf6U1sc0ncjkUFtzcPweeKKZIoQ5Yt97uKK7cK7JnzWca1I37Htd5GsqqHOBjP4YphyIGV2Bx0I9KZJu3HzF3IyqQRzjgVUkEjOIQ20jHy+teO0fojWt7j0kwG2AbhSeaZN29c9gKi8rZIf74OCBTY2b94ZDgA9vT3pWMZyRctCHK+S3ygf55q8uOHByMHv1rKjKW8SiMAq/IweB70yJ3M+AxUK2AM0mru5EPeZuWMg3JACxYgsAQSPz9avpZyXdtiVvMRGGQf4PT+v61QtGAIZQSx6ADkmtPTHFtJ5M33ydzDHUDms31Nb2ehala6Jji2yKm0qGBJEgHBOajndbeG3XyUYSruO0EHpgfX61taNO9+bxHjXy4YmZJTwV568fl6VnrC9yrof8AR44iMOf7gP3gCe360lYqMk/datYz5DeNM3miKLcvyqD82QM/gajW4nllXySMDk7urHvjPUV0It0MBleUSeXt3Fv4+vOR0qJBkyW3kJI7LuBYZHtz707ohTWuhQmdxIsgRjEoK4VsOG6Y/rzVaxtbYjzN0kgyzEEng9uOxPrWvZW0cMTfaNiySsVDPwOe2Pr37UG1SJ5ZLc4I+9tO/OPU8fnioTaeglJK6RnQLBcKq+XMoU/N8q7lX+8G9vQ0yJbuK2lCyrIACyHIY4J7+1XoggHnxJMJG+YsjZAzwPmHT6U9hNEYpIDHNFG21kHT8R26Uug+bWxSEiSWbzLa+WVO1vLYsFbPTnoMetXYiwiRUnSSJHGx8jbk9s/wN9ev5Gi4B1C5iliMccoI3hQyg+m7k/n7+lUZJIVuo7fyXhuJeNpIKnB65q4vqZuKkaDGUypvEYUAsWUDc3Oeo7/Xj6U+O3YXG6wkxLg4feAcjk49/b8qntJM28cMwGwHCMFAbHXB9hjp37elNeNpGiZcBGk/hJCS5PH0rRbnM10JSYJJnw5QSLgxnIDEjGc9+ecH6UtrLJbTwmUyRRg7S8YJKg8Z46/U/SobxpZfJjiJdImJEbL86dyR6559vpUkN26xtGwMlqzYiYAkR8k5HdT+ntVXIdP3S5eW8c3lXdoIracAop8zdG5HXJP3c8cHp61G5hnjWRkZVBzOqoS8TEHBwRyOPu5wRyCORTY7mZSvlOsW3ck8rLvR1JwrOgHp3HOO2RUt4rDN3YD7NMCUlReR16ADkrxnHb2otqZctrJmbdW8jQyRuAyQqWbY+V5I+eMgZI5GRj5eO1RWthGhVfNRI5Yy0EzL5kY7FGxk7CM54yp56YNXlvrJ0W4FtJbXgJaMWmQsbbceYAc5B6EHqKbpkcSabLJ5LRxXbFHIyFSRTyBn7pP5g7T61TZblJR7FSO0mtJluIgYomJAKuGRTjld/wBOR2xwexq5LZiURkxqJY8Bj0JB6bj/AAhhwM/n0qxb289tez6Xeuu6ba0UkQDHzMHYwwMEdQcHv3qq8hSJ7y3Vlltm8iWFgcSD0B6cjt7AVAk3LYsraWupWkonWVzENsShfniUNgqozxg9vrjtnKjEn2WJ0eE3MBEcV1G2FlXptkHuBjPH55rYt2u7pGv9NkU3UGJZYBFgurdNqkkFccd+6n1rH1W4trhjdoI7YSsY7iILjy+eT0ADDrj/APXQyqTd+X+l/wAOSW7Cxjdo7JJdPmjLXFq4JFsxOCyjsvIPGPwPNYZWU3o+yF5YMh1VlyyZ+UNgdugJH41rR3X2PXVi1lzJDOrRSOgyZVYEbx7g4OPT1zVKW0EBeCaFHjl+aMIcndxggdtw7cZ9QRS2ep0RjZ37/wBfeUAYfIlbZm4iYCSNicMpIBBPpnnPUEipM20uoxKxeaN22KX4Zv7oPYtyKoSzRJA7I68g7d+AxTH/AOsf5NRrJauYs+W0mzzASD1H16NwPyrTl1NHD1GTRCFZI5sqeqsTjLd+3pgVlyXMkYkKooRhhggBVhjnAHQ8d63dRuYbxiQoReX2EZ4x7kmsK7BLFk2owxlvbse2KtLuODuveRVvZrgzhhIHG3AVu6+uT6dM0KwV3MsgcSYB3cEj146GiVlB/euRsGV44+nPbqaam2SVZlypYZXaA2/jO39aJdhTtYhuI2tvMkSV9uMHsAPXnp2ouow9v5keHH8W45/+v6U4yqZD9sQiP7qgqVJ9selV2AEj72xETgADkD/H396NTnmzOupWi37cMScqG9fX3HFZpn+URyIoUEsoHGAa0lYeau87o25Xd1X6ism9JaUqVAAJKnn9Pb2rWNjCViq0w3FSCCO465qtcg7mdWAOfXrUsz8jYMsDy3ce1QynI3OAFI2598VRzTdiK6kYQEs2cjODRVe5ZvsxLAkAcHPFFbUpWR8/ma5px0Pbba58+MIiYO1cZ75AqhM00d1GNmVJ5OeRRRXDuj7+T94lLeXIzuxCn1qCSUPL8mNp7etFFRE5pERcIyhAdi9jVyyZJI2lVchCQRgn9KKKq2hUXY14f3aI4Xkc5B6d/wAKsWitLfxTpI5cZUP6Fuv86KKxlsaRd0dMZGS3lS0AyYwAFYkvyOfoOfzqW6sL6coytGlunDgkMHYDHA7L2/GiiskzOc3Ts11L2lwfYrhY72UqsnRkUFlyepHTGemaddSpvuCbYRRs4WIFfnI9wO/40UUXZmlztSfUht7eGVy1y4BQhzGTyOnGO35dqum1iuZYZ4mcLIpTD4QnJ6Z4AGKKKJOyM6jcVzJ/1Yxr6yCvMrQlJFP3WlIDIOh4/oarzwzTTC5UmO48za5U4IPQBh3/AFooo6WOinNuKZfW3AnCM0WVBO9oypIOOD2+lQXtpDqGZJXjS4gKhkfGH/2l7Z9R7UUU0ZptO44m5eV0lSOaE/IAAOCCDxjqKeDMIGRi/wBkc/Mo4GSOGI9v6UUVt0IvdrQe8aG2+QgyBuJkflMZHzfpQLV7aIlsNHMo3bWySfUkevQ+nWiilcTdrIiaRIlW3jklChScSKAfQqDzkdD79vayyrdrDJCpW8jAYJvBSSPHGGH8Weobn3NFFaW0FUjZXM7UI452V3jL7xgi3QlgevAzk81LCk2n6c0rwG4hV182M5DDuDnrnBwT+fUUUVNr6ilo1Hpf9TevLiPWNOFxbTDz7biLB/1uATuCY9ODjGfTOarXMI1Gwsrrb5Mqq0U7RLnlfvAjoHAywHUgE5BoooRhKPs3aPR/5mU/nW9yj2axo6gspO8o+0kOSM52t1OCCKq6hNJewk+XFHJvV1wfmYjA2gngkYyPUc9aKKHodUbb9TP1GaQvc2N15YmhfYlzEw2yqM8r7YAxjnt0qrcSR+ZGIJoppIJsbt4IPzEfiOPxGD2ooqopNnVBe4mZ16yXyqk1uilJDtJbDAEEnn/9fOMVQlleUxjC5hVgJFfLFccEDt6UUVomWtCgZ5GlVpYWB4wVYcHPX68GrheN5jnlgNpUHAyBjkUUUbsKiRRm8piIkBTy2G1h1X2HvUBViVm3qoIwfmwc/wB7H+RRRQc0u5BMJpJESWNGfGct1/8Ar+tRPOELMMuyDByuOnQn6UUUN6nO9TJuYt1tuj39z16DpzUdyI54QwdQxUbiTwrZ/wDr0UVcXoYSd0ZN4hi2hSGZQDvU/wCfeqbkH5WY889aKKpO5zTKl2zLbyoOFAP8qKKKo8PHfEj/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A reddish-purple eruption on the upper eyelid (the heliotrope eruption), accompanied by swelling of the eyelid in a patient with dermatomyositis (DM). This is the most specific&nbsp;cutaneous eruption&nbsp;in DM, although it is only present in a minority of patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_418=[""].join("\n");
var outline_f0_26_418=null;
var title_f0_26_419="Seizures in children";
var content_f0_26_419=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Seizures in children (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?0/26/419/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/419/contributors\" id=\"au1329\">",
"       Angus Wilfong, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?0/26/419/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/419/contributors\" id=\"se1864\">",
"       Douglas R Nordli, Jr, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/419/contributors\" id=\"se6945\">",
"       Timothy A Pedley, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?0/26/419/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/419/contributors\" id=\"de8764\">",
"       April F Eichler, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?0/26/419?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      SEIZURE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The brain contains billions of neurons (nerve cells) that create and receive electrical impulses. Electrical impulses allow neurons to communicate with one another. During a seizure, there is abnormal and excessive electrical activity in the brain. This can cause changes in awareness, behavior,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     abnormal movements. This activity usually lasts only a few seconds to minutes.",
"    </p>",
"    <p>",
"     Seizures are frightening to watch, but children rarely suffer long-term harm as a result of a seizure. Fortunately, most seizures can be controlled with medication, and the risk of seizures often declines as a child grows older.",
"    </p>",
"    <p>",
"     This article will discuss the most common types of seizures and tests used in children who have seizures. Articles about seizure treatment and febrile seizures are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/5/19540?source=see_link\">",
"      \"Patient information: Treatment of seizures in children (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39473?source=see_link\">",
"      \"Patient information: Febrile seizures (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      SEIZURES VERSUS EPILEPSY",
"     </span>",
"    </p>",
"    <p>",
"     Epilepsy is not a specific disease, but rather a tendency to have recurrent seizures over a period of time. Seizures that occur when a child has a fever, head injury, or after taking drugs often do not recur and are not considered epilepsy. In addition, what appears to be a seizure may actually be something else (eg, breath holding spell). Having one seizure does not mean that a child has epilepsy. Many clinicians require a child to have more than one seizure before diagnosing epilepsy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      TYPES OF SEIZURE",
"     </span>",
"    </p>",
"    <p>",
"     Seizures have many forms and symptoms can be mild or severe. Seizures are classified according to the child's appearance or behavior during the seizure, and the pattern of electrical activity in the brain, as measured by a test called an electroencephalogram (EEG). (See",
"     <a class=\"local\" href=\"#H8\">",
"      'Electroencephalogram'",
"     </a>",
"     below.)",
"    </p>",
"    <p>",
"     One of the most common seizure types is a convulsion. This may be called a \"tonic clonic\" or \"grand mal\" seizure. In this type of seizure, the child loses consciousness and may stiffen and have jerking muscle movements. During the muscle-stiffening, the child may bite their tongue, causing bleeding or frothing at the mouth.",
"    </p>",
"    <p>",
"     Other seizure types are less dramatic. Shaking movements may be isolated to one arm or part of the face. Alternatively, the child may suddenly stop responding and stare for a few seconds, sometimes with chewing motions or smacking the lips. These may be called simple partial or complex partial seizures depending on whether the child remains aware.",
"    </p>",
"    <p>",
"     Seizures may also cause \"sensations\" that only the child feels. As an example, one type of seizure can cause stomach discomfort, fear, or an unpleasant smell. These feelings are simple partial seizures, commonly referred to as auras. A child usually experiences the same symptoms with each seizure aura. Sometimes, a seizure aura can occur before a convulsive seizure. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21912?source=see_link\">",
"      \"Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      After a seizure (postictal state)",
"     </span>",
"     &nbsp;&mdash;&nbsp;With some types of seizures, the child may appear to be awake during the seizure, but is actually unaware and will have no memory of the event.",
"    </p>",
"    <p>",
"     The period following a seizure is called the postictal state. During this time, the child may be confused and tired, and may develop a throbbing headache. This period usually lasts several minutes, although it can last for hours or even days.",
"    </p>",
"    <p>",
"     In some children, the postictal period comes with other symptoms. For example, the child may experience mild to severe weakness in a hand, arm, or leg.",
"    </p>",
"    <p>",
"     Other people have difficulty speaking or experience temporary (partial) vision loss or other types of sensory loss. These symptoms usually resolve over several minutes and can be important clues about the type of seizure and the part of the brain that was affected during the seizure.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      SEIZURE TESTING",
"     </span>",
"    </p>",
"    <p>",
"     Determining the type of seizure helps determine what testing is needed and which treatments are most likely to be effective. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=see_link\">",
"      \"Clinical and laboratory diagnosis of seizures in infants and children\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Medical and seizure history",
"     </span>",
"     &nbsp;&mdash;&nbsp;Parents can keep a log book of what they observe during a child's seizures, which can be shared with the child's healthcare provider. Questions to consider after a child's seizure are listed in the Table (",
"     <a class=\"graphic graphic_table graphicRef53593 \" href=\"UTD.htm?13/2/13356\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Physical examination",
"     </span>",
"     &nbsp;&mdash;&nbsp;A complete physical examination is important in the process of evaluating a child with seizures. This can be performed by the child's usual healthcare provider (eg, general pediatrician or family practitioner). A neurologist (physician specializing in the brain) may be consulted.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Electroencephalogram",
"     </span>",
"     &nbsp;&mdash;&nbsp;An electroencephalogram (EEG) is a test that measures the electrical activity in the brain. It is performed to search for abnormal electrical activity that is commonly associated with seizures and epilepsy and allows for a clearer understanding of where and why seizures occur. Even if a child does not have a seizure during EEG monitoring, important information can be gained.",
"    </p>",
"    <p>",
"     EEGs are not painful, and there is no risk of being shocked or harmed by the test. Some children will require EEG monitoring while sleeping and while awake. Parents may be asked to keep their child awake for some part of the night (eg, put the child to bed late, awaken early, and prevent sleeping during drive to test). The child should not drink or eat anything with caffeine before the EEG (eg, soda, coffee, tea), and the child's hair should be washed the night before the test.",
"    </p>",
"    <p>",
"     Before the test, the EEG technologist will measure the child's head and make small marks on the skin with a pen. Approximately twenty wires will be attached to the child's head and face with glue or paste (this will wash out after testing) (",
"     <a class=\"graphic graphic_figure graphicRef55691 \" href=\"UTD.htm?38/57/39824\">",
"      figure 1",
"     </a>",
"     ). The child will be asked to lie still and try to sleep, and the technologist and parent can remain in the room with the child during testing. During the EEG testing, the child may be asked to breathe quickly (hyperventilate) or to watch a strobe light. This can provide important additional information for the physician. A typical EEG takes approximately one hour. If the child is unable to sleep, a mild sedative may be given.",
"    </p>",
"    <p>",
"     After the test is completed, the wires will be removed. A neurologist will interpret the results of the EEG and communicate these results with the child's healthcare provider. A repeat EEG or more prolonged EEG with video recording may be needed.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Other tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some children will need to have further testing. These tests may include computed tomography (CT) scans or magnetic resonance imaging (MRI), which provide pictures of the brain. These tests are not painful, but MRI requires that the child lie very still for up to one hour; most children who are less than five years old are sedated for an MRI because any movement can blur the pictures.",
"    </p>",
"    <p>",
"     Blood tests may also be recommended. These provide information about the child's chromosomes and the level of chemicals and substances normally found in blood. A lumbar puncture (also known as a spinal tap) may be recommended for some children who have a seizure during a high fever or who may have a metabolic disorder. The test involves inserting a needle into the low back to remove a small amount of fluid (cerebrospinal fluid or CSF) from around the spinal cord. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39473?source=see_link\">",
"      \"Patient information: Febrile seizures (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      PROGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The long-term impact of seizures is small for most children, especially if there are no underlying abnormalities in the child's brain. Many children with epilepsy have normal development and a good chance for a normal life. Some children with seizures will have difficulties with growth or development. This risk depends on the underlying type of epilepsy or cause of seizures.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      SEIZURE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment options for children with seizures is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/5/19540?source=see_link\">",
"      \"Patient information: Treatment of seizures in children (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498776579\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17229106\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/56/28546?source=see_link\">",
"      Patient information: Seizures (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/20/11586?source=see_link\">",
"      Patient information: Febrile seizures (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/0/18434?source=see_link\">",
"      Patient information: EEG (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/40/43650?source=see_link\">",
"      Patient information: Epilepsy in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/54/38754?source=see_link\">",
"      Patient information: Epilepsy in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=see_link\">",
"      Patient information: Closed head injury (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/42/26274?source=see_link\">",
"      Patient information: Arteriovenous malformations in the brain (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/44/2754?source=see_link\">",
"      Patient information: Myoclonus (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/25/19859?source=see_link\">",
"      Patient information: Long QT syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/4/12355?source=see_link\">",
"      Patient information: Fragile X syndrome (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17229121\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/5/19540?source=see_link\">",
"      Patient information: Treatment of seizures in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39473?source=see_link\">",
"      Patient information: Febrile seizures (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/4/14409?source=see_link\">",
"      Clinical and laboratory diagnosis of seizures in infants and children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/28/18888?source=see_link\">",
"      Clinical features and complications of status epilepticus in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1063?source=see_link\">",
"      Clinical features and diagnosis of infantile spasms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6328?source=see_link\">",
"      Clinical features and electrodiagnosis of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=see_link\">",
"      Epilepsy syndromes in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41335?source=see_link\">",
"      Etiology and prognosis of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link\">",
"      Febrile seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/28/30154?source=see_link\">",
"      Management and prognosis of infantile spasms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"      Management of status epilepticus in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35783?source=see_link\">",
"      Neonatal epileptic syndromes",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21912?source=see_link\">",
"      Overview of the classification, etiology, and clinical features of pediatric seizures and epilepsy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/13?source=see_link\">",
"      Treatment of neonatal seizures",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Epilepsy Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsyfoundation.org/\">",
"      www.epilepsyfoundation.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Neurological Disorders and Stroke",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ninds.nih.gov/disorders/epilepsy/detail_epilepsy.htm\">",
"      www.ninds.nih.gov/disorders/epilepsy/detail_epilepsy.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/epilepsy.html\">",
"      www.nlm.nih.gov/medlineplus/epilepsy.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Epilepsy Therapy Development Project",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsy.com/\">",
"      www.epilepsy.com",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       International League Against Epilepsy and the International Bureau for Epilepsy",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.epilepsy.org/\">",
"      www.epilepsy.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?0/26/419/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 19, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?0/26/419?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/419/abstract/1\">",
"      Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/419/abstract/2\">",
"      Berg AT, Shinnar S, Levy SR, Testa FM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia 1999; 40:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/419/abstract/3\">",
"      Berg AT, Levy SR, Testa FM, Shinnar S. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999; 40:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/419/abstract/4\">",
"      Duchowny M, Harvey AS. Pediatric epilepsy syndromes: an update and critical review. Epilepsia 1996; 37 Suppl 1:S26.",
"     </a>",
"    </li>",
"    <li>",
"     Freeman, JM, Vining EPG, Pillas, DJ. Seizures and Epilepsy in Childhood. A Guide. 3rd Ed. The Johns Hopkins University Press 2002.",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f0_26_419=[""].join("\n");
var outline_f0_26_419=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           SEIZURE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           SEIZURES VERSUS EPILEPSY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           TYPES OF SEIZURE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           SEIZURE TESTING",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           PROGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           SEIZURE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/57/39824\" title=\"figure 1\">",
"           EEG PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?13/2/13356\" title=\"table 1\">",
"           Seizure diary PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_420="Isosulfan blue: Drug information";
var content_f0_26_420=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Isosulfan blue: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/62/20451?source=see_link\">",
"    see \"Isosulfan blue: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5577185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lymphazurin&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F5577187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Contrast Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F5577217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lymphography: SubQ: Inject 0.5 mL into 3 interdigital spaces of each extremity per study; maximum: 3 mL (30 mg)",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16160052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16160053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F5577222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 1% (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lymphazurin&trade;: 1% (5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F5598929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5577218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     SubQ: Single patient use only; do not mix with local anesthetics (in same syringe)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F5577208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Local anesthetics (eg, lidocaine)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F5577188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct to lymphography for visualization of the lymphatic system; sentinel node identification",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F5577198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Pruritus (2%; affecting hands, abdomen and neck)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Administration site swelling (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Hypersensitivity reactions (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Postmarketing and/or case reports: Anaphylaxis; body fluid discoloration (urine, serum; may lead to falsely low oximetry readings); skin discoloration (including blue urticaria)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F5577193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to isosulfan, triphenylmethane, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F5577194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse events:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypersensitivity reactions: Hypersensitivity reactions, including anaphylactic reactions (rare), may occur; appropriate equipment and emergency medications should be available during use. Competent personnel and emergency facilities should be available during and for at least 60 minutes after administration, since severe delayed reactions may occur. Risk likely higher risk in patients with history of asthma, allergies, drug reactions, including previous sensitivity to triphenylmethane dyes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Methemoglobin: Methemoglobin levels via ABG may be falsely elevated; co-oximetry may be required to accurately assess.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Oximetry interference: Peripheral oxygenation measurements may be falsely depressed due to discoloration of serum caused by isosulfan blue; (peak interference 30 minutes after administration; minimal effect by 4 hours postdose); direct determination of arterial blood gases (ABG) may be required.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F5577202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F5577189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5577190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F5577192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk is unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Isosulfan Blue Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (5 mL): $714.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Lymphazurin Subcutaneous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (5 mL): $754.83",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F5577209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following subcutaneous administration, isosulfan blue binds to interstitial proteins; these proteins/extracellular fluids are drained by the regional lymphatic system, resulting in concentration of the dye within the lymph. Bright blue coloration imparted by the dye permits delineation of the vessels against the surrounding tissue.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F5577211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: 34% absorbed in 30 minutes; 69% and 100% in 1 and 24 hours, respectively",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: ~50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (10%; as unchanged drug); feces (~90%; via biliary excretion)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hoskin RW and Granger R, &ldquo;Intraoperative Decrease in Pulse Oximeter Readings Following Injection of Isosulfan Blue,&rdquo;",
"      <i>",
"       Can J Anesth",
"      </i>",
"      , 2001, 48(1):38-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/26/420/abstract-text/11212047/pubmed\" id=\"11212047\" target=\"_blank\">",
"        11212047",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kern KA, &ldquo;Sentinel Lymph Node Mapping in Breast Cancer Using Subareolar Injection of Blue Dye,&rdquo;",
"      <i>",
"       J Am Coll Surg",
"      </i>",
"      , 1999, 189(6):539-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/26/420/abstract-text/10589589/pubmed\" id=\"10589589\" target=\"_blank\">",
"        10589589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sadiq TS, Burns WW, Taber DJ et al, &ldquo;Blue Urticaria: A Previously Unreported Adverse Event Associated With Isosulfan Blue,&rdquo;",
"      <i>",
"       Arch Surg",
"      </i>",
"      , 2001, 136(12): 1433-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/26/420/abstract-text/11735875/pubmed\" id=\"11735875\" target=\"_blank\">",
"        11735875",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sprung J, Tully MJ, and Ziser A, &ldquo;Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2003, 96(4):1051-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?0/26/420/abstract-text/12651658/pubmed\" id=\"12651658\" target=\"_blank\">",
"        12651658",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9039 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-46FA143880-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_420=[""].join("\n");
var outline_f0_26_420=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577185\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577187\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577217\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160052\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160053\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577222\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5598929\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577218\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577208\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577188\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577198\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577193\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577194\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299549\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577202\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577189\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577190\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577192\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324129\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577209\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5577211\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9039\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9039|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/62/20451?source=related_link\">",
"      Isosulfan blue: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_421="Buccal SCC resected";
var content_f0_26_421=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69202&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69202&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Buccal SCC resected with 1 cm margins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neil D Gross, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_421=[""].join("\n");
var outline_f0_26_421=null;
var title_f0_26_422="Initial evaluation of the hypertensive adult";
var content_f0_26_422=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial evaluation of the hypertensive adult",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/422/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/422/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/422/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/422/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/422/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/422/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/26/422/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most hypertensive patients present with a modest elevation in blood pressure. The diagnosis of hypertension is made in this setting only after an elevated and properly measured blood pressure has been confirmed on at least three separate occasions. Two aspects of the initial evaluation of hypertensive adults deserve emphasis; first, there is a need for more accurate measurements of blood pressure in the office with the addition of out of office measurements, either by home or ambulatory monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], and second, the assessment of overall cardiovascular risk is important, particularly in the large number of patients with prehypertension in order to establish appropriate management [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43080?source=see_link\">",
"     \"Blood pressure measurement in the diagnosis and management of hypertension in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4169?source=see_link\">",
"     \"Hypertension: Who should be treated?\"",
"    </a>",
"    .), for a detailed review of the definition of hypertension and the specific individuals in whom therapy should be initiated, (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    After the presence of hypertension has been established, an evaluation should be performed to ascertain the following information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence and extent of target organ damage.",
"     </li>",
"     <li>",
"      The patient's overall cardiovascular risk status. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link\">",
"       \"Overview of the risk equivalents and established risk factors for cardiovascular disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      To rule out identifiable (secondary) and often curable causes of hypertension (",
"      <a class=\"graphic graphic_table graphicRef56130 \" href=\"UTD.htm?41/38/42604\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/21/27991?source=see_link\">",
"       \"Who should be evaluated for renovascular or other causes of secondary hypertension?\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient with severe hypertension (eg, systolic blood pressure &ge;180 mmHg",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diastolic blood pressure &ge;120 mmHg) requires immediate evaluation for signs of acute target organ damage, and possibly immediate treatment. The complete evaluation for potentially contributing causes is usually delayed in these circumstances until the blood pressure is brought to safe levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18614?source=see_link\">",
"     \"Treatment of specific hypertensive emergencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28246?source=see_link\">",
"     \"Management of severe asymptomatic hypertension (hypertensive urgencies)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE BASIC WORKUP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The features of the history and physical examination described below are directed specifically toward hypertension. Additional features may need to be included for other indications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should search for those facts that help determine the presence of precipitating or aggravating factors, the natural course of the blood pressure, the extent of target organ damage, and the presence of other risk factors for cardiovascular disease (",
"    <a class=\"graphic graphic_table graphicRef77599 \" href=\"UTD.htm?17/8/17549\">",
"     table 2",
"    </a>",
"    ). The patient should also be asked about the signs and symptoms that suggest an identifiable cause of hypertension (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"UTD.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One important consideration is the duration of hypertension. Simply asking the patient \"How long have you had high blood pressure?\" may lead to a misleading answer. Suppose, as an example, that the patient says two years. This should be followed by the question: \"When was the last time you were told your blood pressure was normal?\" In some cases, the patient will not have a blood pressure measurement for many years. Thus, the patient may have had undiagnosed hypertension for many years.",
"   </p>",
"   <p>",
"    Another important consideration, particularly in the patient with severe hypertension",
"    <span class=\"nowrap\">",
"     (&ge;180/120",
"    </span>",
"    mmHg), is the history of prior treatment for hypertension and nonadherence to antihypertensive medications, since this is a common finding in patients with severe hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main goals on the physical examination are to evaluate for signs of end-organ damage (such as retinopathy) and for evidence of a cause of identifiable hypertension (",
"    <a class=\"graphic graphic_table graphicRef69470 \" href=\"UTD.htm?13/39/13948\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21859?source=see_link\">",
"     \"Ocular effects of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The various pulses should be palpated and the abdomen should be auscultated for a renal artery bruit. The presence of an upper abdominal bruit with a diastolic component that lateralizes toward one side is highly suggestive of renal artery stenosis.",
"   </p>",
"   <p>",
"    The 2008 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association guidelines for adults with congenital heart disease recommend that every patient with hypertension should have the brachial and femoral pulses palpated simultaneously to assess timing and amplitude to evaluate for brachial-femoral delay characteristic of coarctation of the aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, supine bilateral arm (brachial artery) blood pressures and prone right or left supine leg (popliteal artery) blood pressures should be measured to search for differential pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link&amp;anchor=H2#H2\">",
"     \"Examination of the arterial pulse\", section on 'Unequal or delayed pulses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The procedures that should be routinely performed to evaluate for underlying causes (and signs of end-organ damage), as well as cardiovascular risk are [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Blood chemistries including electrolytes, glucose, and creatinine. An estimated glomerular filtration rate (eGFR) should be determined.",
"     </li>",
"     <li>",
"      Lipid profile",
"     </li>",
"     <li>",
"      Urinalysis to detect hematuria and a",
"      <span class=\"nowrap\">",
"       protein/creatinine",
"      </span>",
"      ratio to estimate proteinuria",
"     </li>",
"     <li>",
"      Electrocardiogram",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If there are abnormalities in the patient with severe hypertension, an attempt should be made to determine whether they are new or were previously documented, since the patient with acute changes generally requires more aggressive blood pressure reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Additional tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional tests may be indicated in certain settings. These include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Serum Uric Acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperuricemia has been found to be a precursor and possible pathogenetic factor for hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/6\">",
"     6",
"    </a>",
"    ]. It is not known whether the presence of hyperuricemia or its treatment will influence the management of hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Limited echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited echocardiography is a more sensitive method to detect left ventricular hypertrophy than the ECG and is considerably less expensive than a complete echocardiographic examination. The main indication for echocardiography is to detect possible end-organ damage in a patient with borderline blood pressure values. It will also identify some patients who would not be treated based upon clinical criteria alone [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\", section on 'Indications for echocardiography in hypertensive patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Ambulatory blood pressure monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ambulatory BP monitoring is capable of reducing the costs of the management of hypertension by rapidly identifying the 20 percent of patients with \"white-coat hypertension\" and by ensuring adequacy of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/8\">",
"     8",
"    </a>",
"    ]. However, most third-party payers refuse to pay adequately for this procedure. As a result, the main indication for its use is in the patient with persistent office hypertension but normal blood pressure readings in the ambulatory setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7113?source=see_link\">",
"     \"Ambulatory blood pressure monitoring and white coat hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Microalbuminuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of microalbuminuria is an early manifestation of nephropathy in either diabetes mellitus or hypertension, and is associated with an increased incidence of cardiovascular disease. Testing for microalbuminuria is at present primarily limited to patients with diabetes to screen for early nephropathy. The value of measuring albumin excretion in patients with primary hypertension without diabetes is being increasingly advocated [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20745?source=see_link\">",
"     \"High albuminuria (microalbuminuria) and cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42777?source=see_link\">",
"     \"Microalbuminuria in type 1 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39449?source=see_link\">",
"     \"Microalbuminuria in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Plasma renin activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the plasma renin activity (PRA) may provide prognostic information [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/10\">",
"     10",
"    </a>",
"    ], the test is usually performed only in patients with possible low-renin forms of hypertension, such as primary mineralocorticoid excess. The PRA may provide guidance in the evaluation of resistant hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/55/36728?source=see_link\">",
"     \"Definition, risk factors, and evaluation of resistant hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Workup for renovascular hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional testing for renovascular disease is indicated",
"    <strong>",
"     only",
"    </strong>",
"    in patients in whom the history is suggestive (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"UTD.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ) and in whom a corrective procedure will be performed if significant renal artery stenosis is detected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=see_link\">",
"     \"Establishing the diagnosis of renovascular hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ASSESSMENT OF CARDIOVASCULAR RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;As well defined by data from the Framingham study, a number of other risk factors interact with hypertension to determine the overall risk status of each individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/12\">",
"     12",
"    </a>",
"    ]. The presence or absence of other risk factors can influence the decision as to whether to institute antihypertensive medications in a patient with borderline values [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/422/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37685?source=see_link\">",
"     \"Cardiovascular risks of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/54/33635?source=see_link\">",
"       \"Patient information: High blood pressure in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"       \"Patient information: High blood pressure treatment in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/8/9347?source=see_link\">",
"       \"Patient information: High blood pressure, diet, and weight (Beyond the Basics)\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with mild to moderate hypertension, the diagnosis of hypertension is made only after an elevated and properly measured blood pressure has been confirmed on at least three separate occasions. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation should determine the duration of hypertension, the presence and extent of target organ damage and the patient's overall cardiovascular risk status. Among selected patients, secondary causes of hypertension should be ruled out. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination should include evaluation of end-organ damage. The various pulses should be palpated and the abdomen should be auscultated for a renal artery bruit. The presence of an upper abdominal bruit with a diastolic component that lateralizes toward one side is highly suggestive of renal artery stenosis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory tests should include blood chemistries (electrolytes, glucose, creatinine), an estimated glomerular filtration rate (eGFR), a lipid profile, urinalysis and",
"      <span class=\"nowrap\">",
"       protein/creatinine",
"      </span>",
"      ratio and electrocardiogram. An attempt should be made to determine whether any abnormalities are new or were previously documented, since the patient with acute changes generally requires more aggressive blood pressure reduction. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional tests may be indicated in certain settings including a serum uric, limited echocardiography to detect possible end-organ damage, and ambulatory blood pressure monitoring to identify patients with \"white-coat hypertension\". Microalbuminuria should be determined among patients with diabetes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Additional tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/1\">",
"      Shimbo D, Kuruvilla S, Haas D, et al. Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens 2009; 27:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/2\">",
"      Mallick S, Kanthety R, Rahman M. Home blood pressure monitoring in clinical practice: a review. Am J Med 2009; 122:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/3\">",
"      Sehestedt T, Jeppesen J, Hansen TW, et al. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens 2009; 27:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/4\">",
"      Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008; 118:e714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/5\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/6\">",
"      Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/7\">",
"      Cuspidi C, Lonati L, Macca G, et al. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography. J Hypertens 2001; 19:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/8\">",
"      O'Brien E, Beevers G, Lip GY. ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. BMJ 2001; 322:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/9\">",
"      Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/10\">",
"      Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 2001; 14:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/11\">",
"      Egan BM, Basile JN, Rehman SU, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens 2009; 22:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/12\">",
"      Kivim&auml;ki M, Batty GD, Singh-Manoux A, et al. Validating the Framingham Hypertension Risk Score: results from the Whitehall II study. Hypertension 2009; 54:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/422/abstract/13\">",
"      Vasan RS. A risk score for risk factors: rationale and roadmap for preventing hypertension. Hypertension 2009; 54:454.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3849 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-8AB89F2CF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_422=[""].join("\n");
var outline_f0_26_422=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE BASIC WORKUP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Additional tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Serum Uric Acid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Limited echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Ambulatory blood pressure monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Microalbuminuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Plasma renin activity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Workup for renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ASSESSMENT OF CARDIOVASCULAR RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3849\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3849|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/38/42604\" title=\"table 1\">",
"      Features of secondary HTN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/8/17549\" title=\"table 2\">",
"      History in hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/39/13948\" title=\"table 3\">",
"      Physical examination in HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7113?source=related_link\">",
"      Ambulatory blood pressure monitoring and white coat hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43080?source=related_link\">",
"      Blood pressure measurement in the diagnosis and management of hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37685?source=related_link\">",
"      Cardiovascular risks of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/55/36728?source=related_link\">",
"      Definition, risk factors, and evaluation of resistant hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/31001?source=related_link\">",
"      Establishing the diagnosis of renovascular hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20745?source=related_link\">",
"      High albuminuria (microalbuminuria) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4169?source=related_link\">",
"      Hypertension: Who should be treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28246?source=related_link\">",
"      Management of severe asymptomatic hypertension (hypertensive urgencies)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42777?source=related_link\">",
"      Microalbuminuria in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39449?source=related_link\">",
"      Microalbuminuria in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/22/21859?source=related_link\">",
"      Ocular effects of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/54/33635?source=related_link\">",
"      Patient information: High blood pressure in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=related_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/8/9347?source=related_link\">",
"      Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18614?source=related_link\">",
"      Treatment of specific hypertensive emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/21/27991?source=related_link\">",
"      Who should be evaluated for renovascular or other causes of secondary hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_423="Leukoplakia - buccal";
var content_f0_26_423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81049%7EDERM%2F72711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81049%7EDERM%2F72711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leukoplakia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A white plaque is present on the buccal mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leukoplakia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A white plaque is present on the tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_423=[""].join("\n");
var outline_f0_26_423=null;
var title_f0_26_424="Role of lung biopsy in the diagnosis of interstitial lung disease";
var content_f0_26_424=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Role of lung biopsy in the diagnosis of interstitial lung disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/424/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/424/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/424/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/424/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/424/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/424/contributors\">",
"     Andrew Nicholson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/424/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/424/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/26/424/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diffuse parenchymal lung diseases, often collectively referred to as the interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations (",
"    <a class=\"graphic graphic_algorithm graphicRef77345 \" href=\"UTD.htm?42/30/43502\">",
"     algorithm 1",
"    </a>",
"    ). The results of clinical assessment, laboratory tests, imaging, and pulmonary function tests guide the decisions about whether to pursue transbronchoscopic, thoracoscopic, or open lung biopsy, as outlined in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef69044 \" href=\"UTD.htm?17/14/17632\">",
"     algorithm 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The indications and methods for obtaining lung biopsies to evaluate ILD will be reviewed here. The clinical evaluation, diagnostic testing, role of bronchoalveolar lavage, and histopathologic patterns commonly encountered in adults with suspected ILD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=see_link\">",
"     \"Basic principles and technique of bronchoalveolar lavage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the results of clinical evaluation, laboratory testing, imaging studies including high resolution computed tomography (HRCT), and pulmonary function testing do not allow the clinician to make a confident diagnosis of a given type or stage of ILD, lung biopsy with careful examination of lung tissue is often necessary (",
"    <a class=\"graphic graphic_algorithm graphicRef69044 \" href=\"UTD.htm?17/14/17632\">",
"     algorithm 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The evaluation of ILD leading up to lung biopsy is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lung biopsy is helpful in the evaluation of patients with ILD in following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To provide a specific diagnosis. This is especially desirable in a patient with clinical features such as age &lt;50 years, fever, weight loss, hemoptysis, or signs of vasculitis; a progressive course; an atypical or rapidly changing chest radiograph or high resolution computed tomography (HRCT); unexplained extrapulmonary manifestations; or pulmonary vascular disease of unclear origin.",
"     </li>",
"     <li>",
"      To exclude neoplastic and infectious processes that can mimic chronic, progressive ILD.",
"     </li>",
"     <li>",
"      To identify a more treatable process than originally suspected (eg, hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis).",
"     </li>",
"     <li>",
"      To predict the likelihood of response to therapy before proceeding with therapies that may have serious side effects (eg, cellular nonspecific interstitial pneumonia or organizing pneumonia versus idiopathic pulmonary fibrosis) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rarely, to diagnose ILD in a patient with hypoxemia and pulmonary function tests strongly suggestive of ILD and a normal HRCT.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patient preference must also be considered. Patients with minimal symptoms, signs, physiologic impairment, and radiographic abnormality may prefer close observation over several months with interval repetition of pulmonary function tests and HRCT, rather than proceeding immediately to lung biopsy. Other patients prefer to undergo a lung biopsy sooner to obtain a definitive diagnosis and clarify their prognosis, rather than watchful waiting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TYPES OF LUNG BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung tissue can be obtained via transbronchial biopsy (TBLB), open thoracotomy, or video-assisted thoracoscopic lung surgery (VATS). All are subject to potential sampling error because the disease processes causing ILD are often patchy and the sample sizes may be small.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Transbronchial lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transbronchial lung biopsies (TBLB) are obtained during flexible bronchoscopy, using biopsy forceps that are passed through the channel of the bronchoscope. TBLB is often the biopsy procedure of choice when the suspected ILD is likely to have a centrilobular location (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75540 \" href=\"UTD.htm?20/38/21088\">",
"     image 1",
"    </a>",
"    ) and when a diagnosis can be made from small samples of lung tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"     4",
"    </a>",
"    ]. Examples of such diseases include sarcoidosis, hypersensitivity pneumonitis, lymphangitic carcinomatosis, eosinophilic pneumonia, alveolar proteinosis, and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link&amp;anchor=H9#H9\">",
"     \"High resolution computed tomography of the lungs\", section on 'Centrilobular nodules'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TBLB is less likely to be helpful when the pattern on high resolution computed tomography is indeterminant or suggests an idiopathic interstitial pneumonia (",
"    <a class=\"graphic graphic_algorithm graphicRef69044 \" href=\"UTD.htm?17/14/17632\">",
"     algorithm 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4474?source=see_link\">",
"     \"Idiopathic interstitial pneumonias: Clinical manifestations and pathology\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The equipment and technique of flexible bronchoscopy with TBLB are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4657761\">",
"    <span class=\"h3\">",
"     Safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;TBLB is a safe, minimally invasive procedure with an estimated mortality of &lt;0.05 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. Pneumothorax is estimated to occur in 0.7 to 2 percent, although rates up to 10 percent have been reported; less than half require tube thoracostomy drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,7,8\">",
"     4,7,8",
"    </a>",
"    ]. Bleeding (&gt;50 mL) is reported in 1 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"     4",
"    </a>",
"    ]. Additional information about the risks of TBLB and bronchoscopy in general and precautions to minimize procedure-related bleeding are provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link&amp;anchor=H12562876#H12562876\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20485052\">",
"    <span class=\"h3\">",
"     Specimen collection and diagnostic yield",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with ILD, the location for TBLB is generally an area that appears involved on high resolution computed tomography (HRCT). Of note, it is general practice NOT to perform bilateral transbronchial biopsies during a single bronchoscopy because of the risk of bilateral iatrogenic pneumothorax.",
"   </p>",
"   <p>",
"    The optimal number of TBLB specimens reflects a balance between the expected diagnostic yield and the patient&rsquo;s tolerance of the procedure. Usually, four to six TBLB specimens are obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,8-12\">",
"     4,8-12",
"    </a>",
"    ]. The effect of the number of transbronchial biopsies on diagnostic yield has been examined in case series, although the data are influenced by the underlying ILD. Among 244 patients with diffuse ILD, the diagnostic yield was 50 percent, based on five to six biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/8\">",
"     8",
"    </a>",
"    ]. In a series of 24 patients with interstitial lung disease, a total of 118 biopsies were obtained (average five per patient) of which 78 percent were of adequate quality and gave an overall diagnostic yield of 74 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Larger TBLB specimens are more likely to yield diagnostic information, and toothed forceps typically provide larger specimens than cupped forceps [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/12\">",
"     12",
"    </a>",
"    ]. Specimens that float are no more likely to be diagnostic than those that do not float [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4658609\">",
"    <span class=\"h3\">",
"     Ancillary tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;When performing flexible bronchoscopy in patients with interstitial lung disease, endobronchial biopsy and bronchoalveolar lavage (BAL) are often performed during the same procedure as TBLB although the data in support of this practice is limited. Transbronchial needle aspirate of enlarged mediastinal or hilar lymph nodes using an ultrasound guided probe can also be performed during the same procedure if the appropriate equipment is available.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endobronchial mucosal biopsies can be helpful in patients suspected of having sarcoidosis or chronic beryllium disease. Four to six endobronchial biopsies are usually obtained, preferably from a site where the mucosa appears erythematous or from the first and secondary carinas if the mucosa appears normal [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"       4",
"      </a>",
"      ]. In sarcoidosis, endobronchial mucosal biopsies are frequently positive and may increase the diagnostic yield, compared to transbronchial biopsies alone [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/14\">",
"       14",
"      </a>",
"      ]. In a series of 37 patients with sarcoidosis, endobronchial biopsies had a diagnostic yield of 24 percent and increased the yield over transbronchial biopsy alone by 8 percent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link&amp;anchor=H39#H39\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\", section on 'Diagnostic procedures'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/45/22234?source=see_link&amp;anchor=H14#H14\">",
"       \"Chronic beryllium disease (berylliosis)\", section on 'Tissue biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Results of BAL are generally not diagnostic in ILD, but frequently provide supportive evidence for or against a diagnosis. We typically perform BAL after obtaining the TBLB specimens and avoid performing BAL in the same subsegments as the TBLB. The role of BAL in the evaluation of ILD and the analysis of lavage fluid are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link\">",
"       \"Flexible bronchoscopy: Equipment, procedure, and complications\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"       \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) requires a special bronchoscope and is performed under general anesthesia, typically with a laryngeal mask airway in place. It is performed to evaluate enlarged hilar and mediastinal lymph nodes. The bronchoscope for EBUS is different from the standard bronchoscope used for TBLB, but general anesthesia and the laryngeal mask airway make it relatively easy to change bronchoscopes and perform both EBUS-TBNA and TBLB during a single procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/15\">",
"       15",
"      </a>",
"      ]. EBUS-TBNA has a yield of 90 to 96 percent for the diagnosis of sarcoidosis in the presence of hilar or mediastinal adenopathy. The technique of EBUS-TBNA is described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=see_link\">",
"       \"Endobronchial ultrasound: Indications, advantages, and complications\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20485060\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transbronchial lung biopsies (TBLB) are a few millimeters in size and are subject to crush artifact. They may miss ILD when the disease is patchy or be nondiagnostic when visualization of whole pulmonary acini is needed to fully evaluate disease distribution. Among 651 transbronchial lung biopsy procedures in patients with diffuse pulmonary disease, TBLB was diagnostically helpful in 76 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/6\">",
"     6",
"    </a>",
"    ]. If a specific diagnosis is not made by TBLB, surgical lung biopsy is usually indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Surgical lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical lung biopsy specimens can be obtained by video assisted thoracoscopic surgery (VATS) or open thoracotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. The specimens are substantially larger than those obtained by TBLB. Reported diagnostic yields vary, but are in the range of 86 to 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,16-18\">",
"     4,16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5485310\">",
"    <span class=\"h3\">",
"     Safety and contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reported mortality rates for surgical lung biopsy range from 0 to 6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,16,17,19-21\">",
"     4,16,17,19-21",
"    </a>",
"    ]. Estimates of morbidity vary widely (2 to 19 percent), which probably reflects the varying severity of illness among patients undergoing the procedure and different definitions used to define morbidity.",
"   </p>",
"   <p>",
"    Relative contraindications to surgical lung biopsy include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/16,17,20\">",
"     16,17,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiographic evidence of diffuse end-stage disease, eg, \"honeycombing\", without areas of milder disease activity, as biopsy of end-stage fibrosis is unlikely to reveal an etiology.",
"     </li>",
"     <li>",
"      High likelihood that adequate-sized biopsies from multiple sites (usually from two lobes) will not be obtained (eg, in a patient with associated pleural disease or emphysema).",
"     </li>",
"     <li>",
"      Severe pulmonary dysfunction manifest by a diffusing capacity (DLCO) less than 35 percent predicted or the requirement for supplemental oxygen or mechanical ventilation.",
"     </li>",
"     <li>",
"      Serious cardiovascular disease, advanced age, or other major risks for surgery or general anesthesia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulmonary hypertension, mechanical ventilation, and immunosuppressive therapy appear to increase the risk of death and other complications of surgical lung biopsy. Such patients are evaluated on a case-by-case basis to be sure that the procedure is likely to reveal a treatable diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5484649\">",
"    <span class=\"h3\">",
"     VATS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Video assisted thoracoscopic surgery (VATS) is a minimally invasive form of thoracic surgery performed under general anesthesia. Single lung ventilation is usually employed during the biopsy procedure, so the lung being biopsied is deflated and respiratory movement inhibited. A rigid or semi-rigid thoracoscope is introduced into the pleural space and forceps for lung biopsy are typically introduced through a separate small incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5484684\">",
"    <span class=\"h3\">",
"     Thoracotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open thoracotomy, also performed under general anesthesia, requires a surgical incision of 5 to 6 cm. Single lung ventilation can be used during the procedure, so the lung being biopsied is deflated and respiratory movement inhibited. Alternatively, for patients with more advanced lung disease or those on mechanical ventilation who cannot tolerate single lung ventilation, lung biopsy can be obtained through a thoracotomy incision without deflation of the lung being biopsied. The thoracotomy incision allows the surgeon to palpate the lung texture but does not necessarily allow biopsy areas of the lung remote from the incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H979589\">",
"    <span class=\"h3\">",
"     VATS versus thoracotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice between VATS or open thoracotomy is typically determined by the expertise of the thoracic surgeon. Increasingly, VATS is the preferred method in part because several retrospective studies have found that morbidity is improved with VATS compared with open thoracotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/2,22-24\">",
"     2,22-24",
"    </a>",
"    ]. A prospective, randomized trial comparing the two procedures found no difference in morbidity or mortality, however the study was small (42 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/25\">",
"     25",
"    </a>",
"    ]. A separate randomized trial of 61 patients reported reduced need for postoperative analgesia, shorter duration of chest tube drainage, and shorter hospital stay with VATS, but no difference in diagnostic yield or complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specimen adequacy and diagnostic accuracy are the same with both procedures, although it is technically easier to obtain multilobe lung biopsies by VATS than by thoracotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Open thoracotomy is occasionally required instead of VATS because of severe pleural disease or to provide more definitive control of bleeding in a patient with a bleeding diathesis. When necessary, patients receiving mechanical ventilation can undergo surgical lung biopsy; an open procedure is generally preferred in the setting of severe hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Specimen collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal number, size, and location of lung biopsies depend upon the suspected diagnosis and the anatomic distribution of the disease process. The clinician should communicate to the thoracic surgeon any specific concerns and suggestions regarding these issues. High resolution computed tomography (HRCT) scanning may further assist the surgeon in selecting the best location(s) to biopsy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In order to provide the pathologist with adequate tissue to evaluate the pattern and distribution of disease, lung biopsy samples are ideally greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"     4",
"    </a>",
"    ]. Areas that appear completely normal are avoided as are areas of severe disease; the latter tend to exhibit end-stage fibrosis (ie, honeycomb lung) without suggesting an etiology and are therefore unlikely to yield useful results. &ldquo;Honeycombing&rdquo; can be identified radiographically prior to surgery or by inspection at the time of surgery.",
"   </p>",
"   <p>",
"    Biopsies are obtained from more than one lobe of the lung and from areas of varying severity, as several studies suggest that this improves diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,28\">",
"     4,28",
"    </a>",
"    ]. In 28 of 109 patients with usual or nonspecific interstitial pneumonia, the histopathology in at least one lobe was discordant from another lobe [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/29\">",
"     29",
"    </a>",
"    ]. In a separate series of 24 patients, the diagnostic yield was improved by multilobe biopsies in a third [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/13\">",
"     13",
"    </a>",
"    ]. Among 15 patients with chronic hypersensitivity pneumonitis, sampling from more than one lobe helped to identify hypersensitivity pneumonitis in two patients who had chronic hypersensitivity pneumonitis on biopsies from one lobe and usual interstitial pneumonitis on biopsies from another lobe [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is controversial whether sampling of the dependent segments of the right middle lobe and lingula should be avoided due to nonspecific fibrosis that may be present at these sites [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"     4",
"    </a>",
"    ]. However, several studies have found diagnostic yields from lingular and middle lobe biopsies to be comparable to other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4,31-33\">",
"     4,31-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4658163\">",
"    <span class=\"h1\">",
"     PROCESSING LUNG BIOPSY SPECIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy specimens are sent for histopathologic analysis and also for mycobacterial and fungal culture. As the sample size is small, the entirety of the transbronchial biopsy specimens not sent to microbiology should be processed and examined.",
"   </p>",
"   <p>",
"    Frozen sections are generally not useful in the diagnosis of diffuse parenchymal lung disease, but may be used during surgical biopsy to assess whether an adequate sample has been obtained or when malignancy is suspected.",
"   </p>",
"   <p>",
"    Surgical lung biopsy specimens are gently inflated by injection of formalin prior to sectioning [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"     4",
"    </a>",
"    ]. For diffuse parenchymal lung disease in nonimmunosuppressed patients, the routine initial stain is hematoxylin and eosin.",
"   </p>",
"   <p>",
"    Special stains are performed as indicated based on the clinical suspicion or initial findings. As examples, staining for CD1a is done when Langerhans cell histiocytosis is suspected, and special mycobacterial and fungal stains are done whenever granulomas are noted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/63/21497?source=see_link&amp;anchor=H5487023#H5487023\">",
"     \"Interpretation of lung biopsy results in interstitial lung disease\", section on 'Langerhans cell granulomatosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/14/32993?source=see_link\">",
"       \"Patient information: Flexible bronchoscopy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20484825\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diffuse parenchymal lung diseases, often collectively referred to as interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations (",
"      <a class=\"external\" href=\"file:__www.uptodate.com_contents_image?imageKey=PULM_24076\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An approach to evaluating immunocompetent adults with ILD is shown in the algorithm (",
"      <a class=\"external\" href=\"file:__www.uptodate.com_contents_image?imageKey=PULM_23646\">",
"       algorithm 1",
"      </a>",
"      ) and discussed in detail separately. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=see_link\">",
"       \"Approach to the adult with interstitial lung disease: Clinical evaluation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"       \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Indications for lung biopsy in patients with ILD include atypical clinical features (age &lt;50 years, fever, weight loss, hemoptysis, signs of vasculitis); a progressive course; a normal, atypical, or rapidly changing chest radiograph or high resolution CT scan (HRCT); unexplained extrapulmonary manifestations; or pulmonary vascular disease of unclear origin. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flexible bronchoscopy with transbronchial lung biopsy (TBLB) is minimally invasive and is often the biopsy procedure of choice when sarcoidosis, hypersensitivity pneumonitis, lymphangitic carcinomatosis, eosinophilic pneumonia, alveolar proteinosis, or infection is suspected. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Transbronchial lung biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transbronchial lung biopsies (TBLB) are a few millimeters in size and are likely to miss diseases that are patchy or require examination of a larger area of tissue for accurate diagnosis (eg, usual interstitial pneumonitis, nonspecific interstitial pneumonitis, granulomatosis with polyangiitis [Wegener&rsquo;s granulomatosis]). (See",
"      <a class=\"local\" href=\"#H20485060\">",
"       'Limitations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typically, four to six TBLB are obtained from areas of lung that appear involved radiographically. If the lungs are uniformly involved, the lower lobe or both upper and lower lobes are biopsied. (See",
"      <a class=\"local\" href=\"#H4658609\">",
"       'Ancillary tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ancillary bronchoscopic tests such as endobronchial biopsy and bronchoalveolar lavage can help improve the diagnostic yield. For patients with hilar or mediastinal adenopathy, endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) may contribute to the diagnostic yield, although general anesthesia and specialized equipment are required. (See",
"      <a class=\"local\" href=\"#H4658609\">",
"       'Ancillary tests'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=see_link\">",
"       \"Basic principles and technique of bronchoalveolar lavage\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"       \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surgical lung biopsy specimens can be obtained via video assisted thoracoscopic surgery (VATS) or open thoracotomy; the choice between these procedures is typically determined by the expertise and preference of the thoracic surgeon. Open thoracotomy may be preferred in the setting of severe pleural disease, a bleeding diathesis, or mechanical ventilation. (See",
"      <a class=\"local\" href=\"#H979589\">",
"       'VATS versus thoracotomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In order to provide the pathologist with adequate tissue to evaluate the pattern and distribution of disease, surgical biopsies should be greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm. Ideally, specimens are obtained from more than one lobe of the lung. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Specimen collection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TBLB and surgical lung biopsy specimens are sent for histopathologic analysis and also mycobacterial and fungal staining and culture. (See",
"      <a class=\"local\" href=\"#H4658163\">",
"       'Processing lung biopsy specimens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The interpretation of lung biopsy results in the context of the clinical setting is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/63/21497?source=see_link\">",
"       \"Interpretation of lung biopsy results in interstitial lung disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/1\">",
"      Poletti V, Chilosi M, Olivieri D. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004; 71:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/2\">",
"      Halkos ME, Gal AA, Kerendi F, et al. Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease. Ann Thorac Surg 2005; 79:2172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/3\">",
"      Nicholson AG, Fulford LG, Colby TV, et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/4\">",
"      Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5:v1.",
"     </a>",
"    </li>",
"    <li>",
"     King TE Jr. Interstitial Lung Disease. In: Textbook of Bronchoscopy, Feinsilver SH, Fein AM (Eds), Williams &amp; Wilkins, Baltimore 1995. p.185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/6\">",
"      Ensminger SA, Prakash UB. Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease? Eur Respir J 2006; 28:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/7\">",
"      Pue CA, Pacht ER. Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995; 107:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/8\">",
"      Descombes E, Gardiol D, Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis 1997; 52:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/9\">",
"      de Boer S, Milne DG, Zeng I, Wilsher ML. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax 2009; 64:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/10\">",
"      Halme M, Piilonen A, Taskinen E. Comparison of endobronchial and transbronchial biopsies with high-resolution CT (HRCIT) in the diagnosis of sarcoidosis. APMIS 2001; 109:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/11\">",
"      Roethe RA, Fuller PB, Byrd RB, Hafermann DR. Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest 1980; 77:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/12\">",
"      Curley FJ, Johal JS, Burke ME, Fraire AE. Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy? Chest 1998; 113:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/13\">",
"      Vansteenkiste J, Verbeken E, Thomeer M, et al. Medical thoracoscopic lung biopsy in interstitial lung disease: a prospective study of biopsy quality. Eur Respir J 1999; 14:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/14\">",
"      Bjermer L, Thunell M, Rosenhall L, Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/15\">",
"      Nakajima T, Yasufuku K, Kurosu K, et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis--comparisons with other bronchoscopic diagnostic modalities. Respir Med 2009; 103:1796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/16\">",
"      Lee YC, Wu CT, Hsu HH, et al. Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients. J Thorac Cardiovasc Surg 2005; 129:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/17\">",
"      Lettieri CJ, Veerappan GR, Helman DL, et al. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005; 127:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/18\">",
"      Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/19\">",
"      Kreider ME, Hansen-Flaschen J, Ahmad NN, et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg 2007; 83:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/20\">",
"      Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann Thorac Surg 2009; 88:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/21\">",
"      Carrillo G, Estrada A, Pedroza J, et al. Preoperative risk factors associated with mortality in lung biopsy patients with interstitial lung disease. J Invest Surg 2005; 18:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/22\">",
"      Ravini M, Ferraro G, Barbieri B, et al. Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy. Eur Respir J 1998; 11:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/23\">",
"      Zegdi R, Azorin J, Tremblay B, et al. Videothoracoscopic lung biopsy in diffuse infiltrative lung diseases: a 5-year surgical experience. Ann Thorac Surg 1998; 66:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/24\">",
"      Tiitto L, Heiskanen U, Bloigu R, et al. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest 2005; 128:2375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/25\">",
"      Miller JD, Urschel JD, Cox G, et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg 2000; 70:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/26\">",
"      Ayed AK, Raghunathan R. Thoracoscopy versus open lung biopsy in the diagnosis of interstitial lung disease: a randomised controlled trial. J R Coll Surg Edinb 2000; 45:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/27\">",
"      Patel SR, Karmpaliotis D, Ayas NT, et al. The role of open-lung biopsy in ARDS. Chest 2004; 125:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/28\">",
"      Flint A, Martinez FJ, Young ML, et al. Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. Ann Thorac Surg 1995; 60:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/29\">",
"      Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/30\">",
"      Trahan S, Hanak V, Ryu JH, Myers JL. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 2008; 134:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/31\">",
"      Miller RR, Nelems B, M&uuml;ller NL, et al. Lingular and right middle lobe biopsy in the assessment of diffuse lung disease. Ann Thorac Surg 1987; 44:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/32\">",
"      Temes RT, Joste NE, Allen NL, et al. The lingula is an appropriate site for lung biopsy. Ann Thorac Surg 2000; 69:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/424/abstract/33\">",
"      Ayed AK. Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease. A prospective study. J Cardiovasc Surg (Torino) 2003; 44:115.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4379 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-9C20EB8C63-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_424=[""].join("\n");
var outline_f0_26_424=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20484825\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TYPES OF LUNG BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Transbronchial lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4657761\">",
"      - Safety",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20485052\">",
"      - Specimen collection and diagnostic yield",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4658609\">",
"      - Ancillary tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20485060\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Surgical lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5485310\">",
"      - Safety and contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5484649\">",
"      - VATS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5484684\">",
"      - Thoracotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H979589\">",
"      - VATS versus thoracotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Specimen collection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4658163\">",
"      PROCESSING LUNG BIOPSY SPECIMENS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20484825\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4379\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4379|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?42/30/43502\" title=\"algorithm 1\">",
"      Classification diffuse lung dz",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?17/14/17632\" title=\"algorithm 2\">",
"      Approach to patient with ILD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4379|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/38/21088\" title=\"diagnostic image 1\">",
"      Nodules in pneumoconiosis CT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/20/22856?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Clinical evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=related_link\">",
"      Basic principles and technique of bronchoalveolar lavage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/45/22234?source=related_link\">",
"      Chronic beryllium disease (berylliosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=related_link\">",
"      Endobronchial ultrasound: Indications, advantages, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4474?source=related_link\">",
"      Idiopathic interstitial pneumonias: Clinical manifestations and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/63/21497?source=related_link\">",
"      Interpretation of lung biopsy results in interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/14/32993?source=related_link\">",
"      Patient information: Flexible bronchoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_425="Primary coccidioidal infection";
var content_f0_26_425=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Primary coccidioidal infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/425/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/425/contributors\">",
"     John N Galgiani, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/425/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/425/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/425/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/425/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/26/425/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coccidioidomycosis is the infection caused by the dimorphic fungi of the genus Coccidioides (C. immitis and C. posadasii) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ]. Most infections are caused by inhalation of spores. The clinical expression of disease ranges from self-limited acute pneumonia (Valley Fever) to disseminated disease, especially in immunosuppressed patients. The concentration of cases of coccidioidomycosis in the United States is in the southwestern part of the country, where the cumulative incidence of patients requiring hospitalization in 2002 was 28.65 per 1 million persons [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of uncomplicated primary infection, specific diagnostic tests, and management strategies for primary infection will be reviewed here. Complicated infections related to coccidioidomycosis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39734?source=see_link\">",
"     \"Management of pulmonary sequelae and complications of coccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=see_link\">",
"     \"Coccidioidal meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=see_link\">",
"     \"Manifestations and treatment of extrapulmonary coccidioidomycosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21848?source=see_link\">",
"     \"Coccidioidomycosis in compromised hosts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coccidioides spp are endemic to certain lower deserts of the western hemisphere, including southern Arizona, the southern and central valleys of California, southwestern New Mexico, and west Texas in the United States. They are also found in parts of Mexico, and Central and South America.",
"   </p>",
"   <p>",
"    A substantial increase in the incidence of coccidioidomycosis has been observed in both California and Arizona in recent years. In Arizona, reported cases of coccidioidomycosis increased from 21 cases per 100,000 in 1997 to 155 cases per 100,000 in 2009 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/3\">",
"     3",
"    </a>",
"    ]. Total new cases reported in 2011 was over 16,000, a 37 percent increase from 2010. In California, the incidence of coccidioidomycosis increased from 2.4 cases per 100,000 in 2000 to 8 per 100,000 in 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/4\">",
"     4",
"    </a>",
"    ]. Inmates of two California state prisons have been disproportionately affected by coccidioidomycosis compared with the general population, with 180 cases recognized in 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Possible reasons for the rise in incidence of coccidioidomycosis include increased construction activity, an expansion in the immunocompromised population, and immigration of previously unexposed person to endemic regions [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the risk of endemic exposure to Coccidioides spp are approximately 3 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, a telephone survey by the Arizona Department of Health Services of patients diagnosed with Valley Fever in 2007 found that the average time of residence was 16 years [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, even persons who have lived in endemic regions for many years may still be susceptible to a new infection.",
"   </p>",
"   <p>",
"    The risk of exposure within endemic regions is seasonal, typically being highest in dry periods following a rainy season. As an example, periods of high incidence in Arizona range from May into July and then between October and early December [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/8\">",
"     8",
"    </a>",
"    ]. In contrast, the central California valley, which rarely receives significant summer rain, has a single peak from late spring to late fall. The estimated number of infections per year has risen to approximately 150,000 as a result of population increases in southern Arizona and central California [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ]. Based upon population sizes within the most highly endemic regions, it is estimated that approximately 60 percent of all United States coccidioidal infections occur within Maricopa, Pinal, and Pima counties of Arizona and 30 percent within Kern, Tulare, and San Louis Obispo counties of California. Cases reported to the United States Centers for Disease Control show similar geographic distributions (",
"    <a class=\"external\" href=\"file://www.cdc.gov/mmwr/summary.html\">",
"     www.cdc.gov/mmwr/summary.html",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;All isolates within the genus Coccidioides were formerly designated C. immitis. However, based upon DNA sequence analysis, two species have been identified as distinct [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Isolates from one species are geographically distributed predominantly in California and have retained the name C. immitis. The other species is distributed in Arizona, Utah, Texas, and other endemic regions throughout the western hemisphere and is now designated C. posadasii.",
"   </p>",
"   <p>",
"    The spectrums of diseases caused by the two species are indistinguishable, and clinical laboratories are not routinely able to determine species. For this reason, it is simplest to refer to all isolates as Coccidioides species.",
"   </p>",
"   <p>",
"    Coccidioides spp grow as mold a few inches below the surface of the desert soil. With dry conditions, the mycelia become very fragile, are easily fractured by even slight air turbulence into single-cell spores (arthroconidia) approximately 3 to 5 microns in size, and can remain suspended for prolonged periods of time in the air.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection is virtually always acquired by inhalation of a single arthroconidium. Within the lung, an arthroconidium changes from a barrel-shaped cell to a spherical structure and then greatly enlarges, sometimes becoming 70 microns or more in diameter. Enlarging spherules produce internal septations, and within each of the resulting subcompartments, individual cells (endospores) evolve. After several days, mature spherules rupture, releasing endospores into the infected tissue; each endospore is potentially capable of producing another spherule [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ]. Organisms grown from patient specimens show a reversion to mycelia on most laboratory media [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;After infection, a wide spectrum of manifestations is possible. It is estimated that less than one half of all infections comes to medical attention because illness is often subclinical [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The proportion of infections that become clinically significant increases with more intensive dust exposure. It is presumed that this represents higher arthroconidial inoculum exposure, as occurs during archeological excavations or desert military maneuvers [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When illness is clinically significant, a subacute process known as Valley Fever with respiratory and systemic complaints is typical, often lasting for weeks to months. In the great majority of such infections, resolution occurs without specific antifungal therapy. Future respiratory exposure to arthroconidia rarely, if ever, results in clinical illness.",
"   </p>",
"   <p>",
"    Primary infections due to Coccidioides species most frequently manifest as community-acquired pneumonia (CAP) approximately 7 to 21 days after exposure. In a study from Pima County, Arizona, 29 percent of patients diagnosed with CAP were serologically positive for coccidioidal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/18\">",
"     18",
"    </a>",
"    ]. The most common presenting symptoms are chest pain, cough, and fever (",
"    <a class=\"graphic graphic_table graphicRef69260 \" href=\"UTD.htm?35/12/36043\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/19-26\">",
"     19-26",
"    </a>",
"    ]. Hemoptysis may occur and suggests the development of a pulmonary cavity.",
"   </p>",
"   <p>",
"    Fatigue can persist for months, and the frequent complaint of arthralgias has contributed to the alternate name of \"desert rheumatism\" for this illness. Cutaneous manifestations of primary coccidioidal infection include erythema nodosum and erythema multiforme. E. nodosum is much more common in women than in men and often is the symptom prompting evaluation for Valley Fever. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=see_link\">",
"     \"Erythema nodosum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most routine laboratory findings are unremarkable [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/27\">",
"     27",
"    </a>",
"    ]. A common but nonspecific abnormality is the erythrocyte sedimentation rate, which often is one- or twofold above the upper limits of normal. The peripheral blood leukocyte count is usually normal or only slightly elevated. However, eosinophilia (&gt;5 percent) was found in approximately one quarter of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ]. In occasional patients, eosinophilia can be striking.",
"   </p>",
"   <p>",
"    Although initial infections usually have a respiratory component, standard PA and lateral chest radiographs may be unremarkable in up to one half of all patients. Common radiographic abnormalities include unilateral infiltrate and ipsilateral hilar adenopathy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76967 \" href=\"UTD.htm?4/56/5001\">",
"     image 1",
"    </a>",
"    ). Less frequent is evidence of a parapneumonic effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/28\">",
"     28",
"    </a>",
"    ]. Peripheral thin-walled pulmonary cavities or nodules are detected in 4 to 8 percent of all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/29\">",
"     29",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51795 \" href=\"UTD.htm?10/49/11027\">",
"     image 2",
"    </a>",
"    ). Rare cases of empyema have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     FREQUENT ABSENCE OF EARLY DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given how nonspecific the symptoms, signs, and routine laboratory findings of primary coccidioidal infection are, many, if not most, infections are not identified because clinicians do not consider the diagnosis. As an example, a cluster of 21 cases of a flu-like illness with rash in the majority of patients was noted in a church group returning to Washington State after building an orphanage in Mexico [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/31\">",
"     31",
"    </a>",
"    ]. Sixteen patients were symptomatic and sought medical attention but the diagnosis of coccidioidomycosis was only confirmed in one case.",
"   </p>",
"   <p>",
"    Although this cluster was located outside of the southwest in an area in which Valley Fever is not common, low rates of disease recognition have also occurred in endemic areas. In Arizona, the number of cases of coccidioidomycosis reported to the Department of Public Health from 1999 to 2001 averaged 1900 per year [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/8\">",
"     8",
"    </a>",
"    ]. This number is less than 10 percent of the expected number of illnesses, as estimated by several methods [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/32\">",
"     32",
"    </a>",
"    ]. In a study from two medical centers in metropolitan Phoenix, Arizona, the number of patients with CAP tested for Valley Fever was only 2 and 13 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/33\">",
"     33",
"    </a>",
"    ]. In one study, the clinician&rsquo;s workload, as measured by number of clinic visits, was directly proportional to both the number of cases of CAP diagnosed and the number of cases of coccidioidomycosis diagnosed (",
"    <a class=\"graphic graphic_figure graphicRef65388 \" href=\"UTD.htm?32/52/33613\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective observational study found that 16 of 55 cases (29 percent) of community acquired pneumonia (CAP) in Tucson, Arizona were caused by Coccidioides spp [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/18\">",
"     18",
"    </a>",
"    ]. In another study, 6 of 35 patients (17 percent) with CAP in Phoenix, Arizona had evidence of acute coccidioidomycosis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/34\">",
"     34",
"    </a>",
"    ]. A similarly high proportion may be evident in persons who develop CAP within the one to three week incubation period after visiting an endemic area.",
"   </p>",
"   <p>",
"    Some practitioners consider the failure to diagnose early coccidioidal infections as an insignificant problem, since many infections resolve without specific therapy. However, identifying coccidioidal infections as early as possible has many benefits, including [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allaying patient anxiety by arriving at a specific diagnosis, often simultaneously dispelling the fear of cancer",
"     </li>",
"     <li>",
"      Reducing the need for additional diagnostic testing, some of which involve invasive or costly procedures",
"     </li>",
"     <li>",
"      Eliminating empiric or protracted use of antibacterial treatments",
"     </li>",
"     <li>",
"      Reducing the morbidity of less frequent but progressively destructive extrapulmonary complications, most of which develop within the first several months following the initial infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For these reasons, the standard of care for management of this disease could be improved by a greater attention to early diagnosis. This approach is emphasized in the 2005 Infectious Diseases Society of America (IDSA) guidelines for the treatment of coccidioidomycosis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ] and the 2007 IDSA guidelines for the treatment of community-acquired pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     METHODS OF DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considering the diagnosis of coccidioidomycosis is an essential first step for detecting most coccidioidal infections. Because exposure usually occurs within an endemic region, it is critical to obtain an accurate travel history. Even brief exposures, such as changing planes in Phoenix, Arizona, have been sufficient to cause infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/31,37-40\">",
"     31,37-40",
"    </a>",
"    ]. In most cases, the incubation period for onset of symptoms is 7 to 21 days. However, for patients who are immunocompromised due to AIDS, solid organ transplantation, or lymphoma, reactivation can occur after much longer time periods [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolation of Coccidioides species in culture definitively establishes the diagnosis, even in patients with relatively mild pneumonia. Although fungal cultures are usually requested only in hospitalized patients or in those with more extensive disease, there is value to early diagnosis as noted above. Direct examination of the smear with KOH preparation or calcofluor white staining is also helpful.",
"   </p>",
"   <p>",
"    There are two disadvantages to culture. First, growth may take several days to weeks with subsequent delays in diagnosis. Furthermore, the propagation of Coccidioides spp in the clinical laboratory represents a significant health risk, since secondary cases have been reported in workers opening the plates for inspection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Thus, laboratory personnel should be notified when a sample with suspected Coccidioides is being sent for processing. In contrast, specimens for culture can be safely collected by health care workers since coccidioidal infection is not transmitted person to person. Coccidioides spp are listed by the CDC as a select agent. Special rules govern its handling and storage. (See",
"    <a class=\"external\" href=\"file://www.cdc.gov/od/sap\">",
"     www.cdc.gov/od/sap",
"    </a>",
"    for further information concerning the handling of select agents).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serologic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is helpful for making the diagnosis and for monitoring patients on therapy. (See",
"    <a class=\"local\" href=\"#H96096634\">",
"     'Patient monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In patients with primary infections managed as outpatients, diagnosis usually relies upon serologic testing. Commercial products are available to perform screening coccidioidal serologies in any general clinical laboratory. Alternatively, reference laboratories can carry out more detailed testing. The details of the laboratory diagnosis of coccidioidomycosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13751?source=see_link\">",
"     \"Laboratory diagnosis of coccidioidomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, regardless of the method chosen for detecting coccidioidal antibodies, three general principles guide interpretation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any positive serologic result is very likely to be clinically relevant. Most patients lose serologic reactivity within months of an infection unless residual lesions are evident or infection is active.",
"     </li>",
"     <li>",
"      A negative serologic result lowers the likelihood, but does not exclude, the diagnosis of coccidioidomycosis. Although most tests for coccidioidal antibodies are very specific, they are relatively insensitive, especially during the first one to two weeks after infection [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Repeating tests, if a first serologic test is negative, will improve diagnostic sensitivity [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of coccidioidomycosis is occasionally made by identification of spherules in tissue specimens. Staining with hematoxylin and eosin, periodic acid-Schiff, or methenamine silver stain will all demonstrate the organism, although silver stain is considered the most sensitive (",
"    <a class=\"graphic graphic_picture graphicRef75250 graphicRef55301 graphicRef68068 \" href=\"UTD.htm?39/36/40522\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;A real-time polymerase chain reaction (PCR) assay was developed and tested in 266 respiratory specimens and demonstrated 100 percent sensitivity and 98 percent specificity for Coccidioides spp compared with culture [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/46\">",
"     46",
"    </a>",
"    ]. Sensitivity in paraffin-embedded tissue samples was found to be lower (73 percent). If these preliminary results are validated with larger sample numbers, real-time PCR may offer a rapid and safe means of detecting Coccidioides directly from patient specimens, including fixed tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reagents for skin testing are not currently available [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ], and the utility of this modality is limited in patients with severe infection due to anergy. Skin testing is more useful for epidemiologic studies, since dermal reactivity remains present for life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR COMPLICATIONS AND DISEASE SEVERITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;After diagnosis, the presence of complications should be assessed with a careful history and physical examination. Risk factors for complications include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      HIV or AIDS",
"     </li>",
"     <li>",
"      Immunosuppressive medications used in transplants patients",
"     </li>",
"     <li>",
"      Glucocorticoids (20 mg or more per day of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or its equivalent)",
"     </li>",
"     <li>",
"      Lymphoma",
"     </li>",
"     <li>",
"      Anti-tumor necrosis factor (TNF) therapy",
"     </li>",
"     <li>",
"      Chemotherapy for solid tumors",
"     </li>",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Preexisting cardiopulmonary conditions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most significant of these risk factors is major suppression of cellular immunity, as occurs with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/47,48\">",
"     47,48",
"    </a>",
"    ], solid organ transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/49-51\">",
"     49-51",
"    </a>",
"    ], and high-dose glucocorticoid administration [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/52\">",
"     52",
"    </a>",
"    ]. Coccidioidomycosis first developing during pregnancy (especially during the third trimester) is a significant risk factor for severe, disseminated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Diabetes mellitus has been associated with more slowly resolving pulmonary infection and residual pulmonary cavitation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/55\">",
"     55",
"    </a>",
"    ]. Individuals of African or Philippine descent also have an increased risk of extrapulmonary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/26,56,57\">",
"     26,56,57",
"    </a>",
"    ]. Although there appears to be more serious disease with increasing age [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/58\">",
"     58",
"    </a>",
"    ], a comparison of patients younger than 60 years of age versus those &ge;60 years of age did not detect significant differences [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21848?source=see_link\">",
"     \"Coccidioidomycosis in compromised hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=see_link\">",
"     \"Coccidioidal meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To detect extrapulmonary infection, careful review of symptoms and physical examination is usually adequate. Extrapulmonary infection can be found at any site, but skin, bones and joints, and central nervous system localization are the most common [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/60-62\">",
"     60-62",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75408 \" href=\"UTD.htm?39/62/40930\">",
"     image 3",
"    </a>",
"    ). Active coccidioidal lesions typically produce regional symptoms. These include local discomfort, swelling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ulceration. Any focal abnormality of this sort that has developed since the onset of the primary infection should be a source of concern. These physical exam findings should prompt further imaging or sampling for histology and culture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H630889929\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H630028667\">",
"    <span class=\"h2\">",
"     Uncomplicated infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otherwise healthy patients without evidence of extensive coccidioidal infection or risk factors for more serious infection usually do not need antifungal therapy. However, it is important that such patients be followed for a year or longer to monitor for the development of complications. Therapy can be considered for certain patients on an individual basis. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Whom to treat'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Whom to treat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe illness as well as those at greatly increased risk of dissemination due to immunosuppression or pregnancy should be treated. In contrast, the value of antifungal therapy for patients with uncomplicated early coccidioidal infection is not known because prospective randomized trials have not been performed. While it is clear from older studies that most patients resolve their infection without therapy, it is possible that some patients might benefit from treatment, either by shortening the course of illness or by preventing complications.",
"   </p>",
"   <p>",
"    The possible role of treatment was evaluated in an observational study of 105 patients who had primary pulmonary coccidioidomycosis and who were seen at a university-affiliated Veterans Administration clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/63\">",
"     63",
"    </a>",
"    ]. Based upon severity of illness as assessed by the attending staff, 54 patients were treated and 51 were not. Treatment was more likely to be initiated in patients with elevated symptom scores. There was no difference between the groups with respect to overall rates of improvement. Among the untreated patients, none were subsequently found to have complications.",
"   </p>",
"   <p>",
"    However, among 38 of the treated patients, eight had relapse or progression of their coccidioidal infection following discontinuation of therapy; the duration of treatment among these patients ranged from one to 24 months. A possible reason for these findings is that patients with more severe illness are more likely to develop relapse. These findings provide no support for treating patients with mild symptoms of primary coccidioidomycosis, but emphasize the importance of close and prolonged follow-up for patients with severe illness requiring treatment. (See",
"    <a class=\"local\" href=\"#H96096634\">",
"     'Patient monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Given the absence of definitive data, it is a matter of judgment as to whether an individual patient might benefit from therapy with available oral antifungals, most frequently",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    . As noted above, patients with severe illness should be treated. However, opinion varies about the most relevant factors to judge the severity of illness. Commonly used indicators include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Greater than 10 percent loss of body weight",
"     </li>",
"     <li>",
"      Night sweats persisting greater than three weeks",
"     </li>",
"     <li>",
"      Infiltrates involving more than half of one lung or portions of both lungs",
"     </li>",
"     <li>",
"      Prominent or persistent hilar adenopathy",
"     </li>",
"     <li>",
"      Anti-coccidioidal complement fixing antibody concentrations in excess of 1:16",
"     </li>",
"     <li>",
"      Inability to work",
"     </li>",
"     <li>",
"      Persisting symptoms for more than two months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to patients with severe illness, treatment should also be given to those at increased risk of dissemination due to immunosuppression or pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Risk factors for complications and disease severity'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a decision to begin treatment is made, reasonable doses are 400",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    , 400",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    , and 200 mg twice daily for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ]. Of the commercially available azoles, only ketoconazole has been approved for the treatment of coccidioidomycosis by the United States Food and Drug Administration (FDA). However, the Mycoses Study Group has published descriptions of large prospective clinical trials using either fluconazole or itraconazole as treatment of coccidioidomycosis.",
"    <br/>",
"    <br/>",
"    Fluconazole has fewer drug interactions, whereas itraconazole has less of a drying effect on skin and mucous membranes. Both fluconazole and itraconazole have a lower incidence of gastrointestinal side effects compared with ketoconazole. Ketoconazole has also been associated with decreased testosterone synthesis and gynecomastia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=see_link\">",
"     \"Pharmacology of azoles\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is little information available about the value of newer azoles, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/60/33737?source=see_link\">",
"     posaconazole",
"    </a>",
"    , for treating primary coccidioidal pneumonia.",
"    <br/>",
"    <br/>",
"    An",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    preparation should be considered only in the most severe cases of coccidioidal pneumonia due to its toxicity and problems with administration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1895250\">",
"    <span class=\"h3\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;If treatment is instituted, the duration of azole therapy for uncomplicated primary coccidioidal infection generally ranges from three to six months [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ]. However, there is no consensus regarding which factors should guide decisions about duration of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96096634\">",
"    <span class=\"h1\">",
"     PATIENT MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regardless of whether treatment is instituted, immediately following diagnosis, patients are seen in follow-up every two to four weeks. During the weeks to months following presentation, respiratory symptoms (eg, cough and pleurisy) and systemic signs (eg, weight loss, night sweats, and fever) typically markedly diminish or resolve. Once such improvement has occurred, intervals between clinic visits are usually extended to every three to six months for up to two years (especially in those who are treated with antifungals [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/63\">",
"     63",
"    </a>",
"    ]) to document radiographic resolution and identify any evidence of pulmonary or extrapulmonary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fatigue and lethargy associated with coccidioidal pneumonia may persist for many weeks or months, far beyond the resolution of all other symptoms and laboratory abnormalities. The protracted duration of these symptoms resulting from the disease itself is compounded by the resulting deconditioning from reduced physical activity. Developing a structured physical rehabilitation program is often helpful.",
"   </p>",
"   <p>",
"    Serial serologic testing for complement fixing-type anti-coccidioidal antibodies should be repeated at least once several weeks after the initial diagnosis, since a rise in antibody concentrations may be associated with progressive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/64\">",
"     64",
"    </a>",
"    ]. Although the original descriptions of this test noted that titers greater than 1:16 were often found in patients with disseminated infection, this correlation is now less reliable due to differences in commercial assays. Serologic studies may also be compromised in patients with altered immunity (transplant patients or HIV-infected patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiographic abnormalities should be rechecked to determine if they resolve or leave a residual nodule or cavity. Determining whether pulmonary lesions evolve into residual nodules is also useful because it obviates the need to investigate the etiology of this radiographic finding in the future. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39734?source=see_link\">",
"     \"Management of pulmonary sequelae and complications of coccidioidomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An evaluation for disseminated disease should begin if a patient develops any suspicious skin lesions, severe or persistent headaches, or new joint effusions. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Risk factors for complications and disease severity'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/19/13617?source=see_link\">",
"       \"Patient information: Valley Fever (coccidioidomycosis) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H907830\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1895484\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coccidioidomycosis is the infection caused by the dimorphic fungi of the genus Coccidioides (C. immitis and C. posadasii). Most infections are caused by inhalation of spores. The clinical expression of disease ranges from self-limited acute pneumonia (Valley Fever) to disseminated disease, especially in immunosuppressed patients. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coccidioides spp are endemic to certain lower deserts of the western hemisphere including southern Arizona, the southern and central valleys of California, southwestern New Mexico, and west Texas in the United States. They are also found in parts of Mexico, and Central and South America. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1895492\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After infection, a wide spectrum of manifestations is possible. It is estimated that fewer than one half of all infections come to medical attention because illness is often subclinical. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When illness is clinically significant, a subacute process known as Valley Fever with respiratory and systemic complaints is typical, often lasting for weeks to months. In the great majority of such infections, resolution occurs without specific antifungal therapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary infections due to Coccidioides species most frequently manifest as community-acquired pneumonia approximately 7 to 21 days after exposure. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given how nonspecific the symptoms, signs, and routine laboratory findings of primary coccidioidal infection are, many, if not most, infections are not identified because clinicians do not consider the diagnosis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Frequent absence of early diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1895500\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Considering the diagnosis of coccidioidomycosis is an essential first step for detecting most coccidioidal infections. Because exposure nearly always occurs within an endemic region, it is critical to obtain an accurate travel history. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Methods of diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Isolation of Coccidioides species in culture definitively establishes the diagnosis, even in patients with relatively mild pneumonia. Direct examination of the smear with KOH preparation or calcofluor white staining is also helpful. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with primary infections managed as outpatients, diagnosis usually relies upon serologic testing. Commercial products are available to perform screening coccidioidal serologies in any general clinical laboratory. Alternatively, reference laboratories can carry out more detailed testing. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Serologic tests'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13751?source=see_link\">",
"       \"Laboratory diagnosis of coccidioidomycosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1895508\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      After diagnosis, the presence of complications should be assessed with a careful history and physical examination. The most significant risk factor is major suppression of cellular immunity, as occurs in with HIV infection, solid organ transplantation, and high-dose glucocorticoid administration. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Risk factors for complications and disease severity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Otherwise healthy patients without evidence of extensive coccidioidal infection or risk factors for more serious infection usually do not need antifungal therapy. However, it is important that such patients be followed for a year or longer, to monitor for the development of complications.",
"     </li>",
"     <li>",
"      Patients with severe illness as well as those at greatly increased risk of dissemination due to immunosuppression or pregnancy should be treated. These would be considered complicated situations. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Whom to treat'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a decision to begin treatment is made, reasonable doses are 400",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"       ketoconazole",
"      </a>",
"      , 400",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      , and 200 mg twice daily for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"       itraconazole",
"      </a>",
"      . Fluconazole has fewer drug interactions, whereas itraconazole has less of a drying effect on skin and mucous membranes. Both fluconazole and itraconazole have a lower incidence of gastrointestinal and other side effects compared with ketoconazole. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Treatment regimens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of azole therapy for uncomplicated primary coccidioidal infection generally ranges from three to six months. (See",
"      <a class=\"local\" href=\"#H1895250\">",
"       'Duration'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/1\">",
"      Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol 2007; 45:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/2\">",
"      Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006; 42:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/3\">",
"      Hector RF, Rutherford GW, Tsang CA, et al. The public health impact of coccidioidomycosis in Arizona and California. Int J Environ Res Public Health 2011; 8:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/4\">",
"      Centers for Disease Control and Prevention (CDC). Increase in Coccidioidomycosis - California, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/5\">",
"      Pappagianis D, Coccidioidomycosis Serology Laboratory. Coccidioidomycosis in California state correctional institutions. Ann N Y Acad Sci 2007; 1111:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/6\">",
"      Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health 1985; 75:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/7\">",
"      Tsang CA, Anderson SM, Imholte SB, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis 2010; 16:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/8\">",
"      Park BJ, Sigel K, Vaz V, et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 2005; 191:1981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/9\">",
"      Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/10\">",
"      Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/11\">",
"      Umeyama T, Sano A, Kamei K, et al. Novel approach to designing primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification. J Clin Microbiol 2006; 44:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/12\">",
"      Sun SH, Cole GT, Drutz DJ, Harrison JL. Electron-microscopic observations of the Coccidioides immitis parasitic cycle in vivo. J Med Vet Mycol 1986; 24:183.",
"     </a>",
"    </li>",
"    <li>",
"     Cole GT, Sun SH. Arthroconidium - spherule - endospore transformation in Coccidioides immitis. In: Fungal Dimorphism, Szaniszlo PJ (Ed), Plenum Publishing Corporation, New York City 1985. p.281.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/14\">",
"      Smith CE, Beard RR. Varieties of Coccidioidal Infection in Relation to the Epidemiology and Control of the Diseases. Am J Public Health Nations Health 1946; 36:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/15\">",
"      Smith CE. Epidemiology of Acute Coccidioidomycosis with Erythema Nodosum (\"San Joaquin\" or \"Valley Fever\"). Am J Public Health Nations Health 1940; 30:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/16\">",
"      Crum N, Lamb C, Utz G, et al. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area--Coalinga, California. J Infect Dis 2002; 186:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/17\">",
"      Perera P, Stone S. Coccidioidomycosis in workers at an archeologic site-Dinosaur National Monument, Utah, June-July 2001. Ann Emerg Med 2002; 39:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/18\">",
"      Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006; 12:958.",
"     </a>",
"    </li>",
"    <li>",
"     Lundergan LL, Kerrick SS, Galgiani JN. Coccidioidomycosis at a university outpatient clinic: A clinical description. In: Coccidioidomycosis, Einstein HE, Catanzaro A (Eds), Proceedings of the Fourth International Conference. Washington: National Foundation for Infectious Diseases; 1985:47.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/20\">",
"      Goldstein DM, Louie S. Primary pulmonary coccidioidomycosis; report of an epidemic of 75 cases. War Med 1943; 4:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/21\">",
"      Colburn JR. Roentgenological types of pulmonary lesions in primary coccidioidomycosis. Am J Roentgenol 1944; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/22\">",
"      Willett FM, Weiss A. Coccidioidomycosis in Southern California; report of a new endemic area with a review of 100 cases. Ann Intern Med 1945; 23:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/23\">",
"      SWEIGERT CF, TURNER JW, GILLESPIE JB. Clinical and roentgenologic aspects of coccidioidomycosis. Am J Med Sci 1946; 212:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/24\">",
"      TAYLOR AB, BRINEY AK. Observations on primary coccidioidomycosis. Ann Intern Med 1949; 30:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/25\">",
"      Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 1972; 286:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/26\">",
"      Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore) 2004; 83:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/27\">",
"      Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN. Symptoms and routine laboratory abnormalities associated with coccidioidomycosis. West J Med 1988; 149:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/28\">",
"      Merchant M, Romero AO, Libke RD, Joseph J. Pleural effusion in hospitalized patients with Coccidioidomycosis. Respir Med 2008; 102:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/29\">",
"      SMITH CE, BEARD RR, SAITO MT. Pathogenesis of coccidioidomycosis with special reference to pulmonary cavitation. Ann Intern Med 1948; 29:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/30\">",
"      Crum-Cianflone NF, Truett AA, Teneza-Mora N, et al. Unusual presentations of coccidioidomycosis: a case series and review of the literature. Medicine (Baltimore) 2006; 85:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/31\">",
"      Cairns L, Blythe D, Kao A, et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 2000; 30:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/32\">",
"      Campion JM, Gardner M, Galgiani JN. Coccidioidomycosis (valley Fever) in older adults: An increasing problem. Arizona Geriatr Soc J 2003; 8:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/33\">",
"      Chang DC, Anderson S, Wannemuehler K, et al. Testing for coccidioidomycosis among patients with community-acquired pneumonia. Emerg Infect Dis 2008; 14:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/34\">",
"      Kim MM, Blair JE, Carey EJ, et al. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis 2009; 15:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/35\">",
"      Galgiani JN. Coccidioidomycosis: changing perceptions and creating opportunities for its control. Ann N Y Acad Sci 2007; 1111:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/36\">",
"      Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/37\">",
"      Centers for Disease Control and Prevention (CDC). Coccidioidomycosis in workers at an archeologic site--Dinosaur National Monument, Utah, June-July 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/38\">",
"      Desai SA, Minai OA, Gordon SM, et al. Coccidioidomycosis in non-endemic areas: a case series. Respir Med 2001; 95:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/39\">",
"      From the Centers for Disease Control. Coccidiodomycosis in travelers returning for Mexico--Pennsylvania, 2000. JAMA 2000; 284:2990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/40\">",
"      Chaturvedi V, Ramani R, Gromadzki S, et al. Coccidioidomycosis in New York State. Emerg Infect Dis 2000; 6:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/41\">",
"      Hern&aacute;ndez JL, Echevarr&iacute;a S, Garc&iacute;a-Valtuille A, et al. Atypical coccidioidomycosis in an AIDS patient successfully treated with fluconazole. Eur J Clin Microbiol Infect Dis 1997; 16:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/42\">",
"      Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med 1987; 83:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/43\">",
"      Johnson JE, Perry JE, Fekety FR, et al. Laboratory-acquired coccidioidomycosis: A report of 210 cases. Ann Intern Med 1964; 60:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/44\">",
"      Stevens DA, Clemons KV, Levine HB, et al. Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis 2009; 49:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/45\">",
"      Wieden MA, Lundergan LL, Blum J, et al. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J Infect Dis 1996; 173:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/46\">",
"      Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol 2007; 45:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/47\">",
"      Singh VR, Smith DK, Lawerence J, et al. Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 1996; 23:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/48\">",
"      Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990; 69:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/49\">",
"      Hall KA, Sethi GK, Rosado LJ, et al. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993; 12:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/50\">",
"      Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982; 142:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/51\">",
"      Holt CD, Winston DJ, Kubak B, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997; 24:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/52\">",
"      Rutala PJ, Smith JW. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci 1978; 275:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/53\">",
"      Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 1993; 48:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/54\">",
"      Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest 1988; 94:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/55\">",
"      Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med 2006; 119:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/56\">",
"      Pappagianis D, Lindsay S, Beall S, Williams P. Ethnic background and the clinical course of coccidioidomycosis. Am Rev Respir Dis 1979; 120:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/57\">",
"      Crum NF, Lederman ER, Hale BR, et al. A cluster of disseminated coccidioidomycosis cases at a US military hospital. Mil Med 2003; 168:460.",
"     </a>",
"    </li>",
"    <li>",
"     Johnson RH, Caldwell JW, Welch G, et al. The great coccidioidomycosis epidemic: Clinical features. In: Coccidioidomycosis. Proceedings of the 5th International Conference, H. E. Einstein HE, Catanzaro A (Eds), National Foundation for Infectious Diseases, Washington 1996, p.77.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/59\">",
"      Blair JE, Mayer AP, Currier J, et al. Coccidioidomycosis in elderly persons. Clin Infect Dis 2008; 47:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/60\">",
"      Galgiani JN. Coccidioidomycosis. West J Med 1993; 159:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/61\">",
"      Stevens DA. Coccidioidomycosis. N Engl J Med 1995; 332:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/62\">",
"      Drutz DJ, Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis 1978; 117:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/63\">",
"      Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis 2009; 48:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/425/abstract/64\">",
"      Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3:247.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2460 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-EA0AF42627-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_425=[""].join("\n");
var outline_f0_26_425=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H907830\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk of infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      FREQUENT ABSENCE OF EARLY DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      METHODS OF DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Culture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serologic tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Skin testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RISK FACTORS FOR COMPLICATIONS AND DISEASE SEVERITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H630889929\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H630028667\">",
"      Uncomplicated infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Whom to treat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment regimens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1895250\">",
"      - Duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96096634\">",
"      PATIENT MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H907830\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1895484\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1895492\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1895500\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1895508\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2460\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2460|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/56/5001\" title=\"diagnostic image 1\">",
"      Pulmonary coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/49/11027\" title=\"diagnostic image 2\">",
"      Coccidioidomycosis chest CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/62/40930\" title=\"diagnostic image 3\">",
"      Disseminated coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2460|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/52/33613\" title=\"figure 1\">",
"      Dx coccidioidomycosis by Dr",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2460|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/21/4438\" title=\"picture 1A\">",
"      Cocci lung stain A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/57/6040\" title=\"picture 1B\">",
"      Cocci lung stain B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/26/30117\" title=\"picture 1C\">",
"      Cocci lung stain C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2460|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/12/36043\" title=\"table 1\">",
"      Sx primary coccidioidomycosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17271?source=related_link\">",
"      Coccidioidal meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21848?source=related_link\">",
"      Coccidioidomycosis in compromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=related_link\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13751?source=related_link\">",
"      Laboratory diagnosis of coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39734?source=related_link\">",
"      Management of pulmonary sequelae and complications of coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=related_link\">",
"      Manifestations and treatment of extrapulmonary coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/19/13617?source=related_link\">",
"      Patient information: Valley Fever (coccidioidomycosis) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36938?source=related_link\">",
"      Pharmacology of azoles",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_426="Idiopathic systemic capillary leak syndrome";
var content_f0_26_426=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Idiopathic systemic capillary leak syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/426/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/426/contributors\">",
"     Rajesh Aneja, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/426/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/426/contributors\">",
"     Scott Manaker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/26/426/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/426/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/26/426/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/26/426/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disorder characterized by episodes of severe hypotension, hypoalbuminemia, and hemoconcentration [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. During \"attacks\" of ISCLS, profound derangement of the vascular endothelium results in leakage of plasma and proteins into the interstitial compartment [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Episodes vary in severity and frequency and may be fatal. ISCLS was first described by Clarkson in 1960 and is variably referred to as Clarkson's disease or syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 150 cases of ISCLS have been reported worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. These have been diagnosed primarily in middle aged adults, although cases in children as young as five months old have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. There is no apparent gender predilection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vascular endothelium is a semi-permeable barrier that controls the passage of fluid and macromolecules between the intravascular and interstitial spaces. Dysfunction of this barrier leads to leakage, with loss of intravascular fluid and protein into the interstitial compartment. The resulting intravascular fluid depletion can cause hypotension and impair the delivery of oxygen to the tissues. The capillary leak is often severe and results in significant hypotension and shock. Cells and platelets are generally retained within the vasculature, resulting in elevations in white cell, red blood cell, and platelet counts.",
"   </p>",
"   <p>",
"    There are many causes of capillary leak, which can be categorized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased hydrostatic pressure within the capillaries can force fluid and protein through the endothelial barrier and into the interstitium. This is the mechanism of capillary leak in heart failure, renal failure, hepatic venous obstruction (eg, cirrhosis), and lower extremity deep vein thrombosis.",
"     </li>",
"     <li>",
"      Decreased capillary oncotic pressure may fail to retain fluid within the vascular space. This is the mechanism of capillary leak in conditions characterized by albumin loss (eg, nephrotic syndrome, protein losing enteropathy) or decreased albumin synthesis (eg, liver disease).",
"     </li>",
"     <li>",
"      Increased capillary permeability allows fluid and protein to readily pass through the endothelial barrier and into the interstitium. This is the mechanism of capillary leak in many medical conditions, including sepsis, the systemic inflammatory response syndrome, acute pancreatitis, anaphylaxis, snake bites [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/10,11\">",
"       10,11",
"      </a>",
"      ], and certain infectious syndromes (eg, Dengue hemorrhagic fever, brucellosis [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/12\">",
"       12",
"      </a>",
"      ], hantavirus cardiopulmonary syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/13\">",
"       13",
"      </a>",
"      ]). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=see_link\">",
"       \"Pathophysiology of sepsis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=see_link\">",
"       \"Pathophysiology of anaphylaxis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31431?source=see_link\">",
"       \"Principles of snake bite management worldwide\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=see_link\">",
"       \"Clinical presentation and diagnosis of dengue virus infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanisms of capillary leak are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/34/36393?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathophysiology and etiology of edema in adults\", section on 'Pathophysiology of edema formation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hypotheses in ISCLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of ISCLS remains undefined. A small number of hypotheses have been proposed, but the evidence for any one theory is incomplete.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monoclonal proteins &mdash; Several studies have found that the majority of patients in series and case reports had a monoclonal gammopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/1,14-17\">",
"       1,14-17",
"      </a>",
"      ]. One study noted that plasma levels of paraproteins increased during the acute phase of capillary leak and decreased during remission [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/18\">",
"       18",
"      </a>",
"      ]. The paraproteins are most often of the IgG1 subclass with kappa light chains and are typically identified in the serum, rather than the urine [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/15,19\">",
"       15,19",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The role of these paraproteins in the pathogenesis of ISCLS has not been determined. Paraproteins are probably not directly responsible for disrupting the vascular endothelial barrier, since studies in which healthy endothelial cells were exposed in vitro to paraproteins from three patients found no detectable cytotoxic effects [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/15,20\">",
"       15,20",
"      </a>",
"      ]. It is possible that the paraproteins are an epiphenomenon rather than a pathogenic factor.",
"     </li>",
"     <li>",
"      Elevated levels of vascular endothelial growth factor (VGEF) and angiopoietin 2 at baseline, with further elevations during attacks, were noted in a series of 23 patients and in smaller reports [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/3,20,21\">",
"       3,20,21",
"      </a>",
"      ] although not in others [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. VGEF has been implicated in other disorders, such as sepsis, although the source in ISCLS is unknown. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Acute pharmacologic treatments and novel therapies'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Endothelial cell apoptosis &mdash; Contraction of endothelial cells due to apoptosis (ie, programmed cell death) during attacks of ISCLS has been proposed as a mechanism for the increased capillary permeability. This hypothesis is supported by histologic changes consistent with endothelial cell apoptosis in muscle biopsies obtained during attacks of ISCLS [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/24\">",
"       24",
"      </a>",
"      ]. In addition, serum taken from patients with ISCLS mediated extensive apoptosis and contraction of endothelial cells in vitro [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Involvement of IL-2 &mdash; The proposal that endogenous interleukin-2 (IL-2) may contribute to the pathogenesis of ISCLS is based upon the observation that patients who receive high dose recombinant IL-2 therapy can develop a capillary leakage syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/6,26,27\">",
"       6,26,27",
"      </a>",
"      ]. Furthermore, increased IL-2 expression was demonstrated on the perivascular blood mononuclear cells of symptomatic patients with ISCLS [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inflammatory mediators &mdash; Several inflammatory mediators have been studied in the pathogenesis of ISCLS, including leukotrienes and tumor necrosis factor alpha (TNF&alpha;).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Leukotrienes, chemical mediators produced from arachidonic acid metabolism within leukocytes, may increase capillary permeability in patients with ISCLS. One study found that leukocyte-platelet suspensions from patients with ISCLS contained abnormalities of in vitro leukotriene production, compared to normal controls [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A small series of three patients reported elevations of TNF&alpha; during episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/17\">",
"       17",
"      </a>",
"      ]. TNF&alpha; is an inflammatory mediator that can increase vascular permeability [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. One patient was treated acutely with a TNF&alpha; antagonist, with apparent benefit. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Acute pharmacologic treatments and novel therapies'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In contrast, defects in other factors and pathways capable of altering capillary permeability (eg, complement, kinins, prostaglandin, coagulation, histamine, serotonin) have not been identified [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/14,24\">",
"       14,24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attacks of ISCLS usually demonstrate three phases: a prodromal phase, an extravasation phase, and a recovery phase. The frequency and severity of attacks varies significantly among patients. Some individuals have a single attack in a lifetime, while others have several per year. In one series of 25 patients, patients experienced a median of 3 acute attacks per year [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prodromal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 percent of patients report an antecedent upper respiratory tract infection (URI) or a flu-like illness with fever. Nearly 50 percent report other prodromal symptoms that precede more serious signs by one to two days [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/32\">",
"     32",
"    </a>",
"    ]. Common prodromal symptoms include irritability, fatigue, abdominal pain, nausea, myalgias of the extremities, polydipsia, and a sudden increase in body weight. Women may be more prone to attacks during menses [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Extravasation phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Capillary leakage develops over the following one to four days after the prodromal period. As this occurs, the triad of hypotension, hemoconcentration, and hypoalbuminemia develops:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hypotension",
"      </strong>",
"      &mdash; Intravascular hypovolemia causes hypotension, which is generally defined as a systolic blood pressure &lt;90 mmHg, a mean blood pressure &lt;65 mmHg, or a decrease in systolic blood pressure of more than 40 mmHg from baseline. The hypotension can be severe upon presentation. Hypotension develops in nearly all patients and its major consequence is shock, defined as reduced oxygen delivery to the tissues due to systemic hypoperfusion [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Hemoconcentration",
"      </strong>",
"      &mdash; In the series of 25 patients, the median hematocrit during attacks was 60.5 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"       8",
"      </a>",
"      ]. Another review reported a mean hematocrit of 64 &plusmn; 9 percent and a mean white blood cell count of 30",
"      <span class=\"nowrap\">",
"       cells/mm3",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Hypoalbuminemia",
"      </strong>",
"      &mdash; Patients with ISCLS had a mean serum albumin of 1.7 &plusmn; 0.7",
"      <span class=\"nowrap\">",
"       gm/dL",
"      </span>",
"      in the same review [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other findings that are caused by capillary leakage include generalized edema, ascites, bilateral pleural effusions, pericardial effusions, and cerebral edema and encephalopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16,25,33-39\">",
"     16,25,33-39",
"    </a>",
"    ]. There may also be symptoms and signs related to the hypotension and systemic hypoperfusion. These include cool and vasoconstricted skin, obtundation or restlessness, oliguria or anuria, lactic acidosis, and diminished pulses. Acute right axis deviation may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compartment syndrome is a serious complication of ISCLS that is frequently reported during both the extravasation and recovery phases [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/34,35,40-47\">",
"     34,35,40-47",
"    </a>",
"    ]. It is caused by the leakage of fluid into the muscular compartment, which increases the pressure inside that compartment. Fluid resuscitation may exacerbate the problem. Compartment syndrome can lead to rhabdomyolysis, with moderate to severe elevations of creatine phosphokinase (CPK) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Renal insufficiency or failure sometimes follows. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another complication of ISCLS is ischemic end-organ damage due to prolonged hypoperfusion. The most common injuries related to prolonged hypoperfusion include acute kidney injury (ie, acute tubular necrosis), ischemic brain injury,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ischemic hepatitis. Each of these entities is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=see_link\">",
"     \"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/56/19337?source=see_link\">",
"     \"Hypoxic-ischemic brain injury: Evaluation and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18568?source=see_link\">",
"     \"Ischemic hepatitis, hepatic infarction, and ischemic cholangiopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Recovery (recruitment) phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extravasation phase resolves after several days and the recovery phase begins. The transition can occur quickly and is characterized by a decrease in the amount of intravenous fluids that are necessary to maintain an adequate intravascular volume.",
"   </p>",
"   <p>",
"    During the recovery phase, extravasated fluids are recruited back into the intravascular space. The patient is at high risk for intravascular volume overload and pulmonary edema during this period (even those patients with normal renal function). (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Ongoing management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Chronic forms",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of reports describe chronic forms of systemic capillary leak syndrome, in which patients present with subacute edema and monoclonal gammopathies [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. In the series of 25 patients mentioned previously, two patients developed what appeared to be a chronic form of the disease, with progressive generalized edema and pleural and pericardial effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with ISCLS initially attribute their prodromal symptoms to more common alternative etiologies, such as a viral upper respiratory infection. As a result, patients typically do not present until the extravasation phase, when hypotension is present [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"     16",
"    </a>",
"    ]. Since hypotension requires immediate intervention to prevent the complications of prolonged hypoperfusion, the diagnostic evaluation should take place concurrently with initial management. Resuscitative efforts should NOT be delayed by the diagnostic evaluation. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Stabilization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The diagnostic evaluation is the same as that for hypotension or shock of uncertain etiology. The first step is to try and determine the type of shock, thereby narrowing the differential diagnosis. There are three types of shock: hypovolemic shock, cardiogenic shock, and distributive shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=see_link&amp;anchor=H3#H3\">",
"     \"Shock in adults: Types, presentation, and diagnostic approach\", section on 'Types of shock'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distributive shock is initially characterized by warm, flushed skin. The jugular venous pressure and central venous pressure may be normal or low, and peripheral edema is unusual. However, patients with distributive shock can quickly develop a systemic capillary leak that is characterized by falling jugular venous and central venous pressures, as well as new generalized edema and hypoalbuminemia. The edema may be exacerbated by fluid resuscitation, since a large portion of the intravenous fluids will leak into the interstitial space. The skin frequently becomes cool and clammy during this period as blood is redirected to the core organs.",
"   </p>",
"   <p>",
"    Patients with ISCLS similarly exhibit hypotension, low jugular venous and central venous pressures, generalized edema, and hypoalbuminemia. Thus, the initial differential diagnosis for a patient with ISCLS is likely to include typical causes of distributive shock complicated by a systemic capillary leak (eg, severe sepsis, septic shock, toxic shock syndrome, anaphylaxis, and certain drug reactions). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Clues that a patient has ISCLS, rather than distributive shock with systemic capillary leak, include hemoconcentration and the absence of an identifiable cause of distributive shock. In addition, patients with ISCLS are more likely to present with generalized edema, while patients with distributive shock are more likely to develop generalized edema during fluid resuscitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20828386\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;ISCLS is ultimately a diagnosis of exclusion that is made when a patient manifests with one or more episodes of intravascular hypovolemia, generalized edema, and the diagnostic triad (hypotension, hemoconcentration, hypoalbuminemia) in the absence of an identifiable alternative cause. A monoclonal gammopathy supports the diagnosis, although it is not present in all cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several disorders may mimic ISCLS, including severe sepsis or septic shock, toxic shock syndrome, anaphylaxis (as part of systemic mastocytosis or in response to a specific allergen), and certain drug reactions. Hereditary angioedema should also be considered since ISCLS occasionally presents with acute cutaneous edema without hypotension.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Severe sepsis or septic shock",
"      </strong>",
"      &mdash; Sepsis is a clinical syndrome characterized by systemic inflammation due to infection. There is a continuum of severity, ranging from sepsis to severe sepsis and septic shock. Normal levels of serum albumin can help distinguish sepsis from ISCLS. Sepsis is described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/10/24744?source=see_link\">",
"       \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"       \"Evaluation and management of severe sepsis and septic shock in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Recurrent toxic shock syndrome in women",
"      </strong>",
"      &mdash; Toxic shock syndrome (TSS) is a rapidly developing toxin-induced illness that usually affects otherwise healthy individuals (typically young women, but children and men are also susceptible). Patients usually have fever, hypotension, and cutaneous findings. The skin changes are variable, ranging from a sunburn-like rash to erythroderma or a maculopapular eruption. Other manifestations include chills, malaise, headache, sore throat, myalgias, fatigue, vomiting, watery diarrhea, abdominal pain, and orthostatic dizziness or syncope. In menstrual cases, symptoms begin within two to three days of the onset of menstruation, and in post-surgical cases, approximately two days after the procedure. The presence of skin findings, a history of antecedent menstruation, or a recent medical procedure is helpful in distinguishing TSS from ISCLS. TSS can be recurrent [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/51\">",
"       51",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=see_link\">",
"       \"Staphylococcal toxic shock syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Anaphylaxis",
"      </strong>",
"      &mdash; Anaphylaxis is an acute syndrome resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation, usually due to immunologic reactions to foods, medications, and insect stings. If anaphylaxis is suspected, the patient should be treated with epinephrine and fluid resuscitation, and a serum tryptase level should be drawn as soon as possible. Tryptase is found almost exclusively in mast cells and basophils, and is released into the serum when these cells become activated. Any degree of elevation in serum tryptase suggests anaphylaxis, although a normal level does not exclude the possibility of anaphylaxis. In contrast, tryptase levels in ISCLS should be normal. Patients with anaphylaxis have normal albumin levels, as well. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38888?source=see_link\">",
"       \"Differential diagnosis of anaphylaxis in children and adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=see_link\">",
"       \"Laboratory tests to support the clinical diagnosis of anaphylaxis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Anaphylactic attacks of systemic mastocytosis",
"      </strong>",
"      &mdash; Systemic mastocytosis is a rare disorder of excessive mast cell accumulation in one or more tissues, most often afflicting adults. Patients present with sudden episodes of symptoms caused by massive release of mast cell mediators. Symptoms include flushing, syncope, vascular collapse, and anaphylaxis. Mastocytosis \"attacks\" may be precipitated by triggers that non-specifically activate mast cells, such as exercise, alcohol, emotional stress,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and NSAIDs,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      , opiates, infections, exposure to iodinated contrast, and",
"      <span class=\"nowrap\">",
"       medical/surgical",
"      </span>",
"      procedures. Serum tryptase is constitutively elevated in most patients and is an important diagnostic clue. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=see_link\">",
"       \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Drug reactions",
"      </strong>",
"      &mdash; Certain medications have been reported to induce systemic capillary leak, although the precise mechanism is uncertain. They include recombinant interleukin-2 (IL-2) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/6,26,27\">",
"       6,26,27",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"       granulocyte colony-stimulating factor",
"      </a>",
"      (G-CSF) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/52\">",
"       52",
"      </a>",
"      ], interferon alfa [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/53\">",
"       53",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/54\">",
"       54",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/55\">",
"       55",
"      </a>",
"      ], and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      (a systemic retinoid) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/56\">",
"       56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=see_link\">",
"       \"Cardiotoxicity of nonanthracycline cancer chemotherapy agents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37384?source=see_link\">",
"       \"Differentiation (retinoic acid) syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=see_link&amp;anchor=H552584207#H552584207\">",
"       \"Interleukin-2 and other immunotherapies for advanced melanoma\", section on 'High-dose IL-2'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Hereditary angioedema",
"      </strong>",
"      &mdash; Hereditary angioedema is a rare disorder of C1 inhibitor (C1INH) deficiency or dysfunction, which typically presents in adolescence with recurrent attacks of cutaneous or gastrointestinal edema. Edema may also affect the upper respiratory tract, leading to life-threatening airway obstruction. The swelling gradually worsens for 12 to 36 hours and then subsides over a few days. Unlike the generalized edema of ISCLS, the cutaneous swelling of hereditary angioedema is localized, usually asymmetric, and most often affects the face, extremities, genitals, or a limited area of the trunk. Complement component 4 (C4) is low during attacks in nearly all cases. In contrast, complement levels are usually normal in patients with ISCLS. Hereditary angioedema is reviewed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33864?source=see_link\">",
"       \"Hereditary angioedema: Pathogenesis and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19272?source=see_link\">",
"       \"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of ISCLS is extrapolated from the treatment of septic shock because the clinical presentations are similar and there is little direct evidence from patients with ISCLS [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This section summarizes our approach to the management of ISCLS. The treatment of septic shock is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first priority in any patient with ISCLS or shock of unknown etiology is stabilization of their airway and breathing. Supplemental oxygen should be supplied to all patients and oxygenation should be monitored continuously with pulse oximetry. Intubation and mechanical ventilation may be required to support an increased work of breathing (caused by compensation for the lactic acidosis that results from hypotension and systemic tissue hypoperfusion) or for airway protection (since encephalopathy can be caused by cerebral edema or hypoperfusion of the brain).",
"   </p>",
"   <p>",
"    Intubation and mechanical ventilation are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=see_link\">",
"     \"The decision to intubate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Assess perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the airway and breathing are being stabilized, the adequacy of perfusion should be evaluated. The blood pressure needs to be assessed early and often because it is the most common indicator that perfusion is inadequate. However, hypoperfusion can occur even in the absence of hypotension. Common signs of hypoperfusion include cool and vasoconstricted skin, obtundation or restlessness, oliguria or anuria, and lactic acidosis. Patients with chronic hypertension may develop critical hypoperfusion at a higher blood pressure than healthy patients (ie, relative hypotension).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Restore perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sequential rapid and large infusions of intravenous fluids (20",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    over 5 to 10 minutes) are indicated once it has been established that hypoperfusion exists (unless there is coexisting clinical or radiographic evidence of heart failure) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/57\">",
"     57",
"    </a>",
"    ]. Volume status, tissue perfusion, blood pressure, and the presence or absence of pulmonary edema must be assessed before and after each infusion.",
"   </p>",
"   <p>",
"    Hemodynamic resuscitation should target a central venous oxyhemoglobin saturation (ScvO2) &ge;70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Other reasonable goals include a central venous pressure (CVP) 8 to 12 mmHg, a mean arterial pressure (MAP) &ge;65 mmHg, and a urine output &ge;0.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per hour. These values should be considered guides and adjusted according to clinical factors, such as whether the intravenous fluid boluses continue to augment perfusion and whether there is clinical evidence of hypoperfusion or pulmonary edema. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"     \"Initial management of shock in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Crystalloids (eg, normal salines) are the intravenous fluids that are most commonly used because they are inexpensive and readily available. Colloids (eg, intravenous albumin, fresh frozen plasma) are alternative intravenous fluids that normally expand the plasma volume by increasing intravascular oncotic pressure. However, they are costly and their effectiveness is probably greatly reduced in patients with ISCLS because proteins with a molecular weight &le;200 kilodaltons (eg, albumin) leak from the intravascular to the interstitial space during the extravasation phase [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/14\">",
"     14",
"    </a>",
"    ]. For this reason, a trial of colloid is most appropriate as a rescue therapy for patients whose perfusion is not restored by crystalloid alone. Intravenous immunoglobulin (IVIG) is another colloid, and appeared to decrease the severity of the episode in two case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/36,59\">",
"     36,59",
"    </a>",
"    ]. Red blood cell transfusions can increase the intravascular volume and improve both blood pressure perfusion, although transfusion does not increase the intravascular oncotic pressure.",
"   </p>",
"   <p>",
"    Intravenous vasopressors may be useful in patients who remain hypotensive despite adequate fluid resuscitation or who develop cardiogenic pulmonary edema. There is no definitive evidence of the superiority of one vasopressor over another. We prefer norepinephrine, although dopamine is also a reasonable first-choice among vasopressors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/57\">",
"     57",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     Phenylephrine",
"    </a>",
"    , a pure alpha-adrenergic agonist, may be particularly useful when tachycardia or arrhythmias preclude the use of agents with beta-adrenergic activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=see_link\">",
"     \"Use of vasopressors and inotropes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients whose perfusion remains inadequate despite intravenous fluids and vasopressors, sequential trials of red cell transfusions and inotropic medications may be helpful. This strategy has been studied in septic shock and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link&amp;anchor=H12#H12\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\", section on 'Additional therapies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Additional considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the perfusion is being restored, a central venous catheter (CVC) should be inserted in most patients. A CVC can be used to infuse intravenous fluids, infuse medications, infuse blood products, and draw blood. It can also be used for hemodynamic monitoring by measuring the CVP and ScvO2.",
"   </p>",
"   <p>",
"    Insertion of an arterial catheter may be helpful if the blood pressure is labile or restoration of arterial perfusion pressures is expected to be a protracted process, because a sphygmomanometer may be unreliable in hypotensive patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=see_link\">",
"     \"Arterial catheterization techniques for invasive monitoring\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Acute pharmacologic treatments and novel therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no established acute pharmacologic therapies for ISCLS, although case reports describe several treatment modalities that have been given to small numbers of patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A case report found that the combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"       terbutaline",
"      </a>",
"      and intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=see_link\">",
"       aminophylline",
"      </a>",
"      (with a serum target",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"       theophylline",
"      </a>",
"      level of 15 to 25",
"      <span class=\"nowrap\">",
"       mcg/dL)",
"      </span>",
"      appeared to be beneficial in one of two patients, and administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      seemed to help another patient refractory to terbutaline and aminophylline [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/17\">",
"       17",
"      </a>",
"      ]. All three patients had received terbutaline and theophylline prophylactically. However, since TNF alpha antagonists such as infliximab have been shown to be harmful in some patients with sepsis, this latter experimental approach should only be considered if sepsis is believed to be unlikely. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Prevention of future episodes'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29960?source=see_link&amp;anchor=H11#H11\">",
"       \"Investigational and ineffective therapies for sepsis\", section on 'Augmentation of immunomodulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A series of three patients described successful acute treatment with high doses of IVIG [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/59\">",
"       59",
"      </a>",
"      ]. These patients also received IVIG monthly for prophylaxis. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Other treatments'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A case report from Japan described the use of anti-VEGF antibody (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      ; Chugai, Tokyo) to treat the acute phase of life-threatening ISCLS [",
"      <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/23\">",
"       23",
"      </a>",
"      ]. Despite low plasma VEGF levels, the authors administered intravenous bevacizumab (5 mg per kg of body weight) over a 90-minute period. They reported that urine output improved and blood pressure and CVP returned to the normal range within 48 hours.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Detection of compartment syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The muscle compartments should be carefully monitored throughout intravascular resuscitation for signs of compartment syndrome. The tissue pressure needs to be measured if clinical signs of compartment syndrome develop. Fasciotomy is indicated when tissue pressures are within 10 to 30 mmHg of the diastolic pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/61\">",
"     61",
"    </a>",
"    ]. Alkalinization of the urine and diuretics may be required if the patient develops rhabdomyolysis. In the series of 25 patients, the development of rhabdomyolysis correlated to the degree to which albumin declined during an attack [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ]. These complications are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Reassess perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should continue to have their clinical and laboratory parameters followed closely once the hypoperfusion resolves. These include the blood pressure, ScvO2, CVP, urine output, creatinine, platelet count, lactate, Glasgow coma score, oxygenation (ie, arterial oxygen tension or oxyhemoglobin saturation), and ventilation (ie, arterial carbon dioxide tension and pH).",
"   </p>",
"   <p>",
"    Although the lactate level often remains elevated despite restoration of perfusion, a rising level is suggestive of recurrent hypoperfusion. Evidence of recurrent hypoperfusion should prompt a renewed effort to restore perfusion as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ongoing management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The transition from the extravasation phase to the recovery phase can be recognized by a decrease in the volume of intravenous fluid that is required to maintain the target CVP. When this occurs, the clinician's focus must shift from the treatment of intravascular hypovolemia to the prevention of intravascular volume overload and its complications (eg, pulmonary edema). In one series,",
"    <span class=\"nowrap\">",
"     10/25",
"    </span>",
"    patients developed pulmonary edema during treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nearly all patients require diuretics (we prefer loop diuretics) during the recovery phase to avoid intravascular volume overload. Patients with renal insufficiency may require ultrafiltration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PREVENTION OF FUTURE EPISODES",
"    </span>",
"    &nbsp;&mdash;&nbsp;No prophylactic therapy has been conclusively proven to prevent future episodes of ISCLS because the rarity of the disorder makes controlled trials impractical. However, in a series of 28 patients followed for a median of 55 months (range 1 to 161 months), all five of the patients who did not receive prophylactic therapy died, compared to only 3 out of the 23 patients who received prophylactic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At present, we believe that there is enough observational evidence to warrant a trial of combined prophylactic therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    in patients who have had an initial episode of ISCLS. There are also an increasing number of reports of apparent benefit with intravenous immune globulin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Terbutaline and theophylline",
"    </span>",
"    &nbsp;&mdash;&nbsp;The theory that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    may prevent ISCLS is based on the observations that both agents increase intracellular cyclic adenosine monophosphate (cAMP) content [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/25\">",
"     25",
"    </a>",
"    ] and that elevated cAMP inhibits capillary leak [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/62-66\">",
"     62-66",
"    </a>",
"    ]. Terbutaline increases cAMP by facilitating its production of cAMP, while theophylline blocks its degradation.",
"   </p>",
"   <p>",
"    The most compelling evidence for treatment with these agents was a retrospective series that evaluated the clinical course of eight patients with ISCLS who were followed for 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/35\">",
"     35",
"    </a>",
"    ]. All of the patients were treated with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    (dose not specified) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    (serum target level 10 to 20",
"    <span class=\"nowrap\">",
"     micrograms/L).",
"    </span>",
"    The patients had a median of six severe attacks per year prior to being diagnosed with ISCLS. In contrast, the median attack rate was reduced to 0.2 attacks per year after receiving the combination of terbutaline and theophylline.",
"   </p>",
"   <p>",
"    Many of the episodes that occurred while receiving therapy were mild enough that hospitalization was not required [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/35\">",
"     35",
"    </a>",
"    ]. The one patient who continued to have severe attacks, and eventually died of shock, never achieved a therapeutic level of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    . Breakthrough attacks seemed to correlate to subtherapeutic levels of theophylline in two other patients. Sustained release theophylline appeared to be the most effective formulation. Adverse effects from sympathomimetic stimulation were frequent with therapy, but improved with minor dose adjustments and time. A few patients received glucocorticoids intermittently.",
"   </p>",
"   <p>",
"    There are additional reports that support the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    to prevent ISCLS [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/3,16,17,44,47,67,68\">",
"     3,16,17,44,47,67,68",
"    </a>",
"    ]. According to one review, theophylline and terbutaline alone or in combination seemed to be effective in 17 out of 50 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"     16",
"    </a>",
"    ]. Dosing of terbutaline varied among the available reports, but a dose of 5 mg four times daily is at the lower end of the reported range [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/32\">",
"     32",
"    </a>",
"    ]. Some patients require higher serum levels of theophylline to avoid attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reports that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    prevent ISCLS have not been universal. In a series of 13 patients with ISCLS who were followed for a mean period of 6.4 years,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=see_link\">",
"     aminophylline",
"    </a>",
"    and terbutaline did not appear to be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/32\">",
"     32",
"    </a>",
"    ]. However, serum theophylline levels were not used to guide therapy and treatment was usually discontinued if patients had recurrent attacks, potentially accounting for some of the differences in outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H69665446\">",
"    <span class=\"h2\">",
"     Intravenous immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monthly infusions of intravenous immune globulin (IVIG) have been reported to reduce the frequency of attacks in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/4,59\">",
"     4,59",
"    </a>",
"    ], although not in others [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/17,69\">",
"     17,69",
"    </a>",
"    ]. In the series of 28 patients, 18 were treated with IVIG in doses ranging from 0.4 grams to 2 grams per month [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/4\">",
"     4",
"    </a>",
"    ]. Eight of the patients receiving IVIG had no new attacks over multiple years of follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Other treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other therapies that have been administered to patients with ISCLS with variable success include glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , leukotriene modifying agents,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and Ginkgo biloba [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8,16\">",
"     8,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monthly infusions of IVIG have been reported to reduce the frequency of attacks in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/59,70\">",
"     59,70",
"    </a>",
"    ], although not in others [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/17,69\">",
"     17,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fatality rate during acute attacks of ISCLS is not well defined. Early case reports often described fatalities, although better supportive care and more widespread recognition of the disorder have probably reduced mortality. Patients who die during attacks tend to die either of flash pulmonary edema during the recovery phase, or of ischemic organ failure due to hypoperfusion during the extravasation phase [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a review of 50 cases of ISCLS, 70 percent of the patients who survived initial attacks were alive a mean of five years after diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"     16",
"    </a>",
"    ]. The estimated five-year survival in the series of 25 patients mentioned previously was 76 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ]. In the series of 28 patients described above, five-year survival was 73 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/4\">",
"     4",
"    </a>",
"    ]. Some patients with monoclonal gammopathies will eventually develop multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8,32,36,50\">",
"     8,32,36,50",
"    </a>",
"    ]. However, in one group of 25 patients followed for variable numbers of years, none progressed [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/3\">",
"     3",
"    </a>",
"    ]. One group has suggested that the prognosis in children is better than that in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic systemic capillary leak syndrome (ISCLS) is a rare disorder that typically begins in midlife. It is characterized by episodes of severe hypotension, hypoalbuminemia, and hemoconcentration. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Episodes of ISCLS usually begin with prodromal symptoms, followed by hypotension and edema. The hypotension and edema are due to fluid extravasation, which typically worsens over one to four days and may be complicated by a compartment syndrome. The capillary leakage then abruptly reverses and the fluid moves back into the vasculature. During the recovery phase, the patient is at risk for volume overload and pulmonary edema. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic evaluation is the same as that for hypotension or shock of uncertain etiology. ISCLS is a diagnosis of exclusion that is made when a patient manifests intravascular hypovolemia, generalized edema, and the triad of hypotension, hemoconcentration, and hypoalbuminemia in the absence of an identifiable alternative cause. The diagnostic evaluation generally occurs concurrently with initial management. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial management of ISCLS is aimed at securing the airway and correcting hypoxemia. This may require intubation and mechanical ventilation. While the patient's respiratory status is being stabilized, the adequacy of perfusion should be assessed. Patients with hypoperfusion should have their tissue perfusion restored using a strategy similar to that used for septic shock. This begins with the infusion of intravenous fluids to a goal central venous oxygen saturation (ScvO2) &ge;70 percent within six hours. It is reasonable to simultaneously aim for a central venous pressure (CVP) 8 to 12 mmHg, mean arterial pressure (MAP) &ge;65 mmHg, and urine output &ge;0.5 mL per kg per hour. Intravenous vasopressors may be useful in patients who remain hypotensive despite adequate fluid resuscitation or who develop cardiogenic pulmonary edema. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"       \"Evaluation and management of severe sepsis and septic shock in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After initial resuscitation and stabilization, treatment should be redirected toward the prevention of intravascular volume overload and its complications (eg, pulmonary edema). Nearly all patients require diuretics. Patients with renal insufficiency may require ultrafiltration. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Ongoing management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For all patients who have had an ISCLS attack, we suggest combination therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"       theophylline",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"       terbutaline",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The purpose of such therapy is to prevent future attacks. A reasonable regimen is sustained release theophylline (dosed to achieve a serum concentration of 10 to 20",
"      <span class=\"nowrap\">",
"       mcg/mL)",
"      </span>",
"      and terbutaline (5 mg four times daily). Intravenous immune globulin is an alternative preventative therapy.",
"     </li>",
"     <li>",
"      Among patients who survive an initial attack, at least 70 percent are alive five years after diagnosis. Some patients with monoclonal gammopathies develop multiple myeloma over time. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21224979\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Joseph A. Carcillo, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/1\">",
"      CLARKSON B, THOMPSON D, HORWITH M, LUCKEY EH. Cyclical edema and shock due to increased capillary permeability. Am J Med 1960; 29:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/2\">",
"      Marks J, Shuster S. Disorders of capillary permeability. Br J Dermatol 1973; 88:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/3\">",
"      Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med 2010; 153:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/4\">",
"      Gousseff M, Arnaud L, Lambert M, et al. The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med 2011; 154:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/5\">",
"      Foeldvari I, Waida E, Junker AK. Systemic capillary leak syndrome in a child. J Pediatr 1995; 127:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/6\">",
"      Karatzios C, Gauvin F, Egerszegi EP, et al. Systemic capillary leak syndrome presenting as recurrent shock. Pediatr Crit Care Med 2006; 7:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/7\">",
"      Onal H, Aktuglu-Zeybek C, Altun G, et al. Capillary leak syndrome in a 5-month-old infant associated with intractable diarrhoea. Ann Trop Paediatr 2007; 27:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/8\">",
"      Kapoor P, Greipp PT, Schaefer EW, et al. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc 2010; 85:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/9\">",
"      Piastra M, Pietrini D, Conti G, et al. Sudden shock from capillary leak. Lancet 2012; 379:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/10\">",
"      Suchithra N, Pappachan JM, Sujathan P. Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes. Emerg Med J 2008; 25:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/11\">",
"      Nelson BK. Snake envenomation. Incidence, clinical presentation and management. Med Toxicol Adverse Drug Exp 1989; 4:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/12\">",
"      Erkurt MA, Sari I, G&uuml;l HC, et al. The first documented case of brucellosis manifested with pancytopenia and capillary leak syndrome. Intern Med 2008; 47:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/13\">",
"      Chang B, Crowley M, Campen M, Koster F. Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med 2007; 28:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/14\">",
"      Atkinson JP, Waldmann TA, Stein SF, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) 1977; 56:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/15\">",
"      Zhang W, Ewan PW, Lachmann PJ. The paraproteins in systemic capillary leak syndrome. Clin Exp Immunol 1993; 93:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/16\">",
"      Dhir V, Arya V, Malav IC, et al. Idiopathic systemic capillary leak syndrome (SCLS): case report and systematic review of cases reported in the last 16 years. Intern Med 2007; 46:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/17\">",
"      Dowden AM, Rullo OJ, Aziz N, et al. Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks. J Allergy Clin Immunol 2009; 124:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/18\">",
"      Treatment of systemic capillary leak syndrome. Lancet 1988; 2:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/19\">",
"      Dams K, Meersseman W, Verbeken E, Knockaert DC. A 59-year-old man with shock, polycythemia, and an underlying paraproteinemia. Chest 2007; 132:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/20\">",
"      Xie Z, Ghosh CC, Patel R, et al. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood 2012; 119:4321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/21\">",
"      Lesterhuis WJ, Rennings AJ, Leenders WP, et al. Vascular endothelial growth factor in systemic capillary leak syndrome. Am J Med 2009; 122:e5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/22\">",
"      Nagao Y, Harada H, Yamanaka H, Fukuda K. Possible mediators for systemic capillary leak syndrome. Am J Med 2011; 124:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/23\">",
"      Yabe H, Yabe M, Koike T, et al. Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab. Blood 2010; 115:2723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/24\">",
"      Johansson BR, L&ouml;fdahl CG. Ultrastructure of the microvessels in skeletal muscle in a case of systemic capillary leak syndrome. Acta Med Scand 1979; 206:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/25\">",
"      Assaly R, Olson D, Hammersley J, et al. Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome. Chest 2001; 120:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/26\">",
"      Schwartz RN, Stover L, Dutcher J. Managing toxicities of high-dose interleukin-2. Oncology (Williston Park) 2002; 16:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/27\">",
"      Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/28\">",
"      Cicardi M, Gardinali M, Bisiani G, et al. The systemic capillary leak syndrome: appearance of interleukin-2-receptor-positive cells during attacks. Ann Intern Med 1990; 113:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/29\">",
"      Rondeau E, Sraer J, Bens M, et al. Production of 5-lipoxygenase pathway metabolites by peripheral leucocytes in capillary leak syndrome (Clarkson disease). Eur J Clin Invest 1987; 17:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/30\">",
"      Vadlamani L, Iyengar S. Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy. Congest Heart Fail 2004; 10:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/31\">",
"      Lejeune FJ, Li&eacute;nard D, Matter M, R&uuml;egg C. Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun 2006; 6:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/32\">",
"      Amoura Z, Papo T, Ninet J, et al. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med 1997; 103:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/33\">",
"      Chihara R, Nakamoto H, Arima H, et al. Systemic capillary leak syndrome. Intern Med 2002; 41:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/34\">",
"      Barnadas MA, Cister&oacute; A, Sitjas D, et al. Systemic capillary leak syndrome. J Am Acad Dermatol 1995; 32:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/35\">",
"      Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 1999; 130:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/36\">",
"      Vigneau C, Haymann JP, Khoury N, et al. An unusual evolution of the systemic capillary leak syndrome. Nephrol Dial Transplant 2002; 17:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/37\">",
"      Bertorini TE, Gelfand MS, O'Brien TF. Encephalopathy due to capillary leak syndrome. South Med J 1997; 90:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/38\">",
"      Claessens YE, Joly LM, Cariou A, Oksenhendler E. Acute reversible cardiac involvement associated with systemic capillary leak syndrome. Intensive Care Med 1999; 25:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/39\">",
"      Lister G, Hellenbrand WE, Kleinman CS, Talner NS. Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982; 306:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/40\">",
"      Sanghavi R, Aneman A, Parr M, et al. Systemic capillary leak syndrome associated with compartment syndrome and rhabdomyolysis. Anaesth Intensive Care 2006; 34:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/41\">",
"      Matsumura M, Kakuchi Y, Hamano R, et al. Systemic capillary leak syndrome associated with compartment syndrome. Intern Med 2007; 46:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/42\">",
"      Dolberg-Stolik OC, Putterman C, Rubinow A, et al. Idiopathic capillary leak syndrome complicated by massive rhabdomyolysis. Chest 1993; 104:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/43\">",
"      Balcarek P, Frosch KH, Quintel M, St&uuml;rmer KM. [Systemic capillary leak syndrome causes a compartment syndrome of both lower legs and a forearm. A case report with a review of the literature]. Unfallchirurg 2005; 108:770, 772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/44\">",
"      Doubek M, Brychtova Y, Tomiska M, Mayer J. Idiopathic systemic capillary leak syndrome misdiagnosed and treated as polycythemia vera. Acta Haematol 2005; 113:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/45\">",
"      Navarro C, Garc&iacute;a-Bragado F, Lima J, Fern&aacute;ndez JM. Muscle biopsy findings in systemic capillary leak syndrome. Hum Pathol 1990; 21:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/46\">",
"      Prieto Valderrey F, Burillo Putze G, Martinez Azario J, Santana Ramos M. Systemic capillary leak syndrome associated with rhabdomyolysis and compartment syndrome. Am J Emerg Med 1999; 17:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/47\">",
"      Sabbadini DD, Peressutti R, Di Silvestre A, et al. Systemic capillary leak syndrome. Case report. Minerva Anestesiol 2002; 68:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/48\">",
"      Rauzy O, Adoue D, Arlet P. Chronic systemic capillary leak syndrome not requiring treatment? Am J Med 1998; 105:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/49\">",
"      Stirling CM, Boulton-Jones JM, Simpson K. Progressive oedema in a 30-year-old. Lancet 1998; 352:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/50\">",
"      Beermann W, H&ouml;rstrup KA, Will R. Systemic capillary leak syndrome. Am J Med 1998; 105:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/51\">",
"      Andrews MM, Parent EM, Barry M, Parsonnet J. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment. Clin Infect Dis 2001; 32:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/52\">",
"      Rechner I, Brito-Babapulle F, Fielden J. Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF). Hematol J 2003; 4:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/53\">",
"      Yamamoto K, Mizuno M, Tsuji T, Amano T. Capillary leak syndrome after interferon treatment for chronic hepatitis C. Arch Intern Med 2002; 162:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/54\">",
"      Dahan L, Ressiot E, Cournede A, et al. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer]. Gastroenterol Clin Biol 2007; 31:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/55\">",
"      Kaplan MJ, Ellis CN, Bata-Csorgo Z, et al. Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes. Arch Dermatol 1999; 135:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/56\">",
"      Estival JL, Dupin M, Kanitakis J, Combemale P. Capillary leak syndrome induced by acitretin. Br J Dermatol 2004; 150:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/57\">",
"      Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/58\">",
"      Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/59\">",
"      Lambert M, Launay D, Hachulla E, et al. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med 2008; 36:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/60\">",
"      Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/61\">",
"      Whitesides TE, Haney TC, Morimoto K, Harada H. Tissue pressure measurements as a determinant for the need of fasciotomy. Clin Orthop Relat Res 1975; :43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/62\">",
"      Casnocha SA, Eskin SG, Hall ER, McIntire LV. Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J Appl Physiol 1989; 67:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/63\">",
"      Rippe B, Grega GJ. Effects of isoprenaline and cooling on histamine induced changes of capillary permeability in the rat hindquarter vascular bed. Acta Physiol Scand 1978; 103:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/64\">",
"      Sigurdsson GH, Christenson JT. Influence of terbutaline on endotoxin-induced lung injury. Circ Shock 1988; 25:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/65\">",
"      Svensj&ouml; E, Adamski SW, Su K, Grega GJ. Quantitative physiological and morphological aspects of microvascular permeability changes induced by histamine and inhibited by terbutaline. Acta Physiol Scand 1982; 116:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/66\">",
"      Shimura H, Yamaguchi M, Kuzume M, et al. Prevention of reactive oxygen-induced endothelial cell injury by blocking its process. Eur Surg Res 1999; 31:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/67\">",
"      Hiraoka E, Matsushima Y, Inomoto-Naribayashi Y, et al. Systemic capillary leak syndrome associated with multiple myeloma of IgG kappa type. Intern Med 1995; 34:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/68\">",
"      Kawabe S, Saeki T, Yamazaki H, et al. Systemic capillary leak syndrome. Intern Med 2002; 41:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/69\">",
"      Hollenberg J, Frykman J, Lundberg LG, Forsberg S. A case report of systemic capillary leak syndrome (Clarkson's disease). Acta Anaesthesiol Scand 2010; 54:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/26/426/abstract/70\">",
"      Gousseff M, Amoura Z. [Idiopathic capillary leak syndrome]. Rev Med Interne 2009; 30:754.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3919 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.102.30.19-4C5AE98573-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_426=[""].join("\n");
var outline_f0_26_426=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hypotheses in ISCLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prodromal symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Extravasation phase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Recovery (recruitment) phase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Chronic forms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20828386\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Assess perfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Restore perfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Additional considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Acute pharmacologic treatments and novel therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Detection of compartment syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Reassess perfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ongoing management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PREVENTION OF FUTURE EPISODES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Terbutaline and theophylline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H69665446\">",
"      Intravenous immune globulin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Other treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21224979\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=related_link\">",
"      Acute compartment syndrome of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=related_link\">",
"      Advanced emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=related_link\">",
"      Arterial catheterization techniques for invasive monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40138?source=related_link\">",
"      Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=related_link\">",
"      Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=related_link\">",
"      Clinical presentation and diagnosis of dengue virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38888?source=related_link\">",
"      Differential diagnosis of anaphylaxis in children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37384?source=related_link\">",
"      Differentiation (retinoic acid) syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=related_link\">",
"      Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19272?source=related_link\">",
"      Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33864?source=related_link\">",
"      Hereditary angioedema: Pathogenesis and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/56/19337?source=related_link\">",
"      Hypoxic-ischemic brain injury: Evaluation and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=related_link\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7625?source=related_link\">",
"      Interleukin-2 and other immunotherapies for advanced melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29960?source=related_link\">",
"      Investigational and ineffective therapies for sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18568?source=related_link\">",
"      Ischemic hepatitis, hepatic infarction, and ischemic cholangiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=related_link\">",
"      Laboratory tests to support the clinical diagnosis of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/34/36393?source=related_link\">",
"      Pathophysiology and etiology of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=related_link\">",
"      Pathophysiology of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=related_link\">",
"      Pathophysiology of sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31431?source=related_link\">",
"      Principles of snake bite management worldwide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=related_link\">",
"      Sedation or induction agents for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=related_link\">",
"      Shock in adults: Types, presentation, and diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=related_link\">",
"      The decision to intubate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=related_link\">",
"      Use of vasopressors and inotropes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_26_427="Risk of nausea and vomiting with emergency contraception";
var content_f0_26_427=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk of nausea and vomiting with emergency contraception",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percentage of women who experience nausea",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percentage of women who experience vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estradiol + levonorgestrel",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Levonorgestrel (alone)",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_427=[""].join("\n");
var outline_f0_26_427=null;
var title_f0_26_428="Causes of microcytic anemia";
var content_f0_26_428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of microcytic anemia (mean corpuscular volume less than 80 fL)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hereditary disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Defects of globin synthesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <span style=\"color: #ff0000;\">",
"         Thalassemia syndromes",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thalassemic hemoglobinopathies (eg, Hb E, Hb Lepore)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Defects of iron metabolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Iron refractory iron deficiency anemia (IRIDA)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        DMT1 mutations*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Atransferrinemia*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sideroblastic anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acquired disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         Iron deficiency anemia",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Myelodysplastic syndromes (MDS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Refractory anemias with ringed sideroblasts (RARS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        MDS with acquired thalassemia*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sideroblastic anemias due to drugs or toxins (lead poisoning, alcohol, drugs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Copper deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zinc deficiency",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The two most common causes of microcytosis are shown in",
"    <span style=\"color: #ff0000;\">",
"     red",
"    </span>",
"    type.",
"    <div class=\"footnotes\">",
"     DMT: divalent metal transporter.",
"     <br>",
"      * Very rare causes of microcytosis.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_428=[""].join("\n");
var outline_f0_26_428=null;
var title_f0_26_429="Diagnostic criteria for Carney complex";
var content_f0_26_429=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F83442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F83442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for Carney complex (CNC)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major diagnostic criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spotty skin pigmentation with typical distribution (lips, conjunctiva and inner or outer canthi, vaginal and penile mucosa)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myxoma* (cutaneous and mucosal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiac myxoma*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breast myxomatosis* or fat-supressed magnetic resonance imaging findings suggestive of this diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PPNAD* or paroxical positive response of urninary glucocorticoid excretion to dexamethasone administration during Liddle's test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acromegaly due to GH-producing adenoma*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LCCSCT* or characteristic calcification on testicular ultrasound",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyroid carcinoma* or multiple, hypoechoic nodules on thyroid ultrasound in a young patient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psammomatous melanotic schwannomas*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blue nevus, ephithelioid blue nevus*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breast ductal adenoma*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteochondromyxoma*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Supplemental criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Affected first-degree relative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inactivating mutation of the",
"        <em>",
"         PRKAR1A",
"        </em>",
"        gene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Findings suggestive of or possibly associated with CNC, but not diagnostic for the disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intense freckling (without darkly pigmented spots or typical distribution)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blue nevus, common type (if multiple)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Caf&eacute;-au-lait spots or other \"birthmarks\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated IGF-I levels, abnormal GTT, or paradoxical GH response to TRH testing in the absence of clinical acromegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomyopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pilonidal sinus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of Cushing's syndrome, acromegaly, or sudden death in extended family",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple skin tags or other skin lesions; lipomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colonic polyps (usually in association with acromegaly)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperprolactinemia (usually mild and almost always combined with clinical or subclinical acromegaly)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Single, benign thyroid nodule in a young patient; multiple thyroid nodules in an older patient (detected on ultrasound)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history of carcinoma, in particular of the thyroid, colon, pancreas, and ovary; other multiple benign or malignant tumors.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNC: Carney complex; PPNAD: primary pigmented nodular adrenocortical disease; LCCSCT: large-cell calcifying Sertoli cell tumor;",
"     <em>",
"      PRKAR1A",
"     </em>",
"     : protein kinase A regulatory subunit 1&alpha;.",
"     <br/>",
"     * After histological confirmation.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Almeida MQ, Stratakis CA. Carney complex and other conditions associated with micronodular adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab 2010; 24:907. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_429=[""].join("\n");
var outline_f0_26_429=null;
var title_f0_26_430="Patient info search strategies";
var content_f0_26_430=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Three strategies for finding trustworthy information on the web (with examples)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 314px; background-image: url(data:image/gif;base64,R0lGODlh/AE6AcQAAP///wAAAIiIiERERBERESIiIru7u+7u7t3d3VVVVczMzDMzM2ZmZpmZmXd3d6qqqp+fn9/f3+/v7w8PD19fX6+vrx8fH09PT8/Pzz8/P39/f7+/v29vby8vLwAAAAAAACH5BAAAAAAALAAAAAD8AToBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhEgBh4iJiouMjY6PkJGSk5SVlpeYmY2FnHcBnaApn6GkbqOlpaeoq2aqrJyur7JesbOBtba5Vri6fLy9wE6/QgoBCy8EAQfBQMPMz0aqD4sKMgkBDyvFxy7JyyUHAQTQNM7k5z+x4eM019kq28jK6Drm9Pc46uIjCwHu+wL8AWiQTFzAQ8cOBhAAQEEBccZIFEPE8MAAcd6SIQBAoADHcQQPjVPQL8CAjf3c/5Gzh6/lDH3sAJTEBtDfuo0iVAZ0AOAhgocK4pkoNu4aQ28OFjZY+PHmiAIEDhiIOPPdM5Yus7qAyS9AtXUAAiYAwADRWJXXEk0bGXEEgrSHDvSr5q1YgQFRP5I1Gy+csrnosGodLMoEWBGA1x0QO+KAxmsNwgZgQIJA1KnccjL1djGbNwAXBeoV4TjAz8tUvQYmzLoGV8SqASQ16W+iwYbJEiZSMM1YWxEKcnv7aexz72ofbRNgSPLQSZmxV7aeHkMw9S7Wrw/Orj0L9+4tv4OvIn78avNnyqOHpn69MPfj28NfIn9+rvr2j+DP/2o//yH+/ZeKgLQQyFqABvaAYP+ChSzIYA4OPnhLCQMwBAACppnwUCIWPmUWTiVMJeEKEY7ohysVioAhiCHiUkBkCAxQwDckiGgiCiXeuAeKFq6IWQAFIGfjQQtU8+IIBDyAIUIHbOhRWgvQKGGO9Ghi5ZVYWlIOhT2aNlU1CYwFgIjFVMPAAD1FJkKKKmIzZJQydTjljVSOwR2PwCkzpEdjftIAnwZ4dKQISSoQWgAN2FgWIpSZWOc5j4ZxZwkOFLARAx7ZuECjZKqWAJpHxugRA8eEk+g8AsA5wqdzggdBBDJECsakJFiEUDVTIYTTkLf2ZNYyBiTzUANyAQkAXJERYECr3UEQwAUbwCDrF7SqYGP/EQ+gyax2EkxwiAUQSNDCtAW+xMK1OgJoHgeJTEABrCqUuChy1G6ZrhTkEhIBIxlUUFgJixbggJQvgDXVWNOIOYRxolVn771Q5EvIBY1YoIG4JbiSFEMx0kvDNDwh8ZkN1dLA5rjLvnByC+ji0HIOKwMQQMo6xCyExINUAAkFGJDgyjUDDCxCUiXxdEBaBWRjKCKOEWBbkQL9iVCthyqzMUdeHX1I0gMVRABcDhQzVkgCrXOR0xk/vGaGoLGNQoozsxD3CM0ZoyYJNlvriiLSGvByjWyf2QLcKc891KEMECyC4aDJqS6OWUYu+eSUT9IBBIuX4BAiCyBwdT8GuIOh/6BoEzrOTg3VZoziRmF9wNXJKCA6kE4ROo/Y8ewEFmM+q902T0uyaELeONIsU8gCNIq34yu0jGgNf48wFU6Cs0D44sY39rUIBnQ+OPNB8FL5+OSXj+XlmRvmwEUCXO1OQYgIZbpkPImNugmAIbWZV/DHtahAn7FfAHgyjSjtI2FpMxfe8PK6i2wESsuAC0PilpZxOKkajFuAtkagEEOVhDIIKNqFROi8u/0vMjJyzkMIsJGZiagAFUmS9AKHpkAdIjInbNz/MFSSu4WFTySo3pEoSBHJACkoJVEYhNCjs0fwrHckSICFytKAjTXJK5AhAVToZRn6pS4B21BcZ1yXFP+exC6L4NCIRr6YuwGCBYFQjBWFzkSQpSAgVctYgAAEYKnGycwAfBReT3jCOAUsagBBMdwAamiaMOEmdGMJjt/2VkQRkAo0aFrKsmD4RxH9aSBA7FMi0ESAyDwgJmQ5xvVkxhA+BlFbiECAECMzs0A2LjjVcIAUM8MDnAmCYoywGMbiKAIBVJAhSSlIZLQmkoYcqmleFBsop+aWh+BFGcS5pgKYKQ7ltPIQYYtaQSjzxoalT454Y8BSEjC9/02GAY0iHDwb8z/KMC6IC/jkCFK0okEN4E9q+mcJOVgQj6TIRoQTkWO658PpWfIkirhjQf04t7jps5hAXNEs/zjPxi3/BRGWukY+e2mefS2iX/9SwdVENo8mlAw0lFHW9PDIwRk1aYKA7ONA5rGpP5JgpGRBpCI51shIzsyRxZhkxtSEoWxUyo8IxembUNkn6pHybk2VjUEn+A6LhhIBBBjAMopxx0yV8o98PMBNcWkCV+7Al4BgFyLcBa+UpmClRxgZE146AOU5FFnF6ghO2yaOEG7NnsabjTE20kF+msawAxwhOPu01H1ubauUpahSARAOxzk0qGNyEmELgNlFYWhZFwUO4g5AnAWcdWaB5aRCGKAQH+ZjPN36VrjGFYqXhiJYipuQq54VrRfAFQu+BcUCQgaL8bwKnZ1ILsSUcNxZVHcX/76bLn3o1NvsKuEBQZJB9E5AvIxl7w2peiudzMfe9vpWIQnYSDiAeCiG9LVNgDwEZciGyBJwbSqcmozewrLBFKxsRfscLA+mobwaCKDACV4T+Mg7YehqFxgaC2+MlpUqZa2JMl+674Xi9mDOYoOzCfBhA7iRq2WUpcEmGO/w5IRg8/ZgkXn5QXlTAN56XJgZrpChf5MXz0aVUsSnJbCJJ8yAkE2lQo7pqQ2fN+VPlHjKyUMECmnsNrj1sHEyymGFZMRJx1hlxA6JTN0SYKt9BEsckcFyiU/4UUSliEgY/LKJPeaaHwdjb8KbilTycl87Vo3E2mpAaBKHNzVN5U/Ju//vWU/JEYaIqMTLMcElD9zlCbZyHAPw3gg27b1PpjYsCUFTernX0kp3zTEdKvGoVWmhCpUJtExxa0/Oq0A/6yLItnUnCrUMU/wquVbLbTSriWMoBiwplhm6NERBJICJchpE15sem6q9NT9yVllA9VAs32I32RikxqZxW4m5bSw2VUifgfLpRQvAawv72rqUoveFBnDKd6RXxB829pX7Kxc5NXnZJZa0DzMdECVnesROxaxbOu3Tpzo24t5GNVUFvSbm6pqsDI/KwwmcVYuHzNaeQpNXSRMdkt3715pmFEEm3ux04vcgzoaLEgfC4i6DWLQf7YeS37yQ0JA24yNGxCL/J7i1Zbn7shnvLMAURpDa5krAbz4r0feIJqN75KOK/qYxMIhaPvV4iS+3hS+5dgbgfmHH0kq72qEAXj6LIdleWDXa5d4fvkfD730H/OMEPyDCh8/whR91Ik6F+F43vrlBbLCMH3+C61J+Cq7oqAicBNmdX34Elv98xAC2eBuxSvQ4Qv0gMi/5UQxK9QmE/R9YD7gIQlj2oZc9dUmv5WJZKom6l1nwTzR8xxcfD7kfUfKPP3jm89b5yIf+VqTvCerLzfp1WP6DtI99H3c/9d+Pg3vHT/7ym/9K4U+/+tfP/va7//3wj7/850//+tv//vjPv/73z//++///ABiAAjiA/wRYgAZ4gAiYgAq4gAzYgA74gBAYgRI4gRRYgRZ4gRiYgRq4gRz4Vuf3gSAYgh/YgSTlftznfydoICnIfysoIC2ofy/IHzGIfzNoHzVof+QiP/dyg/UnDdRgDScGD79xAgikEvnBg/T3GjNghCmggyrAhPOBhPOnhClBE6cjTiKhELpxCMyxQkPYZgshQFOjEBXWGlIof1SICGshGWxWWKtyYqjjE0Chg0mhPNKkE5HlE+ZxhvGXhl9RE2PxP2dxYnBxCGuog5vTTXdIiIpwZtrBh/DnhyYWFbzzbY30PAHRYJYhFUM4AnW4iJGRifABie8nieZGG2CECJkWHBGhEP9e0Rv9wEtwcRLSxIpbeAh2Rx2kaIKlSILqxYu+uHfst4vtR4zXYYzrh4zToYzpx4wHEozCmIzQeFvAOI19Vo3WaHzq54zft3yyRiDc2H0owjYO9GzGsiH+sBE1JjOHcEeiwUnoaBr1dWzgmI3XaFnA047rmCb7NiP7SGKWERnw6EP39SXf6IL26Ds41kCP5Tb8SChK4pAkBkNRMZA2xxENUGKctCJkU4bP6CgiGJKSoJB0VEoNCVIP2Tj/yGEzQgCYwhDxGCP7ZRoaSVQxwlzoEY5voJPe9Xz7pE7+MD37+HpJspI/ZEQwSZDEVpMjhgDdYxK5qIvcBQp8FVOThAD/QwkjMtKUPsOSm8cUr1dsHNR1lBEQIJIAMPaIzlVXxtVdxgdwQpkIgvIrSeccseRWSwGTiSCTJHBlCCGPWxOVy+hcxBV3VNmT3Yhb3hIA4DJM8eKW9raN69Iu70IiRDAvkoKY4lhS/OIv4BdEWyM0MmAwAgFHCzMPpmmYkdmM6AFMiyBMJqAxTNExNwAySaBXmvmYN9AyB2lEKLMt3dFEjvBEoFcCQCOaRDNZzMQ1SxMXlvE00iQ1X1g1r7M/24Q02UA2X4MI4TQ2BTEWZtNNsecwF5lkzWNl2nKQ4eB0HnlPKnAQIzeYkCOS9FmfAYA+wicR6Ng5n3NU2DA6PVE6/3qBOrizOibQOvpzFFj0n7TjhrYzVqqjGwMDiOOpmgE3YvUGOMd2kMVgXBlKKWK1bzj5kZVnnyYqgvhZCwzZPkzxPoqgg11EoP5wPyWQP1Zjnf2jDILoOl+EOgVUTjtXlcYGQc8WJdPDKHz0EFGyIWcyQV8GWUS0Og9mlqQBUbgYovI5HsLZCMR5TjkxRYhiRUCBRpsnoDEaWQWqKnhzYvpjRgtqW5YIVhmSpvQDpBXalmuaCIAEJ3o0cQ8gbRiFAI7BeBTVSk8CS3uaR3ukb9IjAEtyEo4qlebhmooAmxVqTFlobsqEYqroTExzpvUTNRvCS9k0HNYUO9zkNKoodv/d2TX6NYkAkJr5aW9INjPuxADNiSiAemwvElXyJihqYquJQFsQZhE/4RAWEVxZwZNaYFKKgFKfeVdMwVLK+ndv2SinRVOWVCq6amXcIGu9OgrX80lIVUtq2puy8RzdM6KEwaxZIFeHQFeWuQJ4ZQS4uXvXOqRa9mbDQibJQKybR6jj6hGbAzrHomXoakTxaYaKqVuOaVcNkpvW565X4CzQYqERq42s6SpsOX2HqbHhR7FqILJ4upohO5XRJbFo4J4vMHlvsDLjRbIre6InqpCzGTdPOXae+DxHuXkVhos7JQOnJF+cJAr1xm5sdgK7CgMMFgRw91nVswLZJj4J+Zb/PnFaYBVPM/Jti4RRT/GzR7cUSzgWDsBLlcdr0wAjC+B5mTUDCwkET0tD3+NTMVu1tHomELWnlZGdLJQhusZJU5E9C7EcYgtZlNGnq4KTjpEU1RAaYhW4iAJbaxtFzFUMi0FaqwOoofaqhlsCGJJmmlETuDhlkaFYCtCRI1BnGdkrM2RVoXVDewG7FXJCviGgXmq3PvlhUxEQBhC1/Bg0fuSKTBG4SxUQDYeWF+I0ulRstrtThqpWerS7i/MAiPu1E1dWglpKmstIbwFCtpte66ZTSYUkpjQOQQga7OpHt+a7V+ccGBmrqLRpg0W8AHe7uDuvP3mw5rq35ugRf/uz/8SyIb6iZaeUkQtAabG5LB2VPNciDmZ7LJWrDODKeAlnk/HoQzGpeRdljjT5EInzlP0VYfAWSlBrpXdpbfM7Cppnv/cLsfe1JAaAIVq7GNxgZv/bJ4IbGR91LDBmGRLFthOpVjDUwCsGYUuhtmMxwZprk8gbYy0VNLaUOjRzViZAxTyMN6EKJgVWwu/bJhgHN9mgKDAms8WHIo1SFsuSs0XSEx3CAFIERIB7Tzz7EJLVjseCJqZytmtjEpwIegYgF2oaFt+5DEqMnn60IlAKIm6cuqDWTB00ZS3JJEbnMWCHZ4DjupA8WqV1Qyo8xi3sscX4ybkrjaKMv8NYyqZMyv+oHK2qvMqxyXs35LKoR8bDR3szJH20HHy2/JVA0nm67MqsLGymd3uwl8u6t8uZFZbHDMyVBzCtZ3vHZ8y4B8uI4nu+vMzMfKcbm83FiY3cLM1/xs3E1Mrf3IvizMIne86zesrqTLPu/M41q87yPM/0XM/2fM/4nM/6vM/83M/+/M8AHdACPdAEXdAGfdAIndAKvdAM3dAO/dAQHdESPdEUXdEWfdEY3R3wXJ90sNH0OQceLZIq6wsdDZlwAM7NDLLCJQco/cosbdIYSwgv+FzkmbJeQNMxvXojvSNgYLHFBcqQ1wU+ndOCIF0r3QW5xZi7dX0fi9SL2ZijLNM7XQP/mDkrYQCvASCvuvld5oRdX4DVWg2xVgCF+pFdASOaMUCaCNPVQMAwbMvUX+CsiQCtKb0CMeIcHukCsnoDhxGNWyDXiEDXLh0DM3EIb/2ekbUCZF2jXkGj1GhvV0ObNmCb1HoDM0ipiWCp44wCgJEtObDXVBCDmI0Imt3NM1CvMODYKLDYJ6DaLmd8x/kNyRlZy6k0z/ScnBOdo0o1iVCdCnqdW8O3IgE20fmdk3g2fDaDW8oIXbrOKfCvHVLbWGPYsWoMC3CLDlBAsSglzXkS2m2g8BlZXVSFTCHdcO0Fy70Izf0dK5UUCUAADgA7WVNfvd3dlyIS5+uq+3ANtqEM/9J52KlcssCxn57DFKAzO6TDRVcYqqkYyJqhoL6NNbLDoDPioDxKp7pDoZsNeiH9CCnaAnVmEgcbkaH0EAbQG8ZQidPQddNapgewFAyw4m0jAHbhRePtQvtN4VHN4R3OCB9OA+3NnfKtAHXIQYkNFS8+GYzBhLVzsAogo8dARSod4Jy1PgvhPtiQozC64D2a2IxNFzf62zl6ADsaQDMaWT96QF0tPj3eCD/eAkRu4mOuWNgAR0yIQHjV38aA5wvBGKhz49u0D2N+3hnT5ovw5jIQ5BYy5InoNDKaCMvVovm9o/yNOsKbvoQu4McCplW0EFc04RhsplyepmLEpjfqpv+gbhhqNKcRWqdqHqRikN6KsN4sYBFq0g/kdjcBgSbuAEcqLhD1ChUgwucCgBk2Pg5zARZkuuNaIOuJQOtAPq1Bjuo7S1sCFqDUFlljlEaX+OQC5oQmS+iYehvJBLup6qnOOeqiSk0qcqrY5O7ALRLeZEStSjbk9OravAWj/S0XM9gqFRoHzKkiEVj98ACmqRDZDewtju7+QOyn2A9mhOxZsw/nnun6XjH9nu8toOjtbhJnpHSCWhIHkKtjcTYFTzer6uTF4t/omNd1XdPS6vI8cK9JEIOAfQiCrfFvx7Ml6AU3HwA5v+FFLbGoTQQ0bwhXTZkd6+9hMBOYbtlgANb/lbnVQQ3zGesFSQ3VFj/0WP/US03lXB/ugDDThanpUn3TZQ/UV2/1Z3/TS7/1R70FOG32Oj3ls1fSTX3SME33YS9+e98GLa3z8WLo59fRhG9+IH345ZfRjD8LP934frYvbw/596IBAaABlO9n3jIBmX9hznIImNP5EJMBgS3694IBitAzpn8jFDDrq28iEgD0zgIBpP+wr08gEaD6o4ABk3/79ej76RL4wG/Vw4+yxQ+cx58gwp/8W7D8zO8dz7990c8gzj/95GH9BoL52L/93N/93k+AIvj9f18E1f/95FL+3n/+4p/3SL/+Vd/+7t/2CvKh6N/9sZCrjBYr9B///2sPAsBBJABgLIi5sm0bGC4byLV947m+873/A4PCIbFoPCKTyuWPxhIUXIhFIOAwDaqDAyBRDQgAsG51wV05meo1u+1+w+PyOX2YNjEGpi8iUVIQGEAdHCwICBCoDITBCJgBGM7UTVJWWl5iZmrG3QFArSAEIBQ0YDUwMJgIoKYCLIoZMHwFtO5t3uLm6u7y9ja1IBBsASiI+hE3FhAWHCofMMM6nr34VltfY2drC3USZ1UxHExVXblqEVIFQI95VZWibcfLz9PXU3YPPb/j4Nv7/wMMKNCWkS96dPQbqHAhw4aYEraB6HAixYoW7UySeHEjx44XNbZ4VQSkx5ImT//S67Sg3KCQYUaijClzZrxOxRQEe+BCJBGSNH8CDQqnm6Njsty5Stfq2zCm01z4FCp1KlVuMgoQeMpggSs9BkQNKtQM3UsZUauiTatWkgsBBxFVifIqFAJUqljdtXF2Ld++QPG5BRBKpwO5YeiGZZa4LFS/jh+nBXzwWwHDgkWZC9D0nF7Inj//3HtENOjSpv2Rhnl6NeuGqXu2ji3732uMs2/jzlbbau7evnV1+volzNclu38jT656xVcViNYcVy59+o7gmB2UKA6lQIBH7cD4iE59PHm2zGeF014AwYgGiBQxRlh+Pn3e51U8c6D9ICm7ruLnIF59A/pmHX7M7Gd6AimLhUeggw82xoJwVSRwQIIAkFJIXADyA6GHD+6mT4Mfkkjfawb9UqKK4wnYQ4srwqjWi9XFWONvM8pno4634Rjgjj/G1mOHQBJp2ixHIpmkkksmWaSTT0IZpZRTUlmllVdimaWWW3LZpZdfghmmmGOSWaaZZ6IJZQgAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_430=[""].join("\n");
var outline_f0_26_430=null;
var title_f0_26_431="AU fibrin glue";
var content_f0_26_431=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F54580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F54580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Injection of fibrin glue into the anal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 166px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A catheter is inserted through the external opening and is gently advanced into the internal opening. A seal of fibrin is injected as the catheter is withdrawn.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bradley J Champagne, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_26_431=[""].join("\n");
var outline_f0_26_431=null;
